{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T03:25:26.843809",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "d2977369-1b26-4146-9149-6e78c14418d6",
    "instanceType": "Study",
    "versions": [
      {
        "id": "e9738705-2801-49a8-8b90-322e05066f08",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "0f162749-f347-44c6-b622-a0c982e7e66c",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "95b49be6-2912-4955-bb6e-e45b88d7d92b",
              "standardCode": {
                "id": "400acb8c-776f-4817-8ae4-f0bb51f42c8b",
                "code": "Open Label",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Open Label",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Non-Randomized"
            },
            "arms": [
              {
                "id": "4b6b71b3-b03f-4c30-8bd2-7e6a9f945096",
                "name": "BIVV009 Treatment Arm",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "All participants receive BIVV009 IV infusion. Dosing is based on body weight: 6.5g for <75kg or 7.5g for ≥75kg. Dosing schedule: Day 0, Day 7, and then every 14 days thereafter.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "2f789b5e-b5e5-4e38-b656-fb7d1ec9f0ee",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "a6666c89-4647-4c0d-b78b-52cd3f6acdd5",
                "name": "Primary CAgD with recent transfusion",
                "instanceType": "StudyCohort",
                "characteristic": "Patients with primary cold agglutinin disease who have a history of at least one documented blood transfusion within 6 months of enrollment."
              }
            ],
            "studyCells": [
              {
                "id": "e9d4822d-f0e2-4ac5-9cab-c3a459f69311",
                "armId": "4b6b71b3-b03f-4c30-8bd2-7e6a9f945096",
                "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c",
                "elementIds": [
                  "de4ee070-c2a3-4cb0-849c-b239842cba20"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "c46939e6-d648-4991-9521-2298c1446117",
                "armId": "4b6b71b3-b03f-4c30-8bd2-7e6a9f945096",
                "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871",
                "elementIds": [
                  "b450f2b4-a5ce-411a-801d-d2f5f8b7ae11"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "6ad123c3-4ff6-4020-a38d-f2667a0e7147",
                "armId": "4b6b71b3-b03f-4c30-8bd2-7e6a9f945096",
                "epochId": "c5ff935e-8199-4996-b53f-2544932963a2",
                "elementIds": [
                  "26bd18dc-f5b6-413b-9745-d2c44437fe8b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "c1bc80ac-d46f-4537-8a10-8433ac7612be",
                "armId": "4b6b71b3-b03f-4c30-8bd2-7e6a9f945096",
                "epochId": "87770647-e529-487f-b35b-9ab91837bd8f",
                "elementIds": [
                  "1513801e-0d01-4f98-9b97-a98dbafc6811"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "de4ee070-c2a3-4cb0-849c-b239842cba20",
                "name": "BIVV009 Treatment Arm - Screening/Observation Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for BIVV009 Treatment Arm during Screening/Observation Period"
              },
              {
                "id": "b450f2b4-a5ce-411a-801d-d2f5f8b7ae11",
                "name": "BIVV009 Treatment Arm - Part A Treatment Phase",
                "instanceType": "StudyElement",
                "description": "Treatment period for BIVV009 Treatment Arm during Part A Treatment Phase"
              },
              {
                "id": "26bd18dc-f5b6-413b-9745-d2c44437fe8b",
                "name": "BIVV009 Treatment Arm - Part B Extension Phase",
                "instanceType": "StudyElement",
                "description": "Treatment period for BIVV009 Treatment Arm during Part B Extension Phase"
              },
              {
                "id": "1513801e-0d01-4f98-9b97-a98dbafc6811",
                "name": "BIVV009 Treatment Arm - Safety Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for BIVV009 Treatment Arm during Safety Follow-up"
              }
            ],
            "maskingRoles": [
              {
                "id": "a0e24e65-7874-435f-9651-282689e3cd41",
                "text": "This is an Open Label study with no masking",
                "isMasked": false,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "eb706230-cab1-40b0-870b-6ad4c41bc00d",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "82cc2eb0-d395-4f84-b032-325f9ed971da",
                "instanceType": "EligibilityCriterion",
                "name": "Age requirement",
                "nextId": "e0220fde-8c9f-48ca-b6dd-fef4a4d398b2"
              },
              {
                "id": "e0220fde-8c9f-48ca-b6dd-fef4a4d398b2",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "94ba7a2e-447f-4755-bedb-11c01dbda633",
                "instanceType": "EligibilityCriterion",
                "name": "Body weight",
                "previousId": "eb706230-cab1-40b0-870b-6ad4c41bc00d",
                "nextId": "583c373d-d455-4c2a-a78c-bc1dfbe51d7e"
              },
              {
                "id": "583c373d-d455-4c2a-a78c-bc1dfbe51d7e",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "90aba16c-926c-4e61-9e17-682b67d825fb",
                "instanceType": "EligibilityCriterion",
                "name": "Confirmed diagnosis of primary CAgD",
                "previousId": "e0220fde-8c9f-48ca-b6dd-fef4a4d398b2",
                "nextId": "d802c3f5-7448-4270-b9e0-09f292b821f7"
              },
              {
                "id": "d802c3f5-7448-4270-b9e0-09f292b821f7",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "144cc2e9-5295-4764-bda4-4759bd4dc43b",
                "instanceType": "EligibilityCriterion",
                "name": "Transfusion history",
                "previousId": "583c373d-d455-4c2a-a78c-bc1dfbe51d7e",
                "nextId": "fad6c21f-595c-42a2-8451-3f6a394df151"
              },
              {
                "id": "fad6c21f-595c-42a2-8451-3f6a394df151",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b15339d2-fa4f-4fad-be2f-91a218a12741",
                "instanceType": "EligibilityCriterion",
                "name": "Hemoglobin level",
                "previousId": "d802c3f5-7448-4270-b9e0-09f292b821f7",
                "nextId": "209703a1-f093-4df7-a304-ba9b5a6fc465"
              },
              {
                "id": "209703a1-f093-4df7-a304-ba9b5a6fc465",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "ac0da57c-de2f-41d6-a486-10ee3e7b5545",
                "instanceType": "EligibilityCriterion",
                "name": "Bilirubin level",
                "previousId": "fad6c21f-595c-42a2-8451-3f6a394df151",
                "nextId": "55c508d0-2cab-4b9f-87e6-be406b63631a"
              },
              {
                "id": "55c508d0-2cab-4b9f-87e6-be406b63631a",
                "identifier": "7",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8c56df00-dada-4414-8dfb-ff3b68424060",
                "instanceType": "EligibilityCriterion",
                "name": "Ferritin levels",
                "previousId": "209703a1-f093-4df7-a304-ba9b5a6fc465",
                "nextId": "94461b73-26ce-4266-8e3a-3d9a263f6e4f"
              },
              {
                "id": "94461b73-26ce-4266-8e3a-3d9a263f6e4f",
                "identifier": "8",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "adcc847f-22b8-4740-b99f-e4ada8bc262a",
                "instanceType": "EligibilityCriterion",
                "name": "CAgD-related signs or symptoms",
                "previousId": "55c508d0-2cab-4b9f-87e6-be406b63631a",
                "nextId": "0c06e971-589f-448f-8868-48695d87f237"
              },
              {
                "id": "0c06e971-589f-448f-8868-48695d87f237",
                "identifier": "9",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "f876bebe-8afb-4c9c-89b1-6692a0f7c2b5",
                "instanceType": "EligibilityCriterion",
                "name": "Bone marrow biopsy",
                "previousId": "94461b73-26ce-4266-8e3a-3d9a263f6e4f",
                "nextId": "3c8dfff8-4cf8-4f49-93a1-262bc6f0863b"
              },
              {
                "id": "3c8dfff8-4cf8-4f49-93a1-262bc6f0863b",
                "identifier": "10",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "31db3567-7c90-4a19-bf8d-3d002a6a7760",
                "instanceType": "EligibilityCriterion",
                "name": "Vaccinations",
                "previousId": "0c06e971-589f-448f-8868-48695d87f237",
                "nextId": "8ba5ac43-3cf9-483c-8a5b-c94f99b9cf47"
              },
              {
                "id": "8ba5ac43-3cf9-483c-8a5b-c94f99b9cf47",
                "identifier": "11",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "3b35cb5d-c505-468b-8f87-a9e3b1c60551",
                "instanceType": "EligibilityCriterion",
                "name": "IV access",
                "previousId": "3c8dfff8-4cf8-4f49-93a1-262bc6f0863b",
                "nextId": "5aee8f94-3660-454a-a26a-ed2e3a6dabc3"
              },
              {
                "id": "5aee8f94-3660-454a-a26a-ed2e3a6dabc3",
                "identifier": "12",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c05fed08-c30d-4c79-a055-04c2951ce82c",
                "instanceType": "EligibilityCriterion",
                "name": "Female contraception",
                "previousId": "8ba5ac43-3cf9-483c-8a5b-c94f99b9cf47",
                "nextId": "2cf0aaf9-7237-4b8e-a372-a71ac97f7f23"
              },
              {
                "id": "2cf0aaf9-7237-4b8e-a372-a71ac97f7f23",
                "identifier": "13",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "bc340ce9-f8f3-4db9-a7e1-6fbef9789b9c",
                "instanceType": "EligibilityCriterion",
                "name": "Male contraception",
                "previousId": "5aee8f94-3660-454a-a26a-ed2e3a6dabc3",
                "nextId": "1b446881-6bdd-410b-83a3-2357b84a42a9"
              },
              {
                "id": "1b446881-6bdd-410b-83a3-2357b84a42a9",
                "identifier": "14",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b18ec504-08cd-4613-a13e-61584ca8b39b",
                "instanceType": "EligibilityCriterion",
                "name": "Informed consent",
                "previousId": "2cf0aaf9-7237-4b8e-a372-a71ac97f7f23",
                "nextId": "e7bd24ca-a6f5-4970-9b47-2e143d63ec36"
              },
              {
                "id": "e7bd24ca-a6f5-4970-9b47-2e143d63ec36",
                "identifier": "15",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "88e4619e-5346-44aa-b948-fbd4c1df2c4f",
                "instanceType": "EligibilityCriterion",
                "name": "Compliance",
                "previousId": "1b446881-6bdd-410b-83a3-2357b84a42a9"
              },
              {
                "id": "66a1615e-f448-459f-ae11-3bae881a4763",
                "identifier": "1",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e32d0d28-641c-4300-9be4-b8923ebbbc9f",
                "instanceType": "EligibilityCriterion",
                "name": "Secondary CAS exclusion",
                "nextId": "4e0848b8-1475-4ba0-9c44-7f3bef53b551"
              },
              {
                "id": "4e0848b8-1475-4ba0-9c44-7f3bef53b551",
                "identifier": "2",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b2c1507f-4d82-4b37-a450-4e27b9e4e37d",
                "instanceType": "EligibilityCriterion",
                "name": "Clinically relevant infection",
                "previousId": "66a1615e-f448-459f-ae11-3bae881a4763",
                "nextId": "9e1c5d16-cb05-4727-852e-e177dd5379ca"
              },
              {
                "id": "9e1c5d16-cb05-4727-852e-e177dd5379ca",
                "identifier": "3",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "6897b7da-b926-4ca3-91b5-7987159e2ded",
                "instanceType": "EligibilityCriterion",
                "name": "SLE or autoimmune disorders",
                "previousId": "4e0848b8-1475-4ba0-9c44-7f3bef53b551",
                "nextId": "7c74bb27-4374-444b-b5f2-763d7ae40783"
              },
              {
                "id": "7c74bb27-4374-444b-b5f2-763d7ae40783",
                "identifier": "4",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5730649f-6676-4e36-b706-fa610c5b4b10",
                "instanceType": "EligibilityCriterion",
                "name": "Hepatitis panel",
                "previousId": "9e1c5d16-cb05-4727-852e-e177dd5379ca",
                "nextId": "2d668c1f-6989-4f67-a8b1-af7ce3d50cd6"
              },
              {
                "id": "2d668c1f-6989-4f67-a8b1-af7ce3d50cd6",
                "identifier": "5",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "9cb6647f-96ea-49b9-b964-4936f8aea1e5",
                "instanceType": "EligibilityCriterion",
                "name": "HIV antibody",
                "previousId": "7c74bb27-4374-444b-b5f2-763d7ae40783",
                "nextId": "1cf54e45-ea8b-4877-b6a5-1cb0d9a2672e"
              },
              {
                "id": "1cf54e45-ea8b-4877-b6a5-1cb0d9a2672e",
                "identifier": "6",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5e8630ed-0c04-409c-9e80-c3aee820f522",
                "instanceType": "EligibilityCriterion",
                "name": "Rituximab treatment",
                "previousId": "2d668c1f-6989-4f67-a8b1-af7ce3d50cd6",
                "nextId": "1825241c-47aa-45f1-9c00-8eb4332c4851"
              },
              {
                "id": "1825241c-47aa-45f1-9c00-8eb4332c4851",
                "identifier": "7",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5d405a8f-c2ee-4577-a1a0-ef3a2b9b788e",
                "instanceType": "EligibilityCriterion",
                "name": "Corticosteroids",
                "previousId": "1cf54e45-ea8b-4877-b6a5-1cb0d9a2672e",
                "nextId": "16485087-ae80-4170-93ed-c1d08f0ba01f"
              },
              {
                "id": "16485087-ae80-4170-93ed-c1d08f0ba01f",
                "identifier": "8",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "30b8d02f-33f2-4e86-943b-d4af6aa06fd9",
                "instanceType": "EligibilityCriterion",
                "name": "Erythropoietin deficiency",
                "previousId": "1825241c-47aa-45f1-9c00-8eb4332c4851",
                "nextId": "59830775-8f7d-4a8a-baa9-5b5e54ad43d6"
              },
              {
                "id": "59830775-8f7d-4a8a-baa9-5b5e54ad43d6",
                "identifier": "9",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "a16710ae-4cda-4f98-b2a7-5ab4204692f3",
                "instanceType": "EligibilityCriterion",
                "name": "Iron supplementation",
                "previousId": "16485087-ae80-4170-93ed-c1d08f0ba01f",
                "nextId": "3de85af6-9fc0-44dd-a4b2-1fee752f7648"
              },
              {
                "id": "3de85af6-9fc0-44dd-a4b2-1fee752f7648",
                "identifier": "10",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "fb03eac7-a3bc-4926-926e-b75855d0f15e",
                "instanceType": "EligibilityCriterion",
                "name": "Significant medical history",
                "previousId": "59830775-8f7d-4a8a-baa9-5b5e54ad43d6",
                "nextId": "d21b269e-f437-4876-9aca-aa35c6c7d84d"
              },
              {
                "id": "d21b269e-f437-4876-9aca-aa35c6c7d84d",
                "identifier": "11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "984fde3d-d820-44ee-b419-28c9ef72406b",
                "instanceType": "EligibilityCriterion",
                "name": "Experimental drugs",
                "previousId": "3de85af6-9fc0-44dd-a4b2-1fee752f7648",
                "nextId": "c1460eed-0d87-4ac6-9326-c3c0415c73f0"
              },
              {
                "id": "c1460eed-0d87-4ac6-9326-c3c0415c73f0",
                "identifier": "12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4b74efb1-d971-42c7-83fc-2bf8150fb9c1",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy or lactation",
                "previousId": "d21b269e-f437-4876-9aca-aa35c6c7d84d",
                "nextId": "6dd49a1f-d349-4b9d-84e2-0f959e34a11d"
              },
              {
                "id": "6dd49a1f-d349-4b9d-84e2-0f959e34a11d",
                "identifier": "13",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5f8c34e7-aefb-458d-a869-9a613bc2aeeb",
                "instanceType": "EligibilityCriterion",
                "name": "Hypersensitivity",
                "previousId": "c1460eed-0d87-4ac6-9326-c3c0415c73f0"
              }
            ],
            "population": {
              "id": "76e717ef-fe6c-4b4e-a031-64b48425bd5a",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "eb706230-cab1-40b0-870b-6ad4c41bc00d",
                "e0220fde-8c9f-48ca-b6dd-fef4a4d398b2",
                "583c373d-d455-4c2a-a78c-bc1dfbe51d7e",
                "d802c3f5-7448-4270-b9e0-09f292b821f7",
                "fad6c21f-595c-42a2-8451-3f6a394df151",
                "209703a1-f093-4df7-a304-ba9b5a6fc465",
                "55c508d0-2cab-4b9f-87e6-be406b63631a",
                "94461b73-26ce-4266-8e3a-3d9a263f6e4f",
                "0c06e971-589f-448f-8868-48695d87f237",
                "3c8dfff8-4cf8-4f49-93a1-262bc6f0863b",
                "8ba5ac43-3cf9-483c-8a5b-c94f99b9cf47",
                "5aee8f94-3660-454a-a26a-ed2e3a6dabc3",
                "2cf0aaf9-7237-4b8e-a372-a71ac97f7f23",
                "1b446881-6bdd-410b-83a3-2357b84a42a9",
                "e7bd24ca-a6f5-4970-9b47-2e143d63ec36",
                "66a1615e-f448-459f-ae11-3bae881a4763",
                "4e0848b8-1475-4ba0-9c44-7f3bef53b551",
                "9e1c5d16-cb05-4727-852e-e177dd5379ca",
                "7c74bb27-4374-444b-b5f2-763d7ae40783",
                "2d668c1f-6989-4f67-a8b1-af7ce3d50cd6",
                "1cf54e45-ea8b-4877-b6a5-1cb0d9a2672e",
                "1825241c-47aa-45f1-9c00-8eb4332c4851",
                "16485087-ae80-4170-93ed-c1d08f0ba01f",
                "59830775-8f7d-4a8a-baa9-5b5e54ad43d6",
                "3de85af6-9fc0-44dd-a4b2-1fee752f7648",
                "d21b269e-f437-4876-9aca-aa35c6c7d84d",
                "c1460eed-0d87-4ac6-9326-c3c0415c73f0",
                "6dd49a1f-d349-4b9d-84e2-0f959e34a11d"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "c2796f78-ffe6-4242-93ea-829f330fbfa3",
                "name": "Primary Objective (Part A)",
                "text": "To determine whether BIVV009 administration results in a ≥2 g/dL increase in hemoglobin (Hgb) levels or increases Hgb to ≥12 g/dL and obviates the need for blood transfusion during treatment in patients with primary CAgD who have a recent history of blood transfusion.",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "30956364-e066-4797-968c-abed64ecafc5"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "ad0583e7-8834-49d8-9b2f-4ca160b769e1",
                "name": "Secondary Efficacy Objective (Part A)",
                "text": "To assess the effect of BIVV009 on clinical events and laboratory parameters related to hemolysis and anemia in patients with primary CAgD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "0f44a8c8-1c6e-45f8-871c-b1cab17a0756",
                  "a00beb19-7018-4dc8-8b1a-359da684f7a1",
                  "324170a4-a9d5-47d0-b85b-296156a703a2",
                  "ae712d76-cdf7-460e-8f7e-2ddd1ceae8f2"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "7d716203-92fb-4b4d-b399-2659fd2f510a",
                "name": "Secondary Quality of Life Objective (Part A)",
                "text": "To assess the effect of BIVV009 on quality of life (QOL) in patients with primary CAgD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "0b56626c-57ce-49d1-a340-40857fb28126"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "5f443f46-5c20-4a8c-b87d-c5d6227f10fc",
                "name": "Secondary Safety Objective (Part A)",
                "text": "To evaluate the overall safety and tolerability of BIVV009 in patients with primary CAgD",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "085f815b-f651-4260-963d-c5f1a224c386",
                  "24dc76f6-1a0e-4655-b22b-c064fc370f18",
                  "97765745-d097-44c6-89cf-35e4fcfefdde",
                  "d23e0e99-e03c-4fac-a272-d83f8bab0818"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "0ba27fd7-0ee4-4f5a-87e8-9e10e6116712",
                "name": "Exploratory Objective (Part A) - Complications",
                "text": "To assess the effect of BIVV009 on specific complications of CAgD (acrocyanosis, Raynaud’s syndrome, hemoglobinuria, and thromboembolism)",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "609f4f1e-4d47-4ce1-b501-a3838ca5e54e",
                  "b1c9edfb-6d44-4f9d-9f7d-9c1b4a9b859a"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "8ebcac93-8038-4084-ad75-b222cdbd51f3",
                "name": "Exploratory Objective (Part A) - Biomarkers",
                "text": "To evaluate the effect of BIVV009 on certain disease-related biomarkers in patients with primary CAgD",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "1132fa39-3b9c-4e60-8aa5-3fbea6573c9e",
                  "c94cf00b-17a9-49bb-ab35-aa458ccd9bce",
                  "62a15782-87ff-4bad-b4ee-7a48b20ae8e8",
                  "0965440f-f3f0-48bc-b5be-cea5060544fd",
                  "6837df30-70e7-4af8-8c64-a37e164f5abd"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "13958967-737c-4e55-8ac3-078f122a582a",
                "name": "Exploratory Objective (Part A) - Pharmacokinetics",
                "text": "To evaluate the pharmacokinetics of BIVV009",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "a9d2ae71-f66c-43cd-89bf-53a6ca381fe4",
                  "94fb0044-3b0b-46a4-95d8-27e54929259f"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "36d84513-6ed0-4ad5-a583-a9285036f6b2",
                "name": "Exploratory Objective (Part A) - Immunogenicity",
                "text": "To evaluate the immunogenicity of BIVV009",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "2abb2f7f-57cc-4f71-b107-3f47c967cfe8"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "f67aeb63-dcc1-415a-a6d0-68261cc1d1aa",
                "name": "Primary Objective (Part B)",
                "text": "The primary objective of Part B is to evaluate the long-term safety and tolerability of BIVV009 in patients with primary CAgD.",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "085f815b-f651-4260-963d-c5f1a224c386",
                  "24dc76f6-1a0e-4655-b22b-c064fc370f18",
                  "97765745-d097-44c6-89cf-35e4fcfefdde",
                  "d23e0e99-e03c-4fac-a272-d83f8bab0818"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "da9db2d8-5ecf-4c81-8d24-01fb7daee078",
                "name": "Secondary Objective (Part B)",
                "text": "The secondary objective of Part B is to investigate the durability of response during long-term treatment with BIVV009 in patients with primary CAgD.",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "ae712d76-cdf7-460e-8f7e-2ddd1ceae8f2",
                  "0f44a8c8-1c6e-45f8-871c-b1cab17a0756",
                  "a00beb19-7018-4dc8-8b1a-359da684f7a1",
                  "324170a4-a9d5-47d0-b85b-296156a703a2"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "29ce230c-a021-4dd0-9712-ba78e9f9eaad",
                "name": "Exploratory Objective (Part B) - Home Infusion",
                "text": "To describe the safety and patient satisfaction with the convenience of home infusions with BIVV009 in a subset of patients",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "d23e0e99-e03c-4fac-a272-d83f8bab0818",
                  "cf8ccf1c-6c8d-4173-b4c2-df8bd92c51d5"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "30956364-e066-4797-968c-abed64ecafc5",
                "name": "Primary Efficacy Endpoint (Part A)",
                "text": "The primary efficacy endpoint is the responder rate as defined in Table 2 (≥2 g/dL increase in Hgb or Hgb ≥12 g/dL and no transfusion from Week 5 to 26).",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "0f44a8c8-1c6e-45f8-871c-b1cab17a0756",
                "name": "Secondary Efficacy Endpoint - Bilirubin",
                "text": "Mean change from baseline in bilirubin (excluding patients with Gilbert’s Syndrome) at the treatment assessment endpoint",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "0b56626c-57ce-49d1-a340-40857fb28126",
                "name": "Secondary Efficacy Endpoint - FACIT-Fatigue",
                "text": "Mean change from baseline in QOL, as assessed by the change in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale scores at the treatment assessment endpoint",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "a00beb19-7018-4dc8-8b1a-359da684f7a1",
                "name": "Secondary Efficacy Endpoint - LDH",
                "text": "Mean change from baseline in lactate dehydrogenase (LDH) at the treatment assessment endpoint",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "324170a4-a9d5-47d0-b85b-296156a703a2",
                "name": "Secondary Efficacy Endpoint - Transfusions",
                "text": "Number of transfusions and number of units after the first 5 weeks of study drug administration",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "ae712d76-cdf7-460e-8f7e-2ddd1ceae8f2",
                "name": "Secondary Efficacy Endpoint - Hgb",
                "text": "Mean change from baseline in Hgb at the treatment assessment endpoint",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "7ad06797-d0b6-4684-b789-1288e72b7b50",
                "name": "Exploratory Efficacy Endpoint - Time to Transfusion",
                "text": "Time to first transfusion after the first 5 weeks of study drug administration",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "fdac8e56-c1fc-4d1a-af41-79dc00e87a07",
                "name": "Exploratory Efficacy Endpoint - EQ-5D-5L",
                "text": "Mean change from baseline in QOL, as assessed by the change in the five level EuroQol - five dimensions questionnaire (EQ-5D-5L) scores at the treatment assessment endpoint",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "86644ca7-d260-4b5f-9117-a01cbae61680",
                "name": "Exploratory Efficacy Endpoint - SF-12",
                "text": "Mean change from baseline in QOL, as assessed by the change in the 12-Item Short Form Survey (SF-12®) at the end of treatment assessment endpoint",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "cb3cbef1-dcc5-4d42-958d-c7150ae348a8",
                "name": "Exploratory Efficacy Endpoint - Symptomatic Anemia",
                "text": "Incidence of solicited symptomatic anemia at EOT",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "0e7fd19d-3192-4f92-be10-dab2cced1f96",
                "name": "Exploratory Efficacy Endpoint - Hgb Threshold",
                "text": "Proportion of patients with Hgb level of ≥12 g/dL at the treatment assessment endpoint",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "609f4f1e-4d47-4ce1-b501-a3838ca5e54e",
                "name": "Exploratory Efficacy Endpoint - Thromboembolism",
                "text": "Incidence of thromboembolic events after the first 5 weeks of study drug administration",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "e59a9e01-d61e-407c-b084-34672bcc24b2",
                "name": "Exploratory Efficacy Endpoint - Normalization Time",
                "text": "Median time to normalization of bilirubin, LDH, and haptoglobin",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "1132fa39-3b9c-4e60-8aa5-3fbea6573c9e",
                "name": "Exploratory Efficacy Endpoint - Haptoglobin Normalization",
                "text": "Proportion of patients normalizing haptoglobin at the treatment assessment endpoint",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              },
              {
                "id": "c94cf00b-17a9-49bb-ab35-aa458ccd9bce",
                "name": "Exploratory Efficacy Endpoint - Bilirubin Normalization",
                "text": "Proportion of patients normalizing bilirubin at the treatment assessment endpoint",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              },
              {
                "id": "62a15782-87ff-4bad-b4ee-7a48b20ae8e8",
                "name": "Exploratory Efficacy Endpoint - LDH Normalization",
                "text": "Proportion of patients normalizing LDH at the treatment assessment endpoint",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              },
              {
                "id": "0965440f-f3f0-48bc-b5be-cea5060544fd",
                "name": "Exploratory Efficacy Endpoint - PGIC",
                "text": "Patient’s Global Impression of Change (PGIC) to assess patient’s perception of changes in CAgD disease burden at EOT",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "6837df30-70e7-4af8-8c64-a37e164f5abd",
                "name": "Exploratory Efficacy Endpoint - PGIS",
                "text": "Patient’s Global Impression of [Fatigue] Severity (PGIS) to assess patient’s perception of changes in fatigue at EOT",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "b1c9edfb-6d44-4f9d-9f7d-9c1b4a9b859a",
                "name": "Exploratory Efficacy Endpoint - Circulatory Symptoms",
                "text": "Incidence of disabling circulatory symptoms at EOT",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "94adf846-2831-4625-82d1-611e061114bc",
                "name": "Exploratory Efficacy Endpoint - Resource Utilization",
                "text": "Total healthcare resource utilization at EOT",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "085f815b-f651-4260-963d-c5f1a224c386",
                "name": "Safety Outcome Measures - General",
                "text": "Adverse events (AEs), serious AEs, clinical laboratory evaluations, SLE panel, vital sign measurements, electrocardiograms (ECGs), physical examination findings, and serum disease-related biomarkers.",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "24dc76f6-1a0e-4655-b22b-c064fc370f18",
                "name": "Safety Outcome Measures - Hemolytic Breakthrough",
                "text": "Hemolytic breakthrough (rapid fall in Hgb ≥2 g/dL associated with an increase in LDH/bilirubin and/or decrease in haptoglobin since the last scheduled visit) through the EOT at Week 26",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "97765745-d097-44c6-89cf-35e4fcfefdde",
                "name": "Safety Outcome Measures - Infections",
                "text": "Infections of ≥ Grade 3 severity (ie, requiring IV antibiotics)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "d23e0e99-e03c-4fac-a272-d83f8bab0818",
                "name": "Safety Outcome Measures - Home Infusion",
                "text": "For patients with home infusions, safety assessments will additionally include AEs with onset within 24 hours of the infusion",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "a9d2ae71-f66c-43cd-89bf-53a6ca381fe4",
                "name": "Pharmacokinetic Endpoint - Concentration",
                "text": "Plasma concentrations of BIVV009",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "94fb0044-3b0b-46a4-95d8-27e54929259f",
                "name": "Pharmacokinetic Endpoint - Parameters",
                "text": "PK parameters. Appropriate exposure parameters (Cmax, AUC) will be derived using a population approach.",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "dde9d2c6-abc8-4ced-bbc1-650c97aaa9bd",
                "name": "Pharmacodynamic Primary Outcome Measure",
                "text": "Wieslab-CP",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacodynamic"
              },
              {
                "id": "145566e9-7d00-4556-ba33-ba8b61d56ddd",
                "name": "Exploratory Complement System Measures",
                "text": "CH50, Total C4, C1q, C1s",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacodynamic"
              },
              {
                "id": "2abb2f7f-57cc-4f71-b107-3f47c967cfe8",
                "name": "Immunogenicity Outcome Measures",
                "text": "Pre-existing ADA and treatment-emergent ADA",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              },
              {
                "id": "cf8ccf1c-6c8d-4173-b4c2-df8bd92c51d5",
                "name": "Home Infusion Satisfaction",
                "text": "Satisfaction with home infusion after first home infusion and after four home infusion will be assessed in patients with home infusion",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              }
            ],
            "estimands": [
              {
                "id": "612190ed-1f75-49f2-91d1-ba09fab086bb",
                "name": "Primary Efficacy Estimand (Part A)",
                "populationSummary": "Adult patients with primary cold agglutinin disease (CAgD) who have a recent history of blood transfusion (Full Analysis Set) Summary measure: Proportion of responders with 95% exact Clopper-Pearson confidence interval.",
                "analysisPopulationId": "8a7501c8-077a-4ec5-9d23-d919b8fc8413",
                "variableOfInterestId": "30956364-e066-4797-968c-abed64ecafc5",
                "interventionIds": [
                  "ec17b60e-637b-4252-840a-d6d2c8a6386a"
                ],
                "intercurrentEvents": [
                  {
                    "id": "ea0ddacf-e807-4d5f-8518-1ea11d8072af",
                    "name": "Withdrawal from study",
                    "text": "Any patient withdrawing from the study after Week 5 and prior to the Week 23 visit",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "84329a63-a204-4f6a-ac06-c51dedb10059",
                    "name": "Use of prohibited CAgD therapies",
                    "text": "Patients requiring other treatment for their CAgD in Part A",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "06d4235b-f0a1-4c5e-9dd9-1f25264a4606",
                    "name": "Blood transfusion",
                    "text": "Receipt of blood transfusion from Week 5 through Week 26",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "BIVV009 (6.5 g or 7.5 g based on weight) IV infusion on Day 0, Day 7, and every 14 days thereafter",
                "analysisPopulation": "Adult patients with primary cold agglutinin disease (CAgD) who have a recent history of blood transfusion (Full Analysis Set)",
                "variableOfInterest": "Responder rate (≥2 g/dL increase in Hgb or Hgb ≥12 g/dL and no blood transfusion from Week 5 through Week 26)",
                "summaryMeasure": "Proportion of responders with 95% exact Clopper-Pearson confidence interval"
              },
              {
                "id": "e4e591cc-5a06-4b7f-93de-abf68f1aff13",
                "name": "Secondary Efficacy Estimand - Hemoglobin Change",
                "populationSummary": "Adult patients with primary cold agglutinin disease (CAgD) who have a recent history of blood transfusion (Full Analysis Set) Summary measure: Mean change from baseline analyzed using a one-sample t-test.",
                "analysisPopulationId": "b85ebc7b-7e95-4949-840d-650584b03cff",
                "variableOfInterestId": "ae712d76-cdf7-460e-8f7e-2ddd1ceae8f2",
                "interventionIds": [
                  "59f7ee11-b258-481c-b678-4e4f7c73ec37"
                ],
                "intercurrentEvents": [
                  {
                    "id": "407324d8-5bb9-4876-b94d-08e7c58ed65b",
                    "name": "Treatment discontinuation",
                    "text": "Discontinuation of study drug prior to Week 26",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "BIVV009 (6.5 g or 7.5 g based on weight) IV infusion",
                "analysisPopulation": "Adult patients with primary cold agglutinin disease (CAgD) who have a recent history of blood transfusion (Full Analysis Set)",
                "variableOfInterest": "Mean change from baseline in Hgb at the treatment assessment endpoint (Weeks 23, 25, and 26)",
                "summaryMeasure": "Mean change from baseline analyzed using a one-sample t-test"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "3c096b18-93a3-41b9-bb2d-ffb1ca2ee0dd",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "fcf9a496-f02b-428d-a679-125601c92b41",
                "instances": [
                  {
                    "id": "fcf9a496-f02b-428d-a679-125601c92b41",
                    "activityIds": [
                      "d37e15b8-95a5-4e49-b83f-365e5e0ae2c8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "18348d0e-ac36-4c20-a15d-fd6172638da9",
                    "activityIds": [
                      "6aecd790-48b3-469a-8804-6b2618acb950"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "8f550d22-ebf9-4bb6-9042-2f62b3b9cc53",
                    "activityIds": [
                      "d8c80fa3-a023-4dd4-bef0-b13d8f4d8c56"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "0f8c47a6-81b7-4212-ac6b-5d69d1ac18b2",
                    "activityIds": [
                      "364e3e9a-36de-4323-a893-93f221a7bf98"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "6b136dba-1ed3-4480-9395-8aecc01d55b8",
                    "activityIds": [
                      "364e3e9a-36de-4323-a893-93f221a7bf98"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "6b876070-87e4-4f85-8e78-4d392f8c65b7",
                    "activityIds": [
                      "5ed4abd3-203d-4f44-8009-c9c1de64bf0a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "8b1ab1ed-79ab-4f90-a87a-f7da02000724",
                    "activityIds": [
                      "14dfc34d-7673-4315-928d-4eb043b06261"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "6f5c6c60-8476-440e-bed4-d800f4a1f5cc",
                    "activityIds": [
                      "d331e8fa-4033-4659-b0c0-782411862471"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "1936dc37-301d-4a88-8a02-0d348e75140b",
                    "activityIds": [
                      "d331e8fa-4033-4659-b0c0-782411862471"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "17bc4828-1e05-4f32-bf47-6310352d3169",
                    "activityIds": [
                      "d331e8fa-4033-4659-b0c0-782411862471"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "7e14a7cc-29e9-49f9-957a-43e84c4328d7",
                    "activityIds": [
                      "d331e8fa-4033-4659-b0c0-782411862471"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "fc56f917-9423-4016-b341-86d4b41a5607",
                    "activityIds": [
                      "d331e8fa-4033-4659-b0c0-782411862471"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "474a1928-ac56-4080-849a-6f561321fbb9",
                    "activityIds": [
                      "d331e8fa-4033-4659-b0c0-782411862471"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "18803c6c-155a-4790-af43-6df99028e980",
                    "activityIds": [
                      "3fd65995-e3a0-4b64-a146-ba805ab00f8c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "21b59299-e902-4f81-9730-a42542de4bfd",
                    "activityIds": [
                      "3fd65995-e3a0-4b64-a146-ba805ab00f8c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "86314eba-193f-4c38-96a1-ad3b52857052",
                    "activityIds": [
                      "3fd65995-e3a0-4b64-a146-ba805ab00f8c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "3b9ba110-e6e3-4847-bd2b-cda469f2c50f",
                    "activityIds": [
                      "3fd65995-e3a0-4b64-a146-ba805ab00f8c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "1801f385-30c7-4dac-9596-cc4ea53197ea",
                    "activityIds": [
                      "3fd65995-e3a0-4b64-a146-ba805ab00f8c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "97515e84-c02b-4ea6-843c-cc69fd4b4645",
                    "activityIds": [
                      "a1531342-3acd-40b4-bd41-881839e071a1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "3f24fc78-0931-4ca5-84ad-09777086d196",
                    "activityIds": [
                      "a1531342-3acd-40b4-bd41-881839e071a1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "a6577171-0e33-43ff-9fda-2f0d314f2ff4",
                    "activityIds": [
                      "a1531342-3acd-40b4-bd41-881839e071a1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "7cac3d8b-576e-41ed-864b-2ad5d65ef65c",
                    "activityIds": [
                      "cd33be48-392c-4db4-98d5-8510d9830ae5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "2914a5f2-82e3-447b-b9da-2207cefaf650",
                    "activityIds": [
                      "cd33be48-392c-4db4-98d5-8510d9830ae5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "002b65c4-949d-4125-b888-5ed05a86d4ca",
                    "activityIds": [
                      "cd33be48-392c-4db4-98d5-8510d9830ae5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "74357c8d-612a-4946-a0e7-4c2c48f93eaa",
                    "activityIds": [
                      "f55d98dc-e754-457c-9a37-20d32ee222ee"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "0b7f3eb8-9d53-4eed-a8fe-8c95fe78781d",
                    "activityIds": [
                      "f55d98dc-e754-457c-9a37-20d32ee222ee"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "9e1896fc-c4ca-4400-8657-d3844b7f8b7c",
                    "activityIds": [
                      "f55d98dc-e754-457c-9a37-20d32ee222ee"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "2dad916e-e29f-4750-af53-c18d9cd17c70",
                    "activityIds": [
                      "f55d98dc-e754-457c-9a37-20d32ee222ee"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "f307afb4-f1a9-446e-b69e-55e77dc48618",
                    "activityIds": [
                      "f55d98dc-e754-457c-9a37-20d32ee222ee"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "e9900887-61ec-4913-b6cf-25e55e27633a",
                    "activityIds": [
                      "f55d98dc-e754-457c-9a37-20d32ee222ee"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "7b44b853-c207-4ff7-9ee2-7bd3d57489d7",
                    "activityIds": [
                      "7eb11dc1-a40d-4324-bb56-27cfbcd5392e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "744468ff-0471-4d37-971a-0d2487262bf2",
                    "activityIds": [
                      "7eb11dc1-a40d-4324-bb56-27cfbcd5392e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "e4b969a0-272a-4ad5-ab25-0db2d39843b4",
                    "activityIds": [
                      "7eb11dc1-a40d-4324-bb56-27cfbcd5392e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "56eb1ba7-a60a-4427-a0dd-f7e0469926bd",
                    "activityIds": [
                      "7eb11dc1-a40d-4324-bb56-27cfbcd5392e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "33922b68-a7cc-4c06-92aa-77ce2810a9fc",
                    "activityIds": [
                      "120dba5d-ef65-4a50-a70e-0debf580b872"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "0a0dae13-84bf-47e7-9965-3d47684fae33",
                    "activityIds": [
                      "11cd596b-d9e5-45d5-a897-52b00186c01c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "a3886fb3-6609-417c-9daa-4cc3de4df553",
                    "activityIds": [
                      "5cf0543f-6f13-42a3-8383-4dfd5f401b79"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "607a3b04-c746-4704-bdee-6075bc7f98e7",
                    "activityIds": [
                      "5cf0543f-6f13-42a3-8383-4dfd5f401b79"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "d56ab691-74ec-4a40-9eb9-0d4a7d090d15",
                    "activityIds": [
                      "5cf0543f-6f13-42a3-8383-4dfd5f401b79"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "fd1a897a-eefd-4168-8afb-69305a888afa",
                    "activityIds": [
                      "5cf0543f-6f13-42a3-8383-4dfd5f401b79"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "10a9cdc9-2301-4b12-9530-305bade014db",
                    "activityIds": [
                      "98cb35a4-4911-4c89-be39-d6b48a715f97"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_16@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "8975393c-a35c-4f42-b6ff-b0183e46d91c",
                    "activityIds": [
                      "0518cffb-0cca-426c-92d7-882f57625f35"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "58626bfe-220f-42f0-af85-3011737c705e",
                    "activityIds": [
                      "0518cffb-0cca-426c-92d7-882f57625f35"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "350cf776-0249-430e-871c-7a7728205395",
                    "activityIds": [
                      "0518cffb-0cca-426c-92d7-882f57625f35"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "bf0edc7e-9835-4454-b32b-8fff470c02da",
                    "activityIds": [
                      "0518cffb-0cca-426c-92d7-882f57625f35"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "6fffbf96-2940-4e4c-927d-64534f6c7ca2",
                    "activityIds": [
                      "0518cffb-0cca-426c-92d7-882f57625f35"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "b304eb68-6f39-477a-b21c-b3409cbc7234",
                    "activityIds": [
                      "0518cffb-0cca-426c-92d7-882f57625f35"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "3f34b263-77a9-42bf-80c1-b263dce48953",
                    "activityIds": [
                      "50847781-a266-4d9e-a6e5-d6dcbf1aa374"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "f7f33152-ee0c-4df7-b72f-885eef97327b",
                    "activityIds": [
                      "50847781-a266-4d9e-a6e5-d6dcbf1aa374"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "a77dcc1d-2a36-43cb-97f0-8b1a74c0c08d",
                    "activityIds": [
                      "50847781-a266-4d9e-a6e5-d6dcbf1aa374"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "4186dfe2-affd-4237-90ce-b74b127410cd",
                    "activityIds": [
                      "50847781-a266-4d9e-a6e5-d6dcbf1aa374"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "f73a61cc-c273-4aff-8625-b4d84b11754b",
                    "activityIds": [
                      "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "c746c1ab-14de-422a-98d7-3f1a6aa2485d",
                    "activityIds": [
                      "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "a3983ad0-4ca3-45f6-8a3e-7ce694330e03",
                    "activityIds": [
                      "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "02db36f0-513d-4f9a-a40a-cad0d7b8d600",
                    "activityIds": [
                      "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "9f53c3b5-6931-42e8-a441-03dc896b10f1",
                    "activityIds": [
                      "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "8f09bae6-47bf-4923-acad-99165ca29f36",
                    "activityIds": [
                      "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "2b8b4464-e6dc-4342-b414-cf072110ff9f",
                    "activityIds": [
                      "b60b8f94-e039-4923-bd2a-241bd3c2834b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "1d9857bd-a526-4e78-8de1-759529c84141",
                    "activityIds": [
                      "b60b8f94-e039-4923-bd2a-241bd3c2834b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "caebff02-1a69-45df-a89a-cbac11b6a028",
                    "activityIds": [
                      "b60b8f94-e039-4923-bd2a-241bd3c2834b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "c8b47a88-6c39-4aba-8d7d-3ee6febf523b",
                    "activityIds": [
                      "b60b8f94-e039-4923-bd2a-241bd3c2834b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "a5e88617-87a6-4df0-be90-c37b7fdbaf13",
                    "activityIds": [
                      "b60b8f94-e039-4923-bd2a-241bd3c2834b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "e2e3c3ef-8d0d-4ed3-9594-adaeae5db255",
                    "activityIds": [
                      "eb805dd8-595f-4d59-b066-3940cfe6cd7f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "37634183-b10d-45bd-9a7d-34d465328ba5",
                    "activityIds": [
                      "eb805dd8-595f-4d59-b066-3940cfe6cd7f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "907911a9-65d8-4da7-bffd-f2f26ef503de",
                    "activityIds": [
                      "eb805dd8-595f-4d59-b066-3940cfe6cd7f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "67eca5f3-c361-4b10-a6e1-d7c99296014f",
                    "activityIds": [
                      "eb805dd8-595f-4d59-b066-3940cfe6cd7f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "87aa947f-7df4-41a2-b476-e1c17ecdefe2",
                    "activityIds": [
                      "eb805dd8-595f-4d59-b066-3940cfe6cd7f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "ac0b27cc-0d49-4b1d-9662-7a38ced56a9f",
                    "activityIds": [
                      "cbfe23b3-a95d-488f-8890-6864c48c9a42"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "591f8cee-6b3e-45ea-8899-79681ec802ac",
                    "activityIds": [
                      "cbfe23b3-a95d-488f-8890-6864c48c9a42"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "31b29236-ffa3-4bb1-8e95-1be0f4cc9115",
                    "activityIds": [
                      "cbfe23b3-a95d-488f-8890-6864c48c9a42"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "1b68b7b4-9e6b-4c28-9400-bc70d1a84ffa",
                    "activityIds": [
                      "cbfe23b3-a95d-488f-8890-6864c48c9a42"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "ef1a824a-0395-4ef8-a2b4-494d0bfa085b",
                    "activityIds": [
                      "cbfe23b3-a95d-488f-8890-6864c48c9a42"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "8135649e-371d-4b6d-8d23-9bfce79a2b45",
                    "activityIds": [
                      "016fe66d-377c-414c-b96d-5019b560366c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "def1e1f6-fc69-4b63-a29b-93be782496b7",
                    "activityIds": [
                      "016fe66d-377c-414c-b96d-5019b560366c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "c42d7878-6e97-4910-8c7e-f4cae58c0637",
                    "activityIds": [
                      "016fe66d-377c-414c-b96d-5019b560366c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "1adb0b3c-29c9-410e-b59c-7de293892f0f",
                    "activityIds": [
                      "016fe66d-377c-414c-b96d-5019b560366c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "8edf2534-7615-40a4-b2c7-c4b4d0e2a29a",
                    "activityIds": [
                      "016fe66d-377c-414c-b96d-5019b560366c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "efdb3ca3-0471-4744-96c8-a3c658a60b0e",
                    "activityIds": [
                      "20947b5c-e5f9-45de-8f8f-3146d82d96d1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "2488a362-c4f4-4d5e-a4ef-643d4a3b3c6a",
                    "activityIds": [
                      "20947b5c-e5f9-45de-8f8f-3146d82d96d1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "34fe0414-8ec4-45af-a7ff-607c9f5c57c0",
                    "activityIds": [
                      "20947b5c-e5f9-45de-8f8f-3146d82d96d1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "c88b1dc1-2411-405b-a938-bd1a25cd4884",
                    "activityIds": [
                      "20947b5c-e5f9-45de-8f8f-3146d82d96d1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "c635d2c9-e777-45aa-a934-5103e26b65fe",
                    "activityIds": [
                      "20947b5c-e5f9-45de-8f8f-3146d82d96d1"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "b6558a62-c7bc-4c8d-b447-f777fcf328d3",
                    "activityIds": [
                      "20fb064d-26f4-4e3a-a5e0-132d81f85d0a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "b6a8df9c-4372-4c40-a6d3-85e95421335f",
                    "activityIds": [
                      "20fb064d-26f4-4e3a-a5e0-132d81f85d0a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "ae43011a-51a9-43dd-96a0-6874637cd902",
                    "activityIds": [
                      "20fb064d-26f4-4e3a-a5e0-132d81f85d0a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "76713039-4a69-400d-b2d2-58b82edaef41",
                    "activityIds": [
                      "20fb064d-26f4-4e3a-a5e0-132d81f85d0a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "36541b6a-6e05-4b07-bfb7-4f885bf21f67",
                    "activityIds": [
                      "20fb064d-26f4-4e3a-a5e0-132d81f85d0a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "94abf702-dc17-4eca-a345-45e8ee768938",
                    "activityIds": [
                      "3730d953-953e-4246-9f92-1e528d34f02f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "c7816626-512c-4fd5-a066-a6c6ed5df126",
                    "activityIds": [
                      "3730d953-953e-4246-9f92-1e528d34f02f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "f3ef3189-3b4f-4c23-8d7c-b3125593e8a5",
                    "activityIds": [
                      "3730d953-953e-4246-9f92-1e528d34f02f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "6365d321-2052-4543-ab47-481fffcfd6fc",
                    "activityIds": [
                      "3730d953-953e-4246-9f92-1e528d34f02f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "36727fdf-d568-4362-8fcc-630293cb8123",
                    "activityIds": [
                      "3730d953-953e-4246-9f92-1e528d34f02f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "6c01c22a-9fd7-4a84-b9db-334137ce11f5",
                    "activityIds": [
                      "3730d953-953e-4246-9f92-1e528d34f02f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "4f990489-f4ec-425a-a8c7-95e3fa6cf731",
                    "activityIds": [
                      "886f872e-f25f-40b7-8872-84658a364d9a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_27@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "1117f5fd-aa33-4312-8caf-43951eb5061a",
                    "activityIds": [
                      "886f872e-f25f-40b7-8872-84658a364d9a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_27@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "814c69e0-11b7-481e-ab1b-fccdebdde102",
                    "activityIds": [
                      "886f872e-f25f-40b7-8872-84658a364d9a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_27@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "4732cc40-fc7a-4550-93c9-f98ece33fff1",
                    "activityIds": [
                      "68cad1d5-af4e-4771-9763-81d10a0cce46"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "b2977a8d-df10-4ec3-88c7-23b21398225a",
                    "activityIds": [
                      "68cad1d5-af4e-4771-9763-81d10a0cce46"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "176da31d-30ed-4367-8ddc-e5a709efc561",
                    "activityIds": [
                      "68cad1d5-af4e-4771-9763-81d10a0cce46"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "020e5947-e64b-4480-bb07-af23d65c199d",
                    "activityIds": [
                      "8985d9db-7de4-4c7f-9f0f-756c48d09de0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "a12ab7b2-bda5-4f05-aba8-1021b495665a",
                    "activityIds": [
                      "8985d9db-7de4-4c7f-9f0f-756c48d09de0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "017bd024-7fbc-47f8-a6b7-983485aa56eb",
                    "activityIds": [
                      "8985d9db-7de4-4c7f-9f0f-756c48d09de0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "378dd31d-d408-4c13-9bd4-4d895da4d5c1",
                    "activityIds": [
                      "8985d9db-7de4-4c7f-9f0f-756c48d09de0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "30b12196-375e-4363-a206-241da6b5940e",
                    "activityIds": [
                      "8985d9db-7de4-4c7f-9f0f-756c48d09de0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "33fd325d-c6d2-4bf5-936e-f1b75a894ea6",
                    "activityIds": [
                      "396f3d72-2db6-4b51-94b4-1219ee7ea529"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "a2f2b41c-86e9-4c57-8f07-79efbff35a3e",
                    "activityIds": [
                      "396f3d72-2db6-4b51-94b4-1219ee7ea529"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "a8f5dc7a-4a21-4677-9358-d46c5159e9f7",
                    "activityIds": [
                      "396f3d72-2db6-4b51-94b4-1219ee7ea529"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "5bbb816d-ca52-4651-8949-6d8d22ec89f3",
                    "activityIds": [
                      "396f3d72-2db6-4b51-94b4-1219ee7ea529"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "47bba041-324b-405b-b80c-b867c58e6a1a",
                    "activityIds": [
                      "396f3d72-2db6-4b51-94b4-1219ee7ea529"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "1bc23323-f159-438a-8fe1-bc50c7c7b7e8",
                    "activityIds": [
                      "396f3d72-2db6-4b51-94b4-1219ee7ea529"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_30@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "b0745429-a295-4d72-9835-845e1d96326b",
                    "activityIds": [
                      "8f962aea-e76b-483e-998a-419e8f561273"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "ba502c82-9f03-4a02-9f61-1fca34e91cc0",
                    "activityIds": [
                      "8f962aea-e76b-483e-998a-419e8f561273"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "67c02db9-b5d2-457f-a314-d1da4e85cebe",
                    "activityIds": [
                      "8f962aea-e76b-483e-998a-419e8f561273"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "20ebb0c3-bfdd-4e75-ac1d-e8bc16de387a",
                    "activityIds": [
                      "8f962aea-e76b-483e-998a-419e8f561273"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "9883475b-9a0a-4126-99a7-ea5021dbede1",
                    "activityIds": [
                      "eb1443c9-7250-409b-b07a-916a26ffa649"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "a89643f8-9c10-4ece-b24d-5c353edd34c8",
                    "activityIds": [
                      "eb1443c9-7250-409b-b07a-916a26ffa649"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "0081aff6-2273-4fa2-acca-2eaf40524073",
                    "activityIds": [
                      "eb1443c9-7250-409b-b07a-916a26ffa649"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "5f40964d-614a-41c9-bea5-2324e3a17c51",
                    "activityIds": [
                      "eb1443c9-7250-409b-b07a-916a26ffa649"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "b464f09b-0bcf-41d1-9409-f6a27a09b95e",
                    "activityIds": [
                      "eb1443c9-7250-409b-b07a-916a26ffa649"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "c029d120-5d84-4061-8606-04e188f15d7b",
                    "activityIds": [
                      "eb1443c9-7250-409b-b07a-916a26ffa649"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "8706d74c-7964-413d-8b1e-446433432f86",
                    "activityIds": [
                      "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "f6508ae9-29ff-4db0-880e-ca09513aad23",
                    "activityIds": [
                      "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "4255afd6-efdc-4430-928f-a6821f10d407",
                    "activityIds": [
                      "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "d682e6a4-fc9b-485b-af95-5fce5c92d98a",
                    "activityIds": [
                      "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "c58782e7-922c-4594-b993-60d5469190a5",
                    "activityIds": [
                      "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "21b0c7dd-17e1-4daf-afa7-1b357033a915",
                    "activityIds": [
                      "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "492d3e9f-3af4-4157-80ba-ac1c888c59c4",
                    "activityIds": [
                      "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_1",
                    "encounterId": "20710cf9-b814-46c0-b37b-62946152ea78",
                    "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c"
                  },
                  {
                    "id": "f474cb62-8586-4084-8c6b-c5cc0adb767d",
                    "activityIds": [
                      "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_2",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "8ff6e6a5-9871-4f84-8459-b7ba73a6f2d9",
                    "activityIds": [
                      "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_3",
                    "encounterId": "80173e03-910d-4964-9c27-f260c448a495",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "1b183125-47de-4b1b-84a3-e4eb4272561f",
                    "activityIds": [
                      "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_4",
                    "encounterId": "2207af56-63df-419e-b29d-c2e76150e7ee",
                    "epochId": "c5ff935e-8199-4996-b53f-2544932963a2"
                  },
                  {
                    "id": "8bae17cd-1962-4eba-93e5-29c0abd4d7b2",
                    "activityIds": [
                      "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_5",
                    "encounterId": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                    "epochId": "87770647-e529-487f-b35b-9ab91837bd8f"
                  },
                  {
                    "id": "886a66da-834e-44cd-b85f-d446745542fb",
                    "activityIds": [
                      "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_34@enc_6",
                    "encounterId": "61f29a73-b2db-4000-a087-0d09b0947561",
                    "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee"
                  },
                  {
                    "id": "45639551-e011-4d4a-911b-71e5d22dd5ef",
                    "name": "Baseline",
                    "description": "Visit anchor: Baseline",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "5a17f27c-5cdc-41c4-99a7-794adcdae798",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "79be1872-0049-40a6-a2b8-ef274d749bfd",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 50
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "1fa121f6-d828-4d21-b78f-75a56664db74",
                    "name": "FirstDose",
                    "description": "Event anchor: FirstDose",
                    "activityIds": [
                      "7eb11dc1-a40d-4324-bb56-27cfbcd5392e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "5a17f27c-5cdc-41c4-99a7-794adcdae798",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "79be1872-0049-40a6-a2b8-ef274d749bfd",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 60
                      }
                    ],
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871",
                    "scheduledDay": 1
                  },
                  {
                    "id": "9d471744-8ed8-4303-8baa-81df68aa64ef",
                    "name": "Day1",
                    "description": "Visit anchor: Day1",
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "5a17f27c-5cdc-41c4-99a7-794adcdae798",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "79be1872-0049-40a6-a2b8-ef274d749bfd",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 80
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "efbfcd52-e2e4-43f2-9507-ac075c215b76",
                    "name": "Anchor: Screening/Observation Period",
                    "activityIds": [],
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "c805fede-68f0-40a1-9575-b9a5ca317435",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "bbb821b6-8ea9-4356-9c87-e57eff3df3cf",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "e3aa5f18-c51d-4bac-8bcf-f6c629ee0f64",
                    "name": "Anchor: End-of-Treatment Visit (Part A)",
                    "activityIds": [],
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "b2ab8f4e-54be-415c-877c-4bca5aa22ce3",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "923a6bc0-f94b-40cc-9ac9-eaa4642cfa76",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "bc3cf9d3-3c17-4195-b786-b36ba327044a",
                    "name": "Anchor: Early Termination/Safety Follow-up",
                    "activityIds": [],
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "861e2e8a-384c-45c9-a575-bf8b0b5a943e",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "759c5c4c-0d58-4467-939c-080c87977830",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  },
                  {
                    "id": "8671066d-172a-454d-98f2-6162f00210d8",
                    "name": "Anchor: Standard Visit Window (Part A)",
                    "activityIds": [],
                    "encounterId": "847c9515-6359-47b2-a4af-0e0482c1a031",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "e0a6a4b1-0e5a-4a55-b3af-5df566972c09",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "7bc54833-fd78-4c50-adce-f636c8a885f5",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871"
                  }
                ],
                "timings": [
                  {
                    "id": "05cf307b-cd5b-4994-b04e-3f657966407f",
                    "name": "Screening/Observation Period",
                    "type": {
                      "id": "41e5cb1d-a0d5-4a97-be7b-4170986714d3",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P42D",
                    "valueLabel": "Day 42",
                    "relativeToFrom": {
                      "id": "dd0a7fbd-505c-464f-854c-f38cd3511b76",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "efbfcd52-e2e4-43f2-9507-ac075c215b76",
                    "instanceType": "Timing",
                    "windowLower": "-P42D",
                    "windowUpper": "-P1D"
                  },
                  {
                    "id": "d07a917b-4080-4701-9325-4bd6a42c7161",
                    "name": "Part A Treatment Period",
                    "type": {
                      "id": "28073639-5b77-4471-affe-55db9d91d567",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P25W",
                    "valueLabel": "25 weeks",
                    "relativeToFrom": {
                      "id": "1c34bd2c-ec6d-46a2-b519-cc4ba78557c1",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "facff4f2-9b06-42ac-98a2-508814a6d591",
                    "instanceType": "Timing",
                    "windowLower": "P0W",
                    "windowUpper": "P175W"
                  },
                  {
                    "id": "52e89d06-2a66-42dc-9393-b340964cc5bb",
                    "name": "End-of-Treatment Visit (Part A)",
                    "type": {
                      "id": "45c205a3-d1f4-4d67-9d0a-6b29d89a669e",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P1W",
                    "valueLabel": "1 weeks",
                    "relativeToFrom": {
                      "id": "37e9044d-c2ae-4d8c-a91d-a03848f882a9",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "e3aa5f18-c51d-4bac-8bcf-f6c629ee0f64",
                    "instanceType": "Timing",
                    "windowLower": "P7W",
                    "windowUpper": "P7W"
                  },
                  {
                    "id": "a500588b-8e74-4259-a56a-1e7c385ce296",
                    "name": "Early Termination/Safety Follow-up",
                    "type": {
                      "id": "347d0d88-4fec-4727-9088-4b283c5b5860",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P9W",
                    "valueLabel": "9 weeks",
                    "relativeToFrom": {
                      "id": "88494c12-03ac-4d66-b1ed-554857367748",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "bc3cf9d3-3c17-4195-b786-b36ba327044a",
                    "instanceType": "Timing",
                    "windowLower": "P63W",
                    "windowUpper": "P63W"
                  },
                  {
                    "id": "96635332-5edc-4663-874b-e958aa6342a4",
                    "name": "Standard Visit Window (Part A)",
                    "type": {
                      "id": "2a7b21e3-6f08-4350-9860-6c25757df377",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P14D",
                    "valueLabel": "Day 14",
                    "relativeToFrom": {
                      "id": "c6b6c115-a843-4bde-a27c-3be6227afa65",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "8671066d-172a-454d-98f2-6162f00210d8",
                    "instanceType": "Timing",
                    "windowLower": "-P2D",
                    "windowUpper": "P2D"
                  },
                  {
                    "id": "f3fbe72f-0bc4-468a-a1c6-7e9da24d1711",
                    "name": "Home Infusion Window",
                    "type": {
                      "id": "fb8294e7-5429-45ba-8f0a-a57565a05ff3",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P4W",
                    "valueLabel": "4 weeks",
                    "relativeToFrom": {
                      "id": "e8019357-8ba2-4e52-b0e2-bd957887bfbd",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "36249ee4-d4f7-4b48-a351-c0fd0d537636",
                    "instanceType": "Timing",
                    "windowLower": "-P2W",
                    "windowUpper": "P2W"
                  }
                ],
                "exits": [
                  {
                    "id": "b2e232d5-26c7-4093-91c5-d5219ab588ea",
                    "name": "Early Withdrawal Non-Responder",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Any patient withdrawing after Week 5 and prior to Week 23 is a non-responder and ineligible for Part B."
                  },
                  {
                    "id": "5313a3ab-91af-4d0b-a9ff-e339e9e225f0",
                    "name": "Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Part B runs for 2 years following last patient out (LPO) under Part A."
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "847c9515-6359-47b2-a4af-0e0482c1a031",
                "name": "Baseline (Day 0)",
                "instanceType": "Encounter",
                "type": {
                  "id": "c5aeee4e-de19-4111-87a0-3dbdf2c51892",
                  "code": "C142615",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Baseline Visit",
                  "instanceType": "Code"
                },
                "epochId": "6b7959f1-cfbe-485f-963e-b8bec9012871",
                "extensionAttributes": [
                  {
                    "id": "097dad97-91e4-4752-b63d-f238a4b4c5ac",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "91de796b-4a10-4522-a566-5200c7fd2516",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "cbc60813-90a4-425a-8cc7-aee351313bdc",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 0
                  }
                ]
              },
              {
                "id": "b2e61df2-602b-4ccf-b6ba-b0fb44a92f0a",
                "name": "Part B (Every 2 weeks after Week 25)",
                "instanceType": "Encounter",
                "type": {
                  "id": "65929822-970e-401b-8a50-b370b508cd35",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "87770647-e529-487f-b35b-9ab91837bd8f",
                "extensionAttributes": [
                  {
                    "id": "723a2606-36dd-4488-9fe1-9810cef38c31",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "56a8283f-0227-424d-a1bd-c11123541b11",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "742b73d6-16b1-4191-b711-c8d016c8f95f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 25
                  }
                ]
              },
              {
                "id": "2207af56-63df-419e-b29d-c2e76150e7ee",
                "name": "Part A (Week 26 EOT)",
                "instanceType": "Encounter",
                "type": {
                  "id": "76123c13-51c2-4f9f-bb82-9872a04badf6",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "c5ff935e-8199-4996-b53f-2544932963a2",
                "extensionAttributes": [
                  {
                    "id": "75c73c5e-8321-48aa-afdd-4632665acb39",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "467f625c-9034-4271-8f70-189058f8dcca",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "c0692a28-a819-4da1-ad77-3f427a21b12e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 26
                  }
                ]
              },
              {
                "id": "61f29a73-b2db-4000-a087-0d09b0947561",
                "name": "Follow-up (9 weeks after last dose)",
                "instanceType": "Encounter",
                "type": {
                  "id": "2f310c22-125a-4b1d-9d78-1695d77f9412",
                  "code": "C98777",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Visit",
                  "instanceType": "Code"
                },
                "epochId": "53df373b-c52f-4211-9728-97bfbdb19fee",
                "extensionAttributes": [
                  {
                    "id": "e98b9156-79d1-414d-ad02-63c5a4ca9daa",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d7d456f7-921a-45fb-8a72-63bb51ee396d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "80173e03-910d-4964-9c27-f260c448a495",
                "name": "Part A (Weeks 1-25)",
                "instanceType": "Encounter",
                "type": {
                  "id": "a07b2181-3376-4f29-a76a-63a018719238",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "c5ff935e-8199-4996-b53f-2544932963a2",
                "extensionAttributes": [
                  {
                    "id": "f3ab69e8-fdc1-4f10-91f7-8b349ebd1f59",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "5ce70837-94b0-4ec2-849f-4986e841bc0d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "20710cf9-b814-46c0-b37b-62946152ea78",
                "name": "Screening (Days -42, -28 and -14)",
                "instanceType": "Encounter",
                "type": {
                  "id": "829b9cc0-dab1-4a27-a695-1ce9ccf1ff38",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Visit",
                  "instanceType": "Code"
                },
                "epochId": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c",
                "extensionAttributes": [
                  {
                    "id": "54c2d4be-627c-4f1e-9405-645621103ad3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9d75d07b-c291-43fb-84fb-24be64a08659",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "7eb11dc1-a40d-4324-bb56-27cfbcd5392e",
                "name": "12-lead electrocardiogram (predose and 1 hour after infusion on dosing days)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6cafe0ae-6f40-487e-b2ed-05b3cdd2fab8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "2df4af1c-631b-4d42-8cbd-f55afa03f51a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "administration"
                  },
                  {
                    "id": "4f58b075-2257-4672-98a9-14477954e83c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "68cad1d5-af4e-4771-9763-81d10a0cce46",
                "name": "ADAs against BIVV009",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "0c9f153c-d490-40dd-8e81-f88ce628e19b",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f64e7fce-2741-4877-8d75-de3d36cdb43f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6d8201b8-f5d7-421b-905f-31d7a528f9ee",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16",
                "name": "Adverse events",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "58fed490-1fd2-4108-8a30-74f3b865cafe",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "5b4fbee6-9f8d-4139-9d29-49b30e083d63",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "c0f2cf44-6aab-4970-88c6-eb42f48c9fe2",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ee917e9e-4d7d-4828-84dd-470e77ac30f6",
                "name": "Blood Sampling",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "ee917e9e-4d7d-4828-84dd-470e77ac30f6",
                    "name": "Blood Sampling",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "e33f0722-cb84-49a9-9153-55eae7778a40",
                      "code": "36415",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Collection of venous blood by venipuncture",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Blood Draw",
                    "description": "Collection of blood for PK, PD, ADA, and clinical laboratory panels"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "95126a76-1be8-489c-a680-b8d2e29d8921",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "094347a1-8d11-48de-abab-0cfc9799608d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "9e8888a8-54ca-4c7a-b624-0b4336b637ec",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3a8cd648-8214-42fd-bf70-e89e65346952",
                "name": "Blood Transfusion",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "3a8cd648-8214-42fd-bf70-e89e65346952",
                    "name": "Blood Transfusion",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "dc8fe2cf-654f-44d1-9f54-e078254ea8ad",
                      "code": "36430",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Transfusion, blood or blood components",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Transfusion",
                    "description": "Supportive blood transfusion based on Hgb levels"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a6a5d960-4cc2-4aeb-bd71-0b4ee45c1cd8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "3c878c4a-8c19-4ae4-b0ef-5714b8363f1f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "7ecab39f-9c17-4f60-ab1c-6c44c3116174",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3fd65995-e3a0-4b64-a146-ba805ab00f8c",
                "name": "Body weight and height",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a8523025-39aa-4bb0-be1b-147f46a6655e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "45c99db3-1e9c-4091-8170-e82c81ba01e8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "69ef34a6-ec65-4759-b870-e3f68908d142",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "81d41aa2-14fb-45e8-9f41-f0a57f7c6370",
                "name": "Bone Marrow Biopsy",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "f9f418ae-9004-4c7b-ad56-bab81ccb8524",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "ef1e224b-65bf-4e10-a906-4417e6671e2a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "d2c41bd4-dbfd-4da0-8830-0b5e0fabee4b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5ed4abd3-203d-4f44-8009-c9c1de64bf0a",
                "name": "Bone marrow biopsy report review",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "46f537da-db79-441c-ba0f-931fc02b5429",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "24e71a9d-4d2c-40be-93ab-2edc5cbaf793",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "b9eba712-6019-4a6f-8087-8245d689f744",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1",
                "name": "Clinical chemistry panel",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "930b82df-604b-4c06-97fd-b4d86736af73",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "dc4ea502-d438-4e86-8f72-2450513ba19f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "fad07a66-8d1a-4ade-8ebb-cad7fdb3e156",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "50847781-a266-4d9e-a6e5-d6dcbf1aa374",
                "name": "Coagulation panel",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c92a338a-415c-47d2-9742-69db44153a9f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7baea12b-8189-4fcc-a414-bc1355371dbe",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "ef16793f-e9c7-4e28-92dd-a7d3a3e3a67e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "6aecd790-48b3-469a-8804-6b2618acb950",
                "name": "Demographic & baseline characteristics",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7d5cc078-2ee1-4fd8-923e-347b72239ed9",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "85a857ac-40b3-440f-9d12-530226b7f933",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "94847464-1a22-4e87-a50b-3b7bf5457624",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d8c80fa3-a023-4dd4-bef0-b13d8f4d8c56",
                "name": "Detailed medical history",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b2ca5984-32ee-42ad-adcd-4e7e76cef562",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "51e8a399-ee03-494b-9041-8d40edf7ded3",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "056db362-2d86-4569-97f7-295c503dc151",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "8f962aea-e76b-483e-998a-419e8f561273",
                "name": "Disease-related biomarkers",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "f4ab9300-13bd-40f8-824f-1c78249ff8fd",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "26d43ac5-5af8-41a0-b63f-3561a619349e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "5ab6bc52-e731-4120-9d1f-c63645a1bb7f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "20fb064d-26f4-4e3a-a5e0-132d81f85d0a",
                "name": "EQ-5D-5L",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "15bedc9a-35e5-401e-9609-ed0ae8df5aff",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7a20ea42-f348-467b-a482-86846d3a7e9c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "3192eb2a-2c5b-4402-ab53-0d015a2fa52f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b78e1deb-2286-4d0d-9d82-d1449c4788c5",
                "name": "Electrocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1a4e1291-63ce-47b1-b4a0-e9060bf96221",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "958f3524-c932-4afd-a6c2-693b63fb88b9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "10a4c687-00b2-489b-a237-ab702b274dbe",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "eb805dd8-595f-4d59-b066-3940cfe6cd7f",
                "name": "FACIT-Fatigue",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "68b4acdf-6f81-4048-97db-2ed31de72357",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "10d88081-6bb9-42ea-b275-8082172246d4",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "b6a80304-c9d5-4ade-97ca-f9da50d22937",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "11cd596b-d9e5-45d5-a897-52b00186c01c",
                "name": "Gilbert's Syndrome test (UGT1A1 gene)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "634f0516-ee9c-4d5f-9c21-f34342079656",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "5594a80c-8ed9-49f6-8c1d-b315157fdf6b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "2ed24a1c-9f6d-4d6c-8a30-f32f427a83d4",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3",
                "name": "Healthcare resource utilization",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "0cb78da5-3749-42da-ac2e-c9543e36a4b6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6f399de1-1c02-4a92-8adb-3bd7382bafb5",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "fb29b964-5649-4193-8de9-ac6b22683b24",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "0518cffb-0cca-426c-92d7-882f57625f35",
                "name": "Hematology panel",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4161d5a0-904e-41db-83f8-665c7f93eaf8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "766e0197-0d12-46a0-afff-7299fb9ccc56",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "f030f3ef-9cd4-4c9e-b81a-fac2e7d86e3b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "364e3e9a-36de-4323-a893-93f221a7bf98",
                "name": "Inclusion/exclusion criteria",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e2578480-f4c4-4170-a560-4958f5944063",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9a8d4aae-3b87-4aa4-81cd-07a9065f7a06",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "3e109c2b-0d0c-4748-9229-cc11727f2c0e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f8be0636-8940-4a6e-b86e-9dc4b77d90b1",
                "name": "Intravenous Infusion",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "f8be0636-8940-4a6e-b86e-9dc4b77d90b1",
                    "name": "Intravenous Infusion",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "167dac1f-75d7-4f95-b242-7a75ccf6de01",
                      "code": "96365",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "IV Infusion",
                    "description": "Administration of BIVV009 over approximately 60 minutes"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "68b19fe9-209e-4144-b25b-e87e0492204c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "3e88e04b-34d9-4c6c-a166-34d0025fd872",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "240e86d9-fc92-4cc6-a455-dd865df0dbad",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "98cb35a4-4911-4c89-be39-d6b48a715f97",
                "name": "Iron panel and erythropoietin",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "69a05d06-1f45-4297-a14c-26af5f9294c1",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0d46f499-7659-4a60-8d4f-433b9e7400f3",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "bdd76c54-d212-4e9b-8c88-7690836f774d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "14dfc34d-7673-4315-928d-4eb043b06261",
                "name": "Optional bone marrow testing for MYD88 status for consenting patients",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "37b03838-4e24-4d21-a05e-cfdd2a88dbf5",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d213762a-cba5-4dc6-a094-b9da149e58d8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "2641dc17-4181-4fb7-8c23-6fccfb76c280",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "396f3d72-2db6-4b51-94b4-1219ee7ea529",
                "name": "PD samples",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "abe6bfe9-be77-4e11-80f6-3efe552b0c0b",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4887a9e7-09de-4213-8027-fcf69cec8d05",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "1fcf5703-1afd-43ff-b3a5-1c68affc56dd",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "016fe66d-377c-414c-b96d-5019b560366c",
                "name": "PGIC",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "04581812-7a08-404c-b95e-9d8b70237d6c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "37f5dc80-62b1-4f1b-a04a-040a4997761b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "b1b751ba-4d78-49f1-a9c7-f0990beaf5f9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "cbfe23b3-a95d-488f-8890-6864c48c9a42",
                "name": "PGIS",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "23733cfa-a33b-4a8f-a286-8c35f377e061",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0f007e7e-5d18-414d-9b05-d85ce0345900",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "1ffffeab-fdcf-455b-ad93-62b7621ca154",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "8985d9db-7de4-4c7f-9f0f-756c48d09de0",
                "name": "PK samples",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9625cd83-5890-4b24-b7e8-c1e77932719c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "38332ece-3ed4-4425-af0b-dde4e045ea6c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "13fcc77b-83ca-4220-9d83-c4e1ede5e8e5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "de690a4d-5784-4859-9155-9ca83a41458a",
                "name": "Physical Examination",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9b750dfe-183a-48ed-af89-c804f5852d58",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "70f0bc9e-c165-4d10-9d8a-e366bec26d0a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "f46d86f7-1051-4f1d-80e2-855bcb334947",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "cd33be48-392c-4db4-98d5-8510d9830ae5",
                "name": "Physical examination, brief",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "bba37d00-3b93-4086-9c13-7721835d9b29",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ddf2d540-50a6-436c-89ce-1e4db1ef8331",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "dd2771cb-0eb0-47c0-97d3-fa17053aa31c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a1531342-3acd-40b4-bd41-881839e071a1",
                "name": "Physical examination, full",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "93c71a1f-9fde-446a-b035-663a7ecaaa0c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "18762808-f77d-48c7-af91-9df7eb8b6112",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "3f387174-28c0-44a7-a05b-3fab670daba2",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d331e8fa-4033-4659-b0c0-782411862471",
                "name": "Pregnancy test (if applicable)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ed8bde02-3cc4-4286-90e3-8afd7e612052",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ab720e66-7447-4db5-964f-4271f5ccd99e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "2b34b2ad-50c6-4215-8d43-50b548926268",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "eb1443c9-7250-409b-b07a-916a26ffa649",
                "name": "Prior & concomitant medications including transfusions",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "21fe30fb-1c5e-4af8-aa9b-efda47a3066d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "788b9c8f-55bc-4cd0-b283-c796bbf23d02",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "ca6813c5-90b4-40e6-b0cd-05204e57945f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "20947b5c-e5f9-45de-8f8f-3146d82d96d1",
                "name": "SF-12",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d2d66801-3ced-49f7-9dc6-58274773f59e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "af0c928f-895c-418a-befc-223d4cd82373",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "e05cd16d-9cab-4b29-b1ee-df91a31484b6",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5cf0543f-6f13-42a3-8383-4dfd5f401b79",
                "name": "SLE panel",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "0c2cd914-b327-42f3-8696-6d0e1d402758",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "578779de-3a47-4d93-a772-211523e24a87",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "de07ab13-741c-45f8-ba2c-826fcc78b3bd",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3730d953-953e-4246-9f92-1e528d34f02f",
                "name": "Solicited symptomatic anemia",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d03c1cfd-22ba-4acf-ac43-6d0fe3bf532c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1527d956-93dd-4264-b695-d5fe885dac1f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "a1a15c0c-718d-4c6e-b3a3-3db8940f7b70",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "886f872e-f25f-40b7-8872-84658a364d9a",
                "name": "Study drug administration",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "3242a408-de49-471e-91ac-98d86f08c60d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "99df83d3-578b-4fc6-ac36-77e75f31fe82",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "administration"
                  },
                  {
                    "id": "e8e31b18-5334-4151-9927-608eb63e7bc8",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b60b8f94-e039-4923-bd2a-241bd3c2834b",
                "name": "Urinalysis",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "31bf8a8e-171a-4c26-8345-b0e06d133d0c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e23d9a3c-597d-4b6c-9a40-160018a36abe",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "63007981-bc77-4ef9-a012-22d00ce0fa43",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a4243a3d-3a03-47dd-9086-a47423fceaeb",
                "name": "Vaccination",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "a4243a3d-3a03-47dd-9086-a47423fceaeb",
                    "name": "Vaccination",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "36144b8a-ed9f-4281-bd0f-a83d63da1958",
                      "code": "90719",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Immunization administration",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Immunization",
                    "description": "Vaccination against encapsulated bacterial pathogens"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "86dd132f-f084-4307-9366-938f37f40435",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "0e0d36f9-7eeb-488f-9a2f-aa658c96dba2",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "df42daac-8b0a-487a-9ff5-70535287d614",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "120dba5d-ef65-4a50-a70e-0debf580b872",
                "name": "Virology/serology panel",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d51514d5-d46e-4558-8c48-330c53b7f927",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7a0cf730-5861-4abc-be55-dd8a9807b181",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "1b4449e2-70ed-4d16-94cc-80e8441cfea0",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "814d2ed6-e5ff-4e92-951b-75c6ee449182",
                "name": "Vital Signs Measurement",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "814d2ed6-e5ff-4e92-951b-75c6ee449182",
                    "name": "Vital Signs Measurement",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "eabd6855-6266-4fe4-bd2f-2b7ebcf0f413",
                      "code": "BP_01",
                      "codeSystem": "Internal",
                      "codeSystemVersion": "",
                      "decode": "Vital signs monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Vital Signs",
                    "description": "Measurement of blood pressure, heart rate, and temperature"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "17adbba9-3e73-432f-ae1b-11cb66fc25a0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "01662d12-e36a-478d-90b3-bb2b2d36f659",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "3e935853-13a4-4d96-8b1a-6ac1a20afe0c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f55d98dc-e754-457c-9a37-20d32ee222ee",
                "name": "Vital signs (BP, PR, RR, body temperature)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d6297b0e-6811-4ae8-8e77-f00d281da7ca",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "85295f21-14e3-40d7-a31a-263f4bf273b1",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "81efb131-d70a-4315-9ddf-bc6fd42dd343",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d37e15b8-95a5-4e49-b83f-365e5e0ae2c8",
                "name": "Written informed consent",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "dc2a356b-5208-474f-9e03-6b9c6f9a5dbd",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "602b5bbd-275e-4bbe-b080-432f907fda64",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "162f873f-3e3f-47f5-a666-2ed52e5e111d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "a67bcba4-ec2b-4d12-b75e-0b8968f3591c",
                "name": "Screening/observation period",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "bcc0f042-1c78-4076-a14e-85180fa08fd3",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "d66679d9-ca99-4e8d-b875-a6f75f677b47",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "9d171863-5175-4c5f-bbbd-08b546a8d81e",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "c30514f6-af34-4b12-851a-189b338881bc",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "6b7959f1-cfbe-485f-963e-b8bec9012871",
                "name": "Baseline",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "b46808e5-be33-4225-b5ce-57d4f0494bf7",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "875a45b7-c85c-4cf2-b1d5-b8691e20aac8",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "33030075-39b8-4dfd-9bed-4f8dc9e0a39b",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "d12e3852-72bf-474c-8dd7-feb9fdfc43f4",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "2"
                  }
                ]
              },
              {
                "id": "c5ff935e-8199-4996-b53f-2544932963a2",
                "name": "Part",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "7ebda0b9-9405-4722-a351-163b6186409d",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "73b775c3-6fdd-449b-bbb0-9e4d74a48415",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochRawName",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "Part A"
                  },
                  {
                    "id": "eb67bf91-b7c6-416c-b04a-f1fe217949d0",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "e64a75e5-938c-44e5-956e-f1884bd4d7d0",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "705da8e8-0ff4-40a9-ad52-dbfc93723199",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "3"
                  }
                ]
              },
              {
                "id": "87770647-e529-487f-b35b-9ab91837bd8f",
                "name": "Part B Extension phase",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "bae74547-60f6-4fcd-beb4-ecd8f656921c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "144eb935-43ca-47a6-b3b9-4c74098fb934",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "83a2cb94-fed5-41b0-96bc-b4ad0ae82ff5",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "33c3ed67-1acd-4242-a98b-6be048f7e7de",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "4"
                  }
                ]
              },
              {
                "id": "53df373b-c52f-4211-9728-97bfbdb19fee",
                "name": "ET/EOS/Safety follow-up",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "38342ecf-0292-43f5-87df-a2b1c8388d06",
                  "code": "C98781",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "2ede9cc3-45d0-486e-ad9c-b8e5fcfb993e",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "887dcafc-936b-4d5d-ae8e-d06bf1601f5b",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "f146510b-f479-42fd-baac-d923b3399e5a",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "5"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c",
                "name": "Study Procedures",
                "description": null,
                "childIds": [
                  "d37e15b8-95a5-4e49-b83f-365e5e0ae2c8",
                  "6aecd790-48b3-469a-8804-6b2618acb950",
                  "d8c80fa3-a023-4dd4-bef0-b13d8f4d8c56",
                  "364e3e9a-36de-4323-a893-93f221a7bf98",
                  "5ed4abd3-203d-4f44-8009-c9c1de64bf0a",
                  "14dfc34d-7673-4315-928d-4eb043b06261",
                  "d331e8fa-4033-4659-b0c0-782411862471",
                  "3fd65995-e3a0-4b64-a146-ba805ab00f8c",
                  "a1531342-3acd-40b4-bd41-881839e071a1",
                  "cd33be48-392c-4db4-98d5-8510d9830ae5",
                  "f55d98dc-e754-457c-9a37-20d32ee222ee",
                  "7eb11dc1-a40d-4324-bb56-27cfbcd5392e",
                  "120dba5d-ef65-4a50-a70e-0debf580b872",
                  "11cd596b-d9e5-45d5-a897-52b00186c01c",
                  "5cf0543f-6f13-42a3-8383-4dfd5f401b79",
                  "98cb35a4-4911-4c89-be39-d6b48a715f97",
                  "0518cffb-0cca-426c-92d7-882f57625f35",
                  "50847781-a266-4d9e-a6e5-d6dcbf1aa374",
                  "5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1",
                  "b60b8f94-e039-4923-bd2a-241bd3c2834b",
                  "eb805dd8-595f-4d59-b066-3940cfe6cd7f",
                  "cbfe23b3-a95d-488f-8890-6864c48c9a42",
                  "016fe66d-377c-414c-b96d-5019b560366c",
                  "20947b5c-e5f9-45de-8f8f-3146d82d96d1",
                  "20fb064d-26f4-4e3a-a5e0-132d81f85d0a",
                  "3730d953-953e-4246-9f92-1e528d34f02f",
                  "886f872e-f25f-40b7-8872-84658a364d9a",
                  "68cad1d5-af4e-4771-9763-81d10a0cce46",
                  "8985d9db-7de4-4c7f-9f0f-756c48d09de0",
                  "396f3d72-2db6-4b51-94b4-1219ee7ea529",
                  "8f962aea-e76b-483e-998a-419e8f561273",
                  "eb1443c9-7250-409b-b07a-916a26ffa649",
                  "73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3",
                  "ca745ea0-69ad-41ce-bfd6-95f8e51e8f16"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Written informed consent",
                  "Demographic & baseline characteristics",
                  "Detailed medical history",
                  "Inclusion/exclusion criteria",
                  "Immunization review/vaccination",
                  "Bone marrow biopsy report review",
                  "Optional bone marrow testing for MYD88 status for consenting patients",
                  "Pregnancy test (if applicable)",
                  "Body weight and height",
                  "Physical examination, full",
                  "Physical examination, brief",
                  "Vital signs (BP, PR, RR, body temperature)",
                  "12-lead electrocardiogram (predose and 1 hour after infusion on dosing days)",
                  "Virology/serology panel",
                  "Gilbert's Syndrome test (UGT1A1 gene)",
                  "SLE panel",
                  "Iron panel and erythropoietin",
                  "Hematology panel",
                  "Coagulation panel",
                  "Clinical chemistry panel",
                  "Urinalysis",
                  "FACIT-Fatigue",
                  "PGIS",
                  "PGIC",
                  "SF-12",
                  "EQ-5D-5L",
                  "Solicited symptomatic anemia",
                  "Study drug administration",
                  "ADAs against BIVV009",
                  "PK samples",
                  "PD samples",
                  "Disease-related biomarkers",
                  "Prior & concomitant medications including transfusions",
                  "Healthcare resource utilization",
                  "Adverse events"
                ]
              }
            ],
            "notes": [
              {
                "id": "13769c79-439a-4de1-9019-58dcb51e1ba6",
                "text": "a. The 6-week Screening/Observation Period may be extended by 1 week for patients requiring a blood transfusion prior to study drug administration.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9b08a226-f65d-47a7-9cab-5bcc335bc689",
                "text": "b. Patients should return to the site 9 weeks after last dose for ET procedures, EOS assessment, or Safety Follow-up procedures upon completion of dosing in the study. If patient experiences a hematological breakthrough event, a PK, PD, and ADA sample should be collected at the time of the event.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "81d10a4f-2bae-4202-8f9e-1d551157b791",
                "text": "c. Applicable to patients who do not have documented vaccination against encapsulated bacterial pathogens within 5 years of enrollment. Refer to immunization recommendations per Section 6.1.1.1 for patients requiring vaccination. A blood sample for vaccine titers will be collected on Day 0 prior to study drug infusion to be used to determine serum relevant antibody titers should the patient be diagnosed with an infection associated with an encapsulated organism during the course of the study. A second sample will be collected during the study period if a patient presents with symptoms concerning for an infection with Streptococcus pneumoniae, Neisseria meningitidis or Haemophilus influenzae and analyzed if the infection is confirmed with one of the aforementioned organisms.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "144eeff4-ea6e-4ea1-b2fb-4ef2386a9b56",
                "text": "d. Prior bone marrow biopsy report review, prior tissue assessment, or new bone marrow biopsy (as applicable). Sites will submit de-identified biopsy reports to independent central reader for eligibility adjudication. If biopsy is deemed unsuitable or insufficient to determine eligibility, either prior tissue may be submitted for additional hematopathology assessment or a new bone marrow biopsy will be performed during the screening period.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "988164fb-fd87-4ef2-8d73-70f8dabc8eca",
                "text": "e. Females of child-bearing potential only. Serum pregnancy test to be performed at Screening. Serum or urine pregnancy test to be performed on Days 0, 21, 49, 77, 105, 133, and 161, and at Week 26/EOT or at the ET Visit. Repeat serum or urine pregnancy test every 4 weeks (±2 days) during Part B.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "fb6636af-37d3-4f8f-a8dc-eedcd59dcc15",
                "text": "f. Height measured at Screening only. Body weight measured every 3 months during Part B.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "88daab3c-9150-4d59-be77-9d3d06a6097f",
                "text": "g. Vital signs measurements (supine BP, PR, RR, and oral temperature) are to be obtained at Screening and at each subsequent visit, with measurements performed predose and 1 hour (±5 minutes) after completion of administration of each dose of study drug.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "2e9a29fe-b3d9-4c81-b1a6-ee41b7c4efc1",
                "text": "h. For a complete list of analytes, see protocol (Section 10.1, Appendix A).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "914153ab-8a1b-4a43-83d5-08bfcc57f133",
                "text": "i. BIVV009 doses of 6.5 grams (if <75 kg) or 7.5 grams (if ≥75 kg) based on patient's baseline body weight will be administered via IV infusion over ~60 ±5 minutes on Days 0, 7, and every 14 days thereafter during Part A, and every 2 weeks starting at Week 27 during Part B. Patients with underlying cardiopulmonary disease may receive a 2-hour infusion with Sponsor approval. If a patient misses a scheduled dose (outside of the 2-day window or >17 days since last dose), they must return to site (unscheduled visit) to receive another loading dose 1 week prior to the next scheduled dose. Qualifying patients at participating sites may have study drug dosed at home during certain visits in Part B, according to the rules specified in Section 10.10 Appendix J (US, the Netherlands, Norway, France, Italy, Austria, Germany, Spain, and specific amendments.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "17d66d73-ae9a-4571-8f8f-52895a2aa990",
                "text": "j. During Part A, PK and PD samples will be collected at predose and 1 hour (±15 minutes) postdose (ie, 1 hour after completion of study drug infusion) from all patients on Days 0, 7, 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175. An additional blood sample for PK and PD analysis will be collected during the EOT visit on Day 182 or at ET if a patient withdraws early. During Part B, PK and PD samples will be collected routinely at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals. PK and PD samples will also be collected if a patient experiences a hematologic breakthrough event at any point during the study.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "cf7fe247-7ebb-483d-9cfa-6f8393226142",
                "text": "k. AEs will be recorded from the time the patient signs the informed consent form until 9 weeks after administration of the last dose of study drug.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "0470878c-3d83-463d-88a5-f1ce2b793d3e",
                "text": "l. To be performed every 3 months.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "755fc714-4a45-4048-869a-bec8ccc675b4",
                "text": "m. Refer to the Laboratory Manual for details of sample collection during Screening.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "0aa2f1db-c2a7-42dd-ad60-080ee9fdc0a3",
                "text": "n. Samples will be collected for a subset of the disease-related biomarkers at Day 91 only. Refer to the Laboratory Manual for details.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "49e1f47f-2710-4032-91e4-3a1ed247ef3f",
                "text": "o. During Part B, a 12-lead ECG will be conducting pre- and postdose at 3 months (Day 273).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "efcbfa9c-dc7a-4eea-ac1a-0293dae4d29d",
                "text": "p. During Part B, the healthcare resource utilization data will be recorded every 4 weeks.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a791e4e6-725d-49c7-83d5-ad8530678ab7",
                "text": "q. To be performed in the following order: FACIT-Fatigue first, PGIS second, PGIC third, SF-12 fourth, and EQ-5D-5L fifth.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7baab0ce-53fc-4de3-9b67-25b68033c6ce",
                "text": "r. During Part B, ADA samples will be collected at predose at 3-month intervals during the 1st year of treatment in Part B and then at 6-month intervals and at safety follow up visit 9 weeks after last dose. Samples will also be collected if a patient experiences a hematologic breakthrough event or withdraws from the study early.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "4d4a6637-6412-4ee0-a4df-2034779c693e",
                "text": "s. SLE panel will be performed every 6 months in Part-B of the study.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "ee43b5e4-edde-4bec-bc80-cc8824748df2",
                "text": "t. In Part B, hematology and clinical chemistry panels to be performed every 2 weeks after Week 25 and up to Week 79. For the remainder of Part B after Week 79, hematology and clinical chemistry panels to be performed every 4 weeks.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "22de7d9f-79a2-4307-9889-81b4b68a8b7f",
                "text": "u. To be performed at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "971c5ca0-c94e-4c9c-a4ed-004b34b2b5c0",
                "text": "h. For a complete list of analytes, see protocol (Section 10.1, Appendix A).",
                "instanceType": "Note"
              },
              {
                "id": "eaa0cac6-79e0-4ad3-bf24-ee17374bb4a6",
                "text": "l. To be performed every 3 months.",
                "instanceType": "Note"
              },
              {
                "id": "56852b16-6c4d-4169-a747-1e03640c0d34",
                "text": "m. Refer to the Laboratory Manual for details of sample collection during Screening.",
                "instanceType": "Note"
              },
              {
                "id": "6f5ee245-9676-44c1-aca0-6e71ad2b47f2",
                "text": "u. To be performed at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals.",
                "instanceType": "Note"
              }
            ],
            "model": {
              "id": "e044fdb2-90a6-48bf-8120-3d20877b7f57",
              "code": "C82638",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Single Group Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "1bc7a9e7-dd46-464c-ab44-ac277253f97f",
                "name": "Primary Cold Agglutinin Disease",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Patients with primary cold agglutinin disease who have a recent history of blood transfusion"
              }
            ],
            "procedures": [
              {
                "id": "f8be0636-8940-4a6e-b86e-9dc4b77d90b1",
                "name": "Intravenous Infusion",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "167dac1f-75d7-4f95-b242-7a75ccf6de01",
                  "code": "96365",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "IV Infusion",
                "description": "Administration of BIVV009 over approximately 60 minutes"
              },
              {
                "id": "ee917e9e-4d7d-4828-84dd-470e77ac30f6",
                "name": "Blood Sampling",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "e33f0722-cb84-49a9-9153-55eae7778a40",
                  "code": "36415",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Collection of venous blood by venipuncture",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Blood Draw",
                "description": "Collection of blood for PK, PD, ADA, and clinical laboratory panels"
              },
              {
                "id": "814d2ed6-e5ff-4e92-951b-75c6ee449182",
                "name": "Vital Signs Measurement",
                "procedureType": "Monitoring",
                "code": {
                  "id": "eabd6855-6266-4fe4-bd2f-2b7ebcf0f413",
                  "code": "BP_01",
                  "codeSystem": "Internal",
                  "codeSystemVersion": "",
                  "decode": "Vital signs monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Vital Signs",
                "description": "Measurement of blood pressure, heart rate, and temperature"
              },
              {
                "id": "3a8cd648-8214-42fd-bf70-e89e65346952",
                "name": "Blood Transfusion",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "dc8fe2cf-654f-44d1-9f54-e078254ea8ad",
                  "code": "36430",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Transfusion, blood or blood components",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Transfusion",
                "description": "Supportive blood transfusion based on Hgb levels"
              },
              {
                "id": "a4243a3d-3a03-47dd-9086-a47423fceaeb",
                "name": "Vaccination",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "36144b8a-ed9f-4281-bd0f-a83d63da1958",
                  "code": "90719",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Immunization administration",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Immunization",
                "description": "Vaccination against encapsulated bacterial pathogens"
              }
            ],
            "analysisPopulations": [
              {
                "id": "76e717ef-fe6c-4b4e-a031-64b48425bd5a",
                "name": "Full Analysis Set",
                "text": "The Full Analysis Set (FAS) is defined as all subjects who received at least one dose of study drug (BIVV009). The FAS will be the primary population for the efficacy analysis.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "FAS",
                "populationDescription": "The Full Analysis Set (FAS) is defined as all subjects who received at least one dose of study drug (BIVV009). The FAS will be the primary population for the efficacy analysis.",
                "criteria": "Received >=1 dose of study drug"
              },
              {
                "id": "b294e3b9-4f45-4eab-9179-4cbf727221cc",
                "name": "Per-protocol Set",
                "text": "The Per-protocol (PP) Set is a subset of the FAS and will include those subjects who completed the 26-week treatment period and did not have any major protocol deviations that would impact the primary efficacy endpoint.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "PP",
                "populationDescription": "The Per-protocol (PP) Set is a subset of the FAS and will include those subjects who completed the 26-week treatment period and did not have any major protocol deviations that would impact the primary efficacy endpoint.",
                "criteria": "Subset of FAS AND completed 26-week treatment AND no major protocol deviations impacting primary endpoint"
              },
              {
                "id": "54429174-f673-4388-9e48-a9d84aec7c0e",
                "name": "Safety Analysis Set",
                "text": "The Safety Analysis Set is defined as all subjects who received at least one dose of study drug. This population will be used for all safety analyses.",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "SAF",
                "populationDescription": "The Safety Analysis Set is defined as all subjects who received at least one dose of study drug. This population will be used for all safety analyses.",
                "criteria": "Received >=1 dose of study drug"
              },
              {
                "id": "9b47ebcf-b42f-4150-b5bc-8a464f0f7ac1",
                "name": "PK Analysis Set",
                "text": "The PK Analysis Set is defined as all subjects who received at least one dose of study drug and have at least one evaluable PK sample.",
                "populationType": "PK/PD",
                "instanceType": "AnalysisPopulation",
                "label": "PK",
                "populationDescription": "The PK Analysis Set is defined as all subjects who received at least one dose of study drug and have at least one evaluable PK sample.",
                "criteria": "Received >=1 dose of study drug AND has >=1 evaluable PK sample"
              },
              {
                "id": "ccb006cd-1893-4333-adeb-d55d0fe3f28e",
                "name": "PD Analysis Set",
                "text": "The PD Analysis Set is defined as all subjects who received at least one dose of study drug and have at least one evaluable PD sample.",
                "populationType": "PK/PD",
                "instanceType": "AnalysisPopulation",
                "label": "PD",
                "populationDescription": "The PD Analysis Set is defined as all subjects who received at least one dose of study drug and have at least one evaluable PD sample.",
                "criteria": "Received >=1 dose of study drug AND has >=1 evaluable PD sample"
              }
            ],
            "characteristics": [
              {
                "id": "b7560153-1157-42bc-b0ad-768a035d8a37",
                "code": "HEMOGLOBIN",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Hemoglobin",
                "instanceType": "Code"
              },
              {
                "id": "a76a988c-9d49-4528-85e0-b07b986bf067",
                "code": "BILIRUBIN",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Bilirubin",
                "instanceType": "Code"
              },
              {
                "id": "68514f4d-cf15-45b5-b4d0-08c04a519407",
                "code": "FACIT-FATIGUE_SCORE",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "FACIT-Fatigue Score",
                "instanceType": "Code"
              },
              {
                "id": "35eb1ba3-35d0-4dc6-bea0-6371cf879f96",
                "code": "LACTATE_DEHYDROGENAS",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Lactate Dehydrogenase",
                "instanceType": "Code"
              }
            ],
            "extensionAttributes": [
              {
                "id": "890372f1-8e50-4c21-97bd-d5d321bc4a0c",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMaps",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"epochAliases\": {\"SCREENING/OBSERVATION PERIOD\": \"epoch_1\", \"SCREENING/OBSERVATION_PERIOD\": \"epoch_1\", \"SCREENING\": \"epoch_1\", \"BASELINE\": \"epoch_2\", \"PART A\": \"epoch_3\", \"PART_A\": \"epoch_3\", \"PART B EXTENSION PHASE\": \"epoch_4\", \"PART_B_EXTENSION_PHASE\": \"epoch_4\", \"ET/EOS/SAFETY FOLLOW-UP\": \"epoch_5\", \"ET/EOS/SAFETY_FOLLOW-UP\": \"epoch_5\", \"FOLLOW_UP\": \"epoch_5\"}, \"visitAliases\": {\"SCREENING (DAYS -42, -28 AND -14)\": \"enc_1\", \"SCREENING_(DAYS_-42,_-28_AND_-14)\": \"enc_1\", \"BASELINE (DAY 0)\": \"enc_2\", \"BASELINE_(DAY_0)\": \"enc_2\", \"PART A (WEEKS 1-25)\": \"enc_3\", \"PART_A_(WEEKS_1-25)\": \"enc_3\", \"PART A (WEEK 26 EOT)\": \"enc_4\", \"PART_A_(WEEK_26_EOT)\": \"enc_4\", \"PART B (EVERY 2 WEEKS AFTER WEEK 25)\": \"enc_5\", \"PART_B_(EVERY_2_WEEKS_AFTER_WEEK_25)\": \"enc_5\", \"FOLLOW-UP (9 WEEKS AFTER LAST DOSE)\": \"enc_6\", \"FOLLOW-UP_(9_WEEKS_AFTER_LAST_DOSE)\": \"enc_6\", \"Screening\": \"enc_1\", \"EOT\": \"enc_4\", \"baseline\": \"enc_2\", \"Week 25\": \"enc_5\", \"Week 26\": \"enc_4\", \"Follow-up\": \"enc_6\"}}"
              },
              {
                "id": "ext_conceptual_d54d0293-4102-443d-9ade-d4b43ddab9e2",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"facff4f2-9b06-42ac-98a2-508814a6d591\", \"name\": \"Part A Treatment Period\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"36249ee4-d4f7-4b48-a351-c0fd0d537636\", \"name\": \"Home Infusion Window\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "0d01bd63-1abe-4c90-b1b9-405cfd08a25d",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: efbfcd52-e2e4-43f2-9507-ac075c215b76 (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Part A Treatment Period' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: e3aa5f18-c51d-4bac-8bcf-f6c629ee0f64 (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: bc3cf9d3-3c17-4195-b786-b36ba327044a (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 8671066d-172a-454d-98f2-6162f00210d8 (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Home Infusion Window' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}]"
              },
              {
                "id": "b2195d30-575c-4431-bbea-994d6ce998bf",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"8e8cdabb-460e-4d55-9931-7e4cd20f67b6\", \"definition\": \"First administration of investigational product\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 60, \"sourceText\": \"first dose of study drug\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"a0e5fb7d-1ae8-4ec6-965e-588036892047\", \"definition\": \"The start of the screening/observation period, with Day 1 implicitly following the Day -42 to Day -1 window\", \"anchorType\": \"Day1\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 80, \"sourceText\": \"Screening/observation period (Day -42 to Day -1)\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"6b129543-d648-4085-8b36-1733075a6a0a\", \"definition\": \"Baseline visit/assessment\", \"anchorType\": \"Baseline\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 50, \"sourceText\": \"baseline visit\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"36744fbb-b164-4dac-b221-0309762996dc\", \"definition\": \"Procedure\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 100, \"sourceText\": \"Procedure\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "351208a1-3d2c-4b22-92e8-c32c86f96af9",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"7b8d15ef-11ac-4aff-93aa-aab01280a549\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"bed432bc-3e15-4998-8e6b-4f3292a1bb30\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"OD\"}, {\"id\": \"570a1e63-def5-4b29-b1dd-440b71b79ca4\", \"type\": \"Interval\", \"sourceText\": \"bid\"}, {\"id\": \"2a00ba15-54a7-40b5-ab7c-7d15c5ddfcfd\", \"type\": \"Interval\", \"sourceText\": \"tid\"}, {\"id\": \"3cc1472c-d295-4f1c-89f5-dd4b88e10f4d\", \"type\": \"Interval\", \"sourceText\": \"PK samples at \"}, {\"id\": \"f728fdc3-4767-4652-85a1-33832cc227ab\", \"type\": \"Continuous\", \"startOffset\": \"-P42D\", \"endOffset\": \"-P1D\", \"sourceText\": \"Day -42 to Day -1\"}, {\"id\": \"f01583f9-ce17-46d3-bdc8-8af92e3ed8e4\", \"type\": \"Continuous\", \"startOffset\": \"-P42D\", \"endOffset\": \"-P1D\", \"sourceText\": \"Days -42 through Day -1\"}, {\"id\": \"616dbb5c-b12d-4c19-ab05-9e345ffca9e6\", \"type\": \"Continuous\", \"endOffset\": \"P175D\", \"sourceText\": \"Day 0 through Day 175\"}, {\"id\": \"79bf7eba-f612-41ce-ada3-6d290ce3d4d0\", \"type\": \"Continuous\", \"startOffset\": \"P1D\", \"endOffset\": \"P25D\", \"sourceText\": \"Weeks 1-25\"}, {\"id\": \"0fcd8d87-fca0-493e-a507-e8775311423d\", \"type\": \"Continuous\", \"startOffset\": \"P5D\", \"endOffset\": \"P26D\", \"sourceText\": \"Week 5 through Week 26\"}, {\"id\": \"a616d931-2aa2-4b14-a1b8-243888bd5486\", \"type\": \"Continuous\", \"sourceText\": \"treatment period\"}, {\"id\": \"2b4f8d44-89e8-4043-b8ad-08ac1f57fd6c\", \"type\": \"Continuous\", \"sourceText\": \"treatment \\nperiod\"}, {\"id\": \"e95d0d8c-e338-4ab1-b3ec-50b625abcf34\", \"type\": \"Continuous\", \"sourceText\": \"dosing window\"}, {\"id\": \"cd0ac86f-2de5-45f5-ad12-e6024bb17f9e\", \"type\": \"Continuous\", \"sourceText\": \"Treatment period\"}, {\"id\": \"cb788261-7624-46c0-9a59-15ac0e6c1fc6\", \"type\": \"Continuous\", \"sourceText\": \"observation period\"}, {\"id\": \"5245cf58-8cbf-484f-8141-5ee3e4f4c770\", \"type\": \"Continuous\", \"sourceText\": \"Observation Period\"}, {\"id\": \"473e602a-01c2-4051-865f-c74bd3b41d10\", \"type\": \"Continuous\", \"sourceText\": \"1 hour post\"}, {\"id\": \"e5285198-dece-44b3-a83a-a6ddd2b45219\", \"type\": \"Continuous\", \"sourceText\": \"1 hour after\"}, {\"id\": \"e5162748-b9b6-4957-b8d8-cccf7659b135\", \"type\": \"Interval\", \"startOffset\": \"P0D\", \"endOffset\": \"P1Y\", \"interval\": \"P3M\", \"minObservations\": 4, \"exitCondition\": \"Completion of 1st year of treatment in Part B\", \"sourceText\": \"Samples will be collected at 3-month intervals during the 1st year of treatment in Part B\"}, {\"id\": \"2f8f1679-74ce-4e2f-be8b-783372b75c05\", \"type\": \"Interval\", \"startOffset\": \"P1Y\", \"endOffset\": \"P2Y\", \"interval\": \"P6M\", \"minObservations\": 2, \"exitCondition\": \"Remainder of the time on study\", \"sourceText\": \"then at 6-month intervals for the remainder of the time on study.\"}, {\"id\": \"80db981e-4142-4544-a469-777aec7e2c9e\", \"type\": \"Interval\", \"startOffset\": \"PT0H\", \"endOffset\": \"PT1H\", \"interval\": \"PT1H\", \"minObservations\": 2, \"exitCondition\": \"null\", \"sourceText\": \"Collection of PK samples at predose and 1 hour (\\u00b115 minutes) postdose was added.\"}, {\"id\": \"b73dddf4-6759-47fc-8a3c-d1f12fa4ddb6\", \"type\": \"Continuous\", \"startOffset\": \"PT0H\", \"endOffset\": \"PT24H\", \"interval\": \"PT24H\", \"minObservations\": 1, \"exitCondition\": \"null\", \"sourceText\": \"safety assessments include AEs with onset within 24 hours of infusion was added.\"}, {\"id\": \"6264450f-912d-4d9f-8c70-fedd07e821ea\", \"type\": \"Cycle\", \"startOffset\": \"P0D\", \"endOffset\": \"P2Y\", \"interval\": \"P2Y\", \"minObservations\": 1, \"exitCondition\": \"24 months following LPO for Part A\", \"sourceText\": \"The Part B open-label extension study will run for 2 years instead of 1 year following last patient out (LPO) under Part A.\"}]"
              },
              {
                "id": "69a30576-9de9-4d2a-be38-96a3623310ae",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"653e1078-148c-4969-8e3f-4e4a69970322\", \"requiredSequence\": [\"epoch_1\", \"epoch_2\", \"epoch_3\", \"epoch_4\", \"epoch_5\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_2\", \"enc_6\", \"enc_1\", \"enc_2\", \"enc_6\"], \"sourceText\": \"[{'condition': 'Subject at preselected site/country qualifies for home infusion', 'path': ['HOME_INFUSION_ADMINISTRATION', 'HOME_INFUSION_SATISFACTION_ASSESSMENT']}, {'condition': 'ADA testing required', 'path': ['PREDOSE_PD_BACKUP_SAMPLE_TESTING']}]\"}]"
              },
              {
                "id": "22f83d3f-a973-447d-8e16-2c1ba055f56a",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"b44b4553-edf0-4551-a367-12253e619fb2\", \"conditionType\": \"timing_before\", \"text\": \"a. The 6-week Screening/Observation Period may be extended by 1 week for patients requiring a blood transfusion prior to study drug administration.\", \"footnoteId\": \"bcf198f1-8b15-4933-ad85-dc46f6da17e8\", \"sourceText\": \"a. The 6-week Screening/Observation Period may be extended by 1 week for patients requiring a blood \", \"appliesToActivityIds\": [\"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"14dfc34d-7673-4315-928d-4eb043b06261\", \"eb1443c9-7250-409b-b07a-916a26ffa649\", \"886f872e-f25f-40b7-8872-84658a364d9a\"]}, {\"id\": \"7d9c6420-33dd-41dc-a7a7-aff028432467\", \"conditionType\": \"timing_after\", \"text\": \"b. Patients should return to the site 9 weeks after last dose for ET procedures, EOS assessment, or Safety Follow-up procedures upon completion of dosing in the study. If patient experiences a hematological breakthrough event, a PK, PD, and ADA sample should be collected at the time of the event.\", \"footnoteId\": \"f2bdebff-fc1c-460d-9250-699e087b2d2d\", \"sourceText\": \"b. Patients should return to the site 9 weeks after last dose for ET procedures, EOS assessment, or \", \"appliesToActivityIds\": [\"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"14dfc34d-7673-4315-928d-4eb043b06261\"]}, {\"id\": \"32c13eb7-7fd1-4b35-8a1f-5a071d100420\", \"conditionType\": \"timing_before\", \"text\": \"c. Applicable to patients who do not have documented vaccination against encapsulated bacterial pathogens within 5 years of enrollment. Refer to immunization recommendations per Section 6.1.1.1 for patients requiring vaccination. A blood sample for vaccine titers will be collected on Day 0 prior to study drug infusion to be used to determine serum relevant antibody titers should the patient be diagnosed with an infection associated with an encapsulated organism during the course of the study. A second sample will be collected during the study period if a patient presents with symptoms concerning for an infection with Streptococcus pneumoniae, Neisseria meningitidis or Haemophilus influenzae and analyzed if the infection is confirmed with one of the aforementioned organisms.\", \"footnoteId\": \"ec051480-fdfb-40fd-9497-ff518940759c\", \"sourceText\": \"c. Applicable to patients who do not have documented vaccination against encapsulated bacterial path\", \"appliesToActivityIds\": [\"886f872e-f25f-40b7-8872-84658a364d9a\", \"3fd65995-e3a0-4b64-a146-ba805ab00f8c\", \"eb1443c9-7250-409b-b07a-916a26ffa649\", \"68cad1d5-af4e-4771-9763-81d10a0cce46\", \"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"14dfc34d-7673-4315-928d-4eb043b06261\"]}, {\"id\": \"0fa71dc4-b872-4b16-bb60-74eea65c36e0\", \"conditionType\": \"general\", \"text\": \"d. Prior bone marrow biopsy report review, prior tissue assessment, or new bone marrow biopsy (as applicable). Sites will submit de-identified biopsy reports to independent central reader for eligibility adjudication. If biopsy is deemed unsuitable or insufficient to determine eligibility, either prior tissue may be submitted for additional hematopathology assessment or a new bone marrow biopsy will be performed during the screening period.\", \"footnoteId\": \"9d5f4bf9-2466-4046-b6af-ea0839ae3cf1\", \"sourceText\": \"d. Prior bone marrow biopsy report review, prior tissue assessment, or new bone marrow biopsy (as ap\", \"appliesToActivityIds\": [\"eb1443c9-7250-409b-b07a-916a26ffa649\", \"d331e8fa-4033-4659-b0c0-782411862471\", \"5ed4abd3-203d-4f44-8009-c9c1de64bf0a\"]}, {\"id\": \"92ccd1ef-02cc-4320-8306-47302b5204c9\", \"conditionType\": \"timing_at\", \"text\": \"e. Females of child-bearing potential only. Serum pregnancy test to be performed at Screening. Serum or urine pregnancy test to be performed on Days 0, 21, 49, 77, 105, 133, and 161, and at Week 26/EOT or at the ET Visit. Repeat serum or urine pregnancy test every 4 weeks (\\u00b12 days) during Part B.\", \"footnoteId\": \"9340ec52-a965-4777-a36e-af0a6e399e2e\", \"sourceText\": \"e. Females of child-bearing potential only. Serum pregnancy test to be performed at Screening. Serum\", \"appliesToActivityIds\": [\"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"d331e8fa-4033-4659-b0c0-782411862471\"]}, {\"id\": \"92e6c11d-90c2-476c-8436-6a53ceb8db67\", \"conditionType\": \"general\", \"text\": \"f. Height measured at Screening only. Body weight measured every 3 months during Part B.\", \"footnoteId\": \"e181ca3d-6eb3-42bf-8638-d4c5bf30eb14\", \"sourceText\": \"f. Height measured at Screening only. Body weight measured every 3 months during Part B.\", \"appliesToActivityIds\": [\"3fd65995-e3a0-4b64-a146-ba805ab00f8c\"]}, {\"id\": \"14752fa9-d02a-450b-8171-5d91b50c3315\", \"conditionType\": \"timing_after\", \"text\": \"g. Vital signs measurements (supine BP, PR, RR, and oral temperature) are to be obtained at Screening and at each subsequent visit, with measurements performed predose and 1 hour (\\u00b15 minutes) after completion of administration of each dose of study drug.\", \"footnoteId\": \"0511553c-62c4-4c96-9497-6b934cf7b3e8\", \"timingConstraint\": \"PT1H\", \"sourceText\": \"g. Vital signs measurements (supine BP, PR, RR, and oral temperature) are to be obtained at Screenin\", \"appliesToActivityIds\": [\"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"f55d98dc-e754-457c-9a37-20d32ee222ee\", \"886f872e-f25f-40b7-8872-84658a364d9a\"]}, {\"id\": \"92e03c2a-7004-4aca-99ae-561059be2da0\", \"conditionType\": \"general\", \"text\": \"h. For a complete list of analytes, see protocol (Section 10.1, Appendix A).\", \"footnoteId\": \"f394e24f-48ec-429c-b76d-7e454311b08d\", \"sourceText\": \"h. For a complete list of analytes, see protocol (Section 10.1, Appendix A).\"}, {\"id\": \"e85db05f-cddd-4237-9712-6505a56c34f3\", \"conditionType\": \"timing_before\", \"text\": \"i. BIVV009 doses of 6.5 grams (if <75 kg) or 7.5 grams (if \\u226575 kg) based on patient's baseline body weight will be administered via IV infusion over ~60 \\u00b15 minutes on Days 0, 7, and every 14 days thereafter during Part A, and every 2 weeks starting at Week 27 during Part B. Patients with underlying cardiopulmonary disease may receive a 2-hour infusion with Sponsor approval. If a patient misses a scheduled dose (outside of the 2-day window or >17 days since last dose), they must return to site (unscheduled visit) to receive another loading dose 1 week prior to the next scheduled dose. Qualifying patients at participating sites may have study drug dosed at home during certain visits in Part B, according to the rules specified in Section 10.10 Appendix J (US, the Netherlands, Norway, France, Italy, Austria, Germany, Spain, and specific amendments.\", \"footnoteId\": \"c524106a-4253-40c2-889a-384e793c6633\", \"timingConstraint\": \"PT5H\", \"sourceText\": \"i. BIVV009 doses of 6.5 grams (if <75 kg) or 7.5 grams (if \\u226575 kg) based on patient's baseline body \", \"appliesToActivityIds\": [\"886f872e-f25f-40b7-8872-84658a364d9a\", \"3fd65995-e3a0-4b64-a146-ba805ab00f8c\", \"eb1443c9-7250-409b-b07a-916a26ffa649\", \"6aecd790-48b3-469a-8804-6b2618acb950\", \"68cad1d5-af4e-4771-9763-81d10a0cce46\", \"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"14dfc34d-7673-4315-928d-4eb043b06261\"]}, {\"id\": \"f4207ca3-bb02-4bc4-af60-031513944c4a\", \"conditionType\": \"timing_after\", \"text\": \"j. During Part A, PK and PD samples will be collected at predose and 1 hour (\\u00b115 minutes) postdose (ie, 1 hour after completion of study drug infusion) from all patients on Days 0, 7, 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175. An additional blood sample for PK and PD analysis will be collected during the EOT visit on Day 182 or at ET if a patient withdraws early. During Part B, PK and PD samples will be collected routinely at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals. PK and PD samples will also be collected if a patient experiences a hematologic breakthrough event at any point during the study.\", \"footnoteId\": \"e5b8a893-aafe-47c7-bc3d-1b7e9a23f4b9\", \"structuredCondition\": \"timing.after(completion of study drug infusion) from all patients on days 0, 7, 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175. an additional blood sample for pk and pd analysis will be collected during the eot visit on day 182 or at et if a patient withdraws early. during part b, pk and pd samples will be collected routinely at 3-month intervals during the 1st year of treatment in part b, and then at 6-month intervals. pk and pd samples will also be collected if a patient experiences a hematologic breakthrough event at any point during the study., PT1M)\", \"timingConstraint\": \"PT1H\", \"sourceText\": \"j. During Part A, PK and PD samples will be collected at predose and 1 hour (\\u00b115 minutes) postdose (\", \"appliesToActivityIds\": [\"886f872e-f25f-40b7-8872-84658a364d9a\", \"396f3d72-2db6-4b51-94b4-1219ee7ea529\", \"8985d9db-7de4-4c7f-9f0f-756c48d09de0\", \"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"14dfc34d-7673-4315-928d-4eb043b06261\"]}, {\"id\": \"efb45b27-ec78-4ef0-bba8-9d27325a3b3e\", \"conditionType\": \"timing_after\", \"text\": \"k. AEs will be recorded from the time the patient signs the informed consent form until 9 weeks after administration of the last dose of study drug.\", \"footnoteId\": \"d8430ac1-340b-4681-99c5-6cffb17617c5\", \"sourceText\": \"k. AEs will be recorded from the time the patient signs the informed consent form until 9 weeks afte\", \"appliesToActivityIds\": [\"886f872e-f25f-40b7-8872-84658a364d9a\", \"f55d98dc-e754-457c-9a37-20d32ee222ee\", \"d37e15b8-95a5-4e49-b83f-365e5e0ae2c8\", \"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\"]}, {\"id\": \"c9d44a59-a08e-4451-b9e3-4efdfb84d809\", \"conditionType\": \"general\", \"text\": \"l. To be performed every 3 months.\", \"footnoteId\": \"006114e9-af47-4254-8937-bda5e4ef3034\", \"sourceText\": \"l. To be performed every 3 months.\"}, {\"id\": \"a95c851a-113c-43b2-a312-a44ccbeb6ea4\", \"conditionType\": \"general\", \"text\": \"m. Refer to the Laboratory Manual for details of sample collection during Screening.\", \"footnoteId\": \"48d1b48f-b31b-4c5a-8761-02e8604d8da2\", \"sourceText\": \"m. Refer to the Laboratory Manual for details of sample collection during Screening.\"}, {\"id\": \"924bc913-f9fd-4ab7-9b0f-9bd19380c453\", \"conditionType\": \"timing_at\", \"text\": \"n. Samples will be collected for a subset of the disease-related biomarkers at Day 91 only. Refer to the Laboratory Manual for details.\", \"footnoteId\": \"9765d62f-b418-43ff-b202-410f2447c930\", \"sourceText\": \"n. Samples will be collected for a subset of the disease-related biomarkers at Day 91 only. Refer to\", \"appliesToActivityIds\": [\"8985d9db-7de4-4c7f-9f0f-756c48d09de0\", \"8f962aea-e76b-483e-998a-419e8f561273\"]}, {\"id\": \"9f2e5b36-0f52-4af1-96c9-a1dcba4dd1f0\", \"conditionType\": \"general\", \"text\": \"o. During Part B, a 12-lead ECG will be conducting pre- and postdose at 3 months (Day 273).\", \"footnoteId\": \"0a790877-b89d-4e13-902c-556e4606c7a3\", \"sourceText\": \"o. During Part B, a 12-lead ECG will be conducting pre- and postdose at 3 months (Day 273).\", \"appliesToActivityIds\": [\"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\"]}, {\"id\": \"24989384-c9b6-4b08-988c-6b9c817619cb\", \"conditionType\": \"general\", \"text\": \"p. During Part B, the healthcare resource utilization data will be recorded every 4 weeks.\", \"footnoteId\": \"a26f6e20-0b15-4a82-a27f-b9da72d15c2e\", \"sourceText\": \"p. During Part B, the healthcare resource utilization data will be recorded every 4 weeks.\", \"appliesToActivityIds\": [\"73ec8aef-a9ea-4d9a-b432-ebb5f75c6ed3\"]}, {\"id\": \"7ecfb860-ffab-4887-a11d-fe219ab0b250\", \"conditionType\": \"timing_after\", \"text\": \"q. To be performed in the following order: FACIT-Fatigue first, PGIS second, PGIC third, SF-12 fourth, and EQ-5D-5L fifth.\", \"footnoteId\": \"8df2be77-ab8e-4a47-8d72-295c9a710ce9\", \"sourceText\": \"q. To be performed in the following order: FACIT-Fatigue first, PGIS second, PGIC third, SF-12 fourt\", \"appliesToActivityIds\": [\"cbfe23b3-a95d-488f-8890-6864c48c9a42\", \"20fb064d-26f4-4e3a-a5e0-132d81f85d0a\", \"20947b5c-e5f9-45de-8f8f-3146d82d96d1\", \"016fe66d-377c-414c-b96d-5019b560366c\", \"eb805dd8-595f-4d59-b066-3940cfe6cd7f\"]}, {\"id\": \"a8f004d5-350c-48b3-bf88-3d0e91c93d7b\", \"conditionType\": \"timing_after\", \"text\": \"r. During Part B, ADA samples will be collected at predose at 3-month intervals during the 1st year of treatment in Part B and then at 6-month intervals and at safety follow up visit 9 weeks after last dose. Samples will also be collected if a patient experiences a hematologic breakthrough event or withdraws from the study early.\", \"footnoteId\": \"c5307557-c071-402e-8d17-ef84e4cc30bf\", \"sourceText\": \"r. During Part B, ADA samples will be collected at predose at 3-month intervals during the 1st year \", \"appliesToActivityIds\": [\"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"8985d9db-7de4-4c7f-9f0f-756c48d09de0\"]}, {\"id\": \"a5ffc35a-7bb7-497c-afca-5e9b4e434f93\", \"conditionType\": \"general\", \"text\": \"s. SLE panel will be performed every 6 months in Part-B of the study.\", \"footnoteId\": \"96770af7-5c52-4bcc-b04a-c69225e90c66\", \"sourceText\": \"s. SLE panel will be performed every 6 months in Part-B of the study.\", \"appliesToActivityIds\": [\"e9772bc8-dbdc-4af1-93b8-3fd55ec4e62c\", \"5cf0543f-6f13-42a3-8383-4dfd5f401b79\", \"120dba5d-ef65-4a50-a70e-0debf580b872\"]}, {\"id\": \"97ab4192-7d80-46b0-a995-15e8c4538df2\", \"conditionType\": \"timing_after\", \"text\": \"t. In Part B, hematology and clinical chemistry panels to be performed every 2 weeks after Week 25 and up to Week 79. For the remainder of Part B after Week 79, hematology and clinical chemistry panels to be performed every 4 weeks.\", \"footnoteId\": \"a8500771-46d0-4e89-b4cb-ef38a6b22da8\", \"sourceText\": \"t. In Part B, hematology and clinical chemistry panels to be performed every 2 weeks after Week 25 a\", \"appliesToActivityIds\": [\"7eb11dc1-a40d-4324-bb56-27cfbcd5392e\", \"0518cffb-0cca-426c-92d7-882f57625f35\", \"5ae6fe04-743a-4ab4-b71b-5b2b0c162dd1\", \"120dba5d-ef65-4a50-a70e-0debf580b872\"]}, {\"id\": \"73e7837d-26c8-41c0-b6d0-c67a55dedc5b\", \"conditionType\": \"sequence\", \"text\": \"u. To be performed at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals.\", \"footnoteId\": \"fa2891c7-af7c-4f5f-82af-8e3a6a4b5ead\", \"sourceText\": \"u. To be performed at 3-month intervals during the 1st year of treatment in Part B, and then at 6-mo\"}]"
              },
              {
                "id": "dbed1443-51e7-4125-9537-38b1f4b965c4",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"30956364-e066-4797-968c-abed64ecafc5\", \"name\": \"Primary: Efficacy Response (Part A)\", \"endpointType\": \"Primary\", \"inputs\": [\"Hb\", \"transfusion_history\", \"baseline_Hb\"], \"timeWindow\": {\"reference\": \"Baseline to Week 26\", \"duration\": \"P26W\"}, \"algorithm\": \"(Hb_increase >= 2 g/dL OR Hb >= 12 g/dL) AND (no_transfusions_from_week_5_to_26) AND (no_prohibited_CAD_treatments)\", \"successCriteria\": \"Hb increase \\u2265 2 g/dL from baseline or Hb \\u2265 12 g/dL at treatment assessment with no transfusions from Week 5 through Week 26\", \"sourceText\": \"The primary efficacy endpoint is the proportion of patients who respond to BIVV009. A responder is defined as a patient who meets the following criteria: Hb increase \\u2265 2 g/dL from baseline or Hb \\u2265 12 \"}, {\"id\": \"0f44a8c8-1c6e-45f8-871c-b1cab17a0756\", \"name\": \"Secondary: Immunogenicity of BIVV009\", \"endpointType\": \"Secondary\", \"inputs\": [\"ADA_status\", \"ADA_titer\"], \"timeWindow\": {\"reference\": \"Part A and Part B\", \"duration\": \"P2Y\"}, \"algorithm\": \"Count of subjects with positive Anti-Drug Antibodies (ADA) / Total subjects\", \"successCriteria\": \"Characterization of immunogenicity profile\", \"sourceText\": \"Secondary Exploratory Objective for Part A was added: To evaluate the immunogenicity of BIVV009.\"}, {\"id\": \"0b56626c-57ce-49d1-a340-40857fb28126\", \"name\": \"Exploratory: Home Infusion Satisfaction (Part B)\", \"endpointType\": \"Exploratory\", \"inputs\": [\"satisfaction_score\"], \"timeWindow\": {\"reference\": \"First and fourth home infusion\", \"duration\": \"Variable\"}, \"algorithm\": \"Score at 4th infusion - Score at 1st infusion\", \"successCriteria\": \"Assessment of patient satisfaction with convenience of home infusion\", \"sourceText\": \"Part B Satisfaction with home infusion after first home infusion and after four home infusion will be assessed in patients with home infusion was added.\"}, {\"id\": \"a00beb19-7018-4dc8-8b1a-359da684f7a1\", \"name\": \"Safety: Home Infusion Adverse Events\", \"endpointType\": \"Secondary\", \"inputs\": [\"AE_onset_time\", \"infusion_time\"], \"timeWindow\": {\"reference\": \"home infusion\", \"duration\": \"PT24H\"}, \"algorithm\": \"AE_onset_time - infusion_time <= 24 hours\", \"successCriteria\": \"Identification of treatment-emergent adverse events within 24 hours of home administration\", \"sourceText\": \"For patients with home infusions, safety assessments include AEs with onset within 24 hours of infusion was added.\"}]"
              },
              {
                "id": "8b3f1c59-0a7d-4df0-83a3-242bb0e66521",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"d42fe916-9e97-4cff-a5ab-9f8739f8688b\", \"name\": \"Baseline Body Weight\", \"variableType\": \"Baseline\", \"sourceVariables\": [\"Body Weight\"], \"derivationRule\": \"Last non-missing weight measurement prior to the first dose of BIVV009\", \"baselineDefinition\": \"Prior to treatment start\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Pre-dose\", \"imputationRule\": \"None specified\", \"unit\": \"kg\"}, {\"id\": \"91262a99-6625-4fcc-9528-07bb1c4d52ea\", \"name\": \"Dose Group Assignment\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"Body Weight\"], \"derivationRule\": \"If weight < 75 kg then 6.5 g; If weight >= 75 kg then 7.5 g (implied by weight-based fixed dosing logic)\", \"baselineDefinition\": \"Weight at treatment start\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Baseline\", \"imputationRule\": \"None specified\", \"unit\": \"g\"}]"
              },
              {
                "id": "4b7e27f8-ff94-4c65-9997-26a636116704",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"61840a09-d211-4c7b-9b9e-8d678ce4b331\", \"initialState\": \"Screening/observation period\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening/observation period\", \"Baseline\", \"Part A\", \"Part B Extension phase\", \"ET/EOS/Safety follow-up\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening/observation period\", \"toState\": \"Baseline\", \"trigger\": \"Progress to Baseline\"}, {\"fromState\": \"Baseline\", \"toState\": \"Part A\", \"trigger\": \"Progress to Part A\"}, {\"fromState\": \"Part A\", \"toState\": \"Part B Extension phase\", \"trigger\": \"Progress to Part B Extension phase\"}, {\"fromState\": \"Part B Extension phase\", \"toState\": \"ET/EOS/Safety follow-up\", \"trigger\": \"Progress to ET/EOS/Safety follow-up\"}, {\"fromState\": \"Screening/observation period\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Screening/observation period\": \"epoch_1\", \"Baseline\": \"epoch_2\", \"Part A\": \"epoch_3\", \"Part B Extension phase\": \"epoch_4\", \"ET/EOS/Safety follow-up\": \"epoch_5\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "5abfb61f-4845-47d1-b3ce-f6b9bde5767d",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"5581c681-8ff6-4ae3-98d4-f8cf8179995f\", \"treatmentName\": \"Trial Protocol\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 6.0, \"unit\": \"g\"}, {\"amount\": 4.0, \"unit\": \"g\"}, {\"amount\": 5.0, \"unit\": \"g\"}], \"sourceText\": \"Protocol 06 Page 2 of 99 Bioverativ USA Inc. Confidential PROTOCOL AMENDMENT SUMMARY OF CHANGES DOCUMENT HISTORY Document Country/Countries impacted by amendment Date Amended Clinical Trial Protocol 0\"}, {\"id\": \"66aca1cf-04d7-4cca-835e-aa43b35f70e6\", \"treatmentName\": \"Protocol Version\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 5.0, \"unit\": \"g\"}, {\"amount\": 3.0, \"unit\": \"g\"}, {\"amount\": 4.0, \"unit\": \"g\"}, {\"amount\": 6.0, \"unit\": \"g\"}], \"sourceText\": \"ial PROTOCOL AMENDMENT SUMMARY OF CHANGES DOCUMENT HISTORY Document Country/Countries impacted by amendment Date Amended Clinical Trial Protocol 06 Global 19 December 2019 Clinical Study Protocol Vers\"}, {\"id\": \"b7e9289a-c259-4c6d-87a8-6c46fb00059e\", \"treatmentName\": \"BIVV009 is\", \"frequency\": \"QW\", \"route\": \"IV\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 180.0, \"unit\": \"mg\"}], \"durationDescription\": \"26 weeks\", \"sourceText\": \"ffects from exaggerated pharmacology (ie, autoimmune diseases, bacterial infections) were observed in those studies. As a result, the no observed adverse effect (dose) level (NOAEL) established for BI\"}, {\"id\": \"ab444727-9d62-4545-88af-f5d33a8b6e78\", \"treatmentName\": \"BIVV009\", \"frequency\": \"Q2W\", \"route\": \"IV\", \"startDay\": 1, \"durationDescription\": \"Part A (duration not specified in snippet) followed by Part B (2 years)\", \"doseModifications\": [\"Home infusion facilities provided for specific countries in Part B\"]}]"
              },
              {
                "id": "be2c7cc5-5aeb-4c1d-a35e-4e8aa62c14e1",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"be6cd852-566b-4ca7-baba-8c024a39948c\", \"visitName\": \"Screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening\", \"sourceText\": \"Section 6.1.1.1: Screening Assessments (initiating at Day -42)\"}, {\"id\": \"98fbdc6e-7822-455f-be4a-9deaca188f45\", \"visitName\": \"Visit 009\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 2, \"sourceText\": \"BIVV009-03 Cardinal Amended Clinical Trial Protocol 06 Page 5 of 99\"}, {\"id\": \"ed09ace4-11be-44f1-9722-d3786bcf81d0\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 3, \"epoch\": \"Follow-up\", \"sourceText\": \"following completion of LPO in Part A. The change was made to gather more evidence on long-term safety, tolerability\"}, {\"id\": \"007fae54-4575-4bfb-9b6d-b2b83e07a9fa\", \"visitName\": \"end of study\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 4, \"sourceText\": \"early termination/end of study/safety follow-up was renumbered as 6.1.7. This change was made to evaluate the\"}, {\"id\": \"172a4b29-3a66-4ffd-abcc-2e2b6653a4c5\", \"visitName\": \"EOT\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 5, \"sourceText\": \"EOT end of treatment EQ-5D-5L\"}, {\"id\": \"a4fd1ffe-cea0-4c0d-aaae-6ed9951bf3f5\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 6, \"sourceText\": \"baseline visit (and first infusion of study drug) must occur at least 7 days following the transfusion. Part A\"}, {\"id\": \"70e96915-110c-4080-9c96-33d720d64447\", \"visitName\": \"Visit 9\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 7, \"sourceText\": \"Follow up visit 9 weeks after last dose. Samples will also be collected if a patient experiences a hematologic breakthrough or withdraws from the study. SAMPLE SIZE:\"}, {\"id\": \"e16c9413-cd8c-4510-b0d8-752dd756c881\", \"visitName\": \"Part B Extension Phase (Bi-weekly)\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 8, \"epoch\": \"Part B Extension Phase\"}, {\"id\": \"eff1cadd-7554-4b1d-8584-0b37c26e3740\", \"visitName\": \"Randomization\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 9, \"sourceText\": \"Randomization ............................................................................................................................... 54 6.2.4 Dose preparation and administration .............\"}, {\"id\": \"0eda0677-76c1-4efa-929f-a6fe1103c3c8\", \"visitName\": \"Day 7\", \"targetDay\": 7, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 10, \"epoch\": \"Part A\", \"sourceText\": \"points Day 7, 35, 77, 133 and 175, may be used to assay ADA was added. This change was made to help characterize\"}, {\"id\": \"c57e2ba3-313d-400f-8e06-7473514a8a2f\", \"visitName\": \"Week 5\", \"targetDay\": 29, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 11, \"targetWeek\": 5, \"sourceText\": \"transfusion from Week 5 through Week 26 (EOT) and did not receive treatment for CAgD beyond what is permitted per protocol. Additionally, the patient\\u2019s Hgb level must meet either of the following crit\"}, {\"id\": \"970e050a-3b8c-446a-b655-6b89e81d08fa\", \"visitName\": \"Day 35\", \"targetDay\": 35, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 3, \"targetWeek\": 5, \"epoch\": \"Part A\"}, {\"id\": \"c9a54c73-98ab-468a-acb9-dfba77caf1c8\", \"visitName\": \"Day 77\", \"targetDay\": 77, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 4, \"targetWeek\": 11, \"epoch\": \"Part A\"}, {\"id\": \"2c00c713-7dcf-498d-a1d5-6e8983346248\", \"visitName\": \"Day 91\", \"targetDay\": 91, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 14, \"sourceText\": \"(Day 91 only) Xo\"}, {\"id\": \"ff288257-843d-400a-9f05-c536b81eed77\", \"visitName\": \"Day 133\", \"targetDay\": 133, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 5, \"targetWeek\": 19, \"epoch\": \"Part A\"}, {\"id\": \"a43255eb-1a2b-4116-90d5-368a89efdf49\", \"visitName\": \"Week 23\", \"targetDay\": 155, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 16, \"targetWeek\": 23, \"sourceText\": \"Week 23, 25, and 26) \\uf0b7 Mean change from baseline in QOL, as assessed by the change in Functional\"}, {\"id\": \"4b72692f-ff54-422f-a979-e9015b38f08e\", \"visitName\": \"Week 25\", \"targetDay\": 169, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": false, \"visitNumber\": 17, \"targetWeek\": 25, \"sourceText\": \"60 minutes on Day 0, Day 7, and every 14 days thereafter through Week 25 (ie, Days 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175). Patients who miss a dose (ie, outside the dosing window or\"}, {\"id\": \"0ac1aa44-4916-4fc7-bfd7-07f75bb1640e\", \"visitName\": \"Day 175\", \"targetDay\": 175, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 6, \"targetWeek\": 25, \"epoch\": \"Part A\"}, {\"id\": \"f0bb4cd0-44a0-4725-802d-b1536a320e4f\", \"visitName\": \"Week 26\", \"targetDay\": 176, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 19, \"targetWeek\": 26, \"sourceText\": \"(Week 26) ADA: In patients who consented to the use of their blood samples for future research, PD\"}, {\"id\": \"fa4703c3-5a93-4891-b47a-f888ea4cecaf\", \"visitName\": \"Visit 1\", \"targetDay\": 182, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 20, \"targetWeek\": 26, \"epoch\": \"Part A\", \"sourceText\": \"visit 1 week prior to the next scheduled dose in order to receive an additional loading dose. Patients will have an End-of-Treatment (EOT) visit in Part A on Day 182 (Week 26). Patients who meet the t\"}, {\"id\": \"765415c2-942a-4109-b7de-8b92f8a31a42\", \"visitName\": \"Week 27\", \"targetDay\": 183, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 21, \"targetWeek\": 27, \"sourceText\": \"Bi-weekly dosing starting at Week 27 and continuing for 2 years after LPO in Part A\"}, {\"id\": \"af30d680-debd-4f26-86d6-edb9e14b8307\", \"visitName\": \"Week 41\", \"targetDay\": 281, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 22, \"targetWeek\": 41, \"sourceText\": \"qualified by the Investigator and no sooner than after Week 41 (Day 287) and without evidence of intolerance of the study drug as determined by the Investigator. No new risks related to home infusions\"}, {\"id\": \"30fbf002-1c7b-4c6a-a5a6-dda0d2b46541\", \"visitName\": \"Day 287\", \"targetDay\": 287, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 23, \"sourceText\": \"qualified by the Investigator and no sooner than after Week 41 (Day 287) and without evidence of intolerance of the study drug as determined by the Investigator. No new risks related to home infusions\"}, {\"id\": \"d63456f4-6baf-4cfa-a32a-8b6c9b152181\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 24, \"sourceText\": \"early termination/end of study/safety follow-up was renumbered as 6.1.7. This change was made to evaluate the\"}, {\"id\": \"a087a0cc-099e-4d66-ba52-c5c6ecf7085c\", \"visitName\": \"Week 79\", \"targetDay\": 547, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 25, \"targetWeek\": 79, \"epoch\": \"Part B Extension Phase\", \"sourceText\": \"week 79. This change was made to reflect the study assessments frequency in the 2nd year of\"}]"
              },
              {
                "id": "ext_execution_model_45847dcc-f7bd-4e46-ba2a-11a2bafb401b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T03:25:26.885633",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "8e8cdabb-460e-4d55-9931-7e4cd20f67b6",
                        "definition": "First administration of investigational product",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 60,
                        "sourceText": "first dose of study drug",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "a0e5fb7d-1ae8-4ec6-965e-588036892047",
                        "definition": "The start of the screening/observation period, with Day 1 implicitly following the Day -42 to Day -1 window",
                        "anchorType": "Day1",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 80,
                        "sourceText": "Screening/observation period (Day -42 to Day -1)",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "6b129543-d648-4085-8b36-1733075a6a0a",
                        "definition": "Baseline visit/assessment",
                        "anchorType": "Baseline",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 50,
                        "sourceText": "baseline visit",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "36744fbb-b164-4dac-b221-0309762996dc",
                        "definition": "Procedure",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 100,
                        "sourceText": "Procedure",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "7b8d15ef-11ac-4aff-93aa-aab01280a549",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "bed432bc-3e15-4998-8e6b-4f3292a1bb30",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "OD"
                      },
                      {
                        "id": "570a1e63-def5-4b29-b1dd-440b71b79ca4",
                        "type": "Interval",
                        "sourceText": "bid"
                      },
                      {
                        "id": "2a00ba15-54a7-40b5-ab7c-7d15c5ddfcfd",
                        "type": "Interval",
                        "sourceText": "tid"
                      },
                      {
                        "id": "3cc1472c-d295-4f1c-89f5-dd4b88e10f4d",
                        "type": "Interval",
                        "sourceText": "PK samples at "
                      },
                      {
                        "id": "f728fdc3-4767-4652-85a1-33832cc227ab",
                        "type": "Continuous",
                        "startOffset": "-P42D",
                        "endOffset": "-P1D",
                        "sourceText": "Day -42 to Day -1"
                      },
                      {
                        "id": "f01583f9-ce17-46d3-bdc8-8af92e3ed8e4",
                        "type": "Continuous",
                        "startOffset": "-P42D",
                        "endOffset": "-P1D",
                        "sourceText": "Days -42 through Day -1"
                      },
                      {
                        "id": "616dbb5c-b12d-4c19-ab05-9e345ffca9e6",
                        "type": "Continuous",
                        "endOffset": "P175D",
                        "sourceText": "Day 0 through Day 175"
                      },
                      {
                        "id": "79bf7eba-f612-41ce-ada3-6d290ce3d4d0",
                        "type": "Continuous",
                        "startOffset": "P1D",
                        "endOffset": "P25D",
                        "sourceText": "Weeks 1-25"
                      },
                      {
                        "id": "0fcd8d87-fca0-493e-a507-e8775311423d",
                        "type": "Continuous",
                        "startOffset": "P5D",
                        "endOffset": "P26D",
                        "sourceText": "Week 5 through Week 26"
                      },
                      {
                        "id": "a616d931-2aa2-4b14-a1b8-243888bd5486",
                        "type": "Continuous",
                        "sourceText": "treatment period"
                      },
                      {
                        "id": "2b4f8d44-89e8-4043-b8ad-08ac1f57fd6c",
                        "type": "Continuous",
                        "sourceText": "treatment \nperiod"
                      },
                      {
                        "id": "e95d0d8c-e338-4ab1-b3ec-50b625abcf34",
                        "type": "Continuous",
                        "sourceText": "dosing window"
                      },
                      {
                        "id": "cd0ac86f-2de5-45f5-ad12-e6024bb17f9e",
                        "type": "Continuous",
                        "sourceText": "Treatment period"
                      },
                      {
                        "id": "cb788261-7624-46c0-9a59-15ac0e6c1fc6",
                        "type": "Continuous",
                        "sourceText": "observation period"
                      },
                      {
                        "id": "5245cf58-8cbf-484f-8141-5ee3e4f4c770",
                        "type": "Continuous",
                        "sourceText": "Observation Period"
                      },
                      {
                        "id": "473e602a-01c2-4051-865f-c74bd3b41d10",
                        "type": "Continuous",
                        "sourceText": "1 hour post"
                      },
                      {
                        "id": "e5285198-dece-44b3-a83a-a6ddd2b45219",
                        "type": "Continuous",
                        "sourceText": "1 hour after"
                      },
                      {
                        "id": "e5162748-b9b6-4957-b8d8-cccf7659b135",
                        "type": "Interval",
                        "startOffset": "P0D",
                        "endOffset": "P1Y",
                        "interval": "P3M",
                        "minObservations": 4,
                        "exitCondition": "Completion of 1st year of treatment in Part B",
                        "sourceText": "Samples will be collected at 3-month intervals during the 1st year of treatment in Part B"
                      },
                      {
                        "id": "2f8f1679-74ce-4e2f-be8b-783372b75c05",
                        "type": "Interval",
                        "startOffset": "P1Y",
                        "endOffset": "P2Y",
                        "interval": "P6M",
                        "minObservations": 2,
                        "exitCondition": "Remainder of the time on study",
                        "sourceText": "then at 6-month intervals for the remainder of the time on study."
                      },
                      {
                        "id": "80db981e-4142-4544-a469-777aec7e2c9e",
                        "type": "Interval",
                        "startOffset": "PT0H",
                        "endOffset": "PT1H",
                        "interval": "PT1H",
                        "minObservations": 2,
                        "exitCondition": "null",
                        "sourceText": "Collection of PK samples at predose and 1 hour (±15 minutes) postdose was added."
                      },
                      {
                        "id": "b73dddf4-6759-47fc-8a3c-d1f12fa4ddb6",
                        "type": "Continuous",
                        "startOffset": "PT0H",
                        "endOffset": "PT24H",
                        "interval": "PT24H",
                        "minObservations": 1,
                        "exitCondition": "null",
                        "sourceText": "safety assessments include AEs with onset within 24 hours of infusion was added."
                      },
                      {
                        "id": "6264450f-912d-4d9f-8c70-fedd07e821ea",
                        "type": "Cycle",
                        "startOffset": "P0D",
                        "endOffset": "P2Y",
                        "interval": "P2Y",
                        "minObservations": 1,
                        "exitCondition": "24 months following LPO for Part A",
                        "sourceText": "The Part B open-label extension study will run for 2 years instead of 1 year following last patient out (LPO) under Part A."
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "653e1078-148c-4969-8e3f-4e4a69970322",
                        "requiredSequence": [
                          "epoch_1",
                          "epoch_2",
                          "epoch_3",
                          "epoch_4",
                          "epoch_5"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "07a09ec6-2506-4e7d-9d8b-20c717a36a4a"
                        ],
                        "mandatoryVisits": [
                          "Day 1",
                          "End of Study (24 months post-LPO Part A)",
                          "Screening",
                          "Baseline",
                          "End of Study",
                          "Part A Completion",
                          "Part B Year 2 (6-month intervals)",
                          "Part B Year 1 (3-month intervals)"
                        ],
                        "sourceText": "[{'condition': 'Subject at preselected site/country qualifies for home infusion', 'path': ['HOME_INFUSION_ADMINISTRATION', 'HOME_INFUSION_SATISFACTION_ASSESSMENT']}, {'condition': 'ADA testing required', 'path': ['PREDOSE_PD_BACKUP_SAMPLE_TESTING']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Blood Sample",
                        "executionType": "Single",
                        "rationale": "WINDOW signals: 2; EPISODE signals: 1; SINGLE signals: 7; RECURRING signals: 2"
                      },
                      {
                        "activityId": "Vital Signs",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Electrocardiogram",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Ae",
                        "executionType": "Single",
                        "rationale": "WINDOW signals: 2; EPISODE signals: 1; SINGLE signals: 4"
                      },
                      {
                        "activityId": "Concomitant Medications",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Laboratory Test",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Window",
                        "rationale": "WINDOW signals: 2"
                      },
                      {
                        "activityId": "Pharmacodynamic",
                        "executionType": "Window",
                        "rationale": "WINDOW signals: 4"
                      },
                      {
                        "activityId": "Dosing",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 1; SINGLE signals: 1"
                      },
                      {
                        "activityId": "Biopsy",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 7"
                      },
                      {
                        "activityId": "Questionnaire",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "ADA sample collection (Part B)",
                        "executionType": "Single",
                        "rationale": "Samples are collected during the 1st year and then every 6 months, indicating a scheduled repeat at specific intervals."
                      },
                      {
                        "activityId": "Satisfaction with home infusion",
                        "executionType": "Single",
                        "rationale": "Assessed at two specific scheduled points: after the first home infusion and after the fourth home infusion."
                      },
                      {
                        "activityId": "SLE panel (Part B)",
                        "executionType": "Single",
                        "rationale": "The protocol introduces additional time points for this panel throughout the Part B extension."
                      },
                      {
                        "activityId": "Immunogenicity assessment (Part A)",
                        "executionType": "Single",
                        "rationale": "Added as a secondary exploratory objective for Part A to evaluate the drug's immunogenicity profile."
                      }
                    ],
                    "footnoteConditions": [
                      {
                        "id": "b44b4553-edf0-4551-a367-12253e619fb2",
                        "conditionType": "timing_before",
                        "text": "a. The 6-week Screening/Observation Period may be extended by 1 week for patients requiring a blood transfusion prior to study drug administration.",
                        "footnoteId": "bcf198f1-8b15-4933-ad85-dc46f6da17e8",
                        "sourceText": "a. The 6-week Screening/Observation Period may be extended by 1 week for patients requiring a blood "
                      },
                      {
                        "id": "7d9c6420-33dd-41dc-a7a7-aff028432467",
                        "conditionType": "timing_after",
                        "text": "b. Patients should return to the site 9 weeks after last dose for ET procedures, EOS assessment, or Safety Follow-up procedures upon completion of dosing in the study. If patient experiences a hematological breakthrough event, a PK, PD, and ADA sample should be collected at the time of the event.",
                        "footnoteId": "f2bdebff-fc1c-460d-9250-699e087b2d2d",
                        "sourceText": "b. Patients should return to the site 9 weeks after last dose for ET procedures, EOS assessment, or "
                      },
                      {
                        "id": "32c13eb7-7fd1-4b35-8a1f-5a071d100420",
                        "conditionType": "timing_before",
                        "text": "c. Applicable to patients who do not have documented vaccination against encapsulated bacterial pathogens within 5 years of enrollment. Refer to immunization recommendations per Section 6.1.1.1 for patients requiring vaccination. A blood sample for vaccine titers will be collected on Day 0 prior to study drug infusion to be used to determine serum relevant antibody titers should the patient be diagnosed with an infection associated with an encapsulated organism during the course of the study. A second sample will be collected during the study period if a patient presents with symptoms concerning for an infection with Streptococcus pneumoniae, Neisseria meningitidis or Haemophilus influenzae and analyzed if the infection is confirmed with one of the aforementioned organisms.",
                        "footnoteId": "ec051480-fdfb-40fd-9497-ff518940759c",
                        "sourceText": "c. Applicable to patients who do not have documented vaccination against encapsulated bacterial path"
                      },
                      {
                        "id": "0fa71dc4-b872-4b16-bb60-74eea65c36e0",
                        "conditionType": "general",
                        "text": "d. Prior bone marrow biopsy report review, prior tissue assessment, or new bone marrow biopsy (as applicable). Sites will submit de-identified biopsy reports to independent central reader for eligibility adjudication. If biopsy is deemed unsuitable or insufficient to determine eligibility, either prior tissue may be submitted for additional hematopathology assessment or a new bone marrow biopsy will be performed during the screening period.",
                        "footnoteId": "9d5f4bf9-2466-4046-b6af-ea0839ae3cf1",
                        "sourceText": "d. Prior bone marrow biopsy report review, prior tissue assessment, or new bone marrow biopsy (as ap"
                      },
                      {
                        "id": "92ccd1ef-02cc-4320-8306-47302b5204c9",
                        "conditionType": "timing_at",
                        "text": "e. Females of child-bearing potential only. Serum pregnancy test to be performed at Screening. Serum or urine pregnancy test to be performed on Days 0, 21, 49, 77, 105, 133, and 161, and at Week 26/EOT or at the ET Visit. Repeat serum or urine pregnancy test every 4 weeks (±2 days) during Part B.",
                        "footnoteId": "9340ec52-a965-4777-a36e-af0a6e399e2e",
                        "sourceText": "e. Females of child-bearing potential only. Serum pregnancy test to be performed at Screening. Serum"
                      },
                      {
                        "id": "92e6c11d-90c2-476c-8436-6a53ceb8db67",
                        "conditionType": "general",
                        "text": "f. Height measured at Screening only. Body weight measured every 3 months during Part B.",
                        "footnoteId": "e181ca3d-6eb3-42bf-8638-d4c5bf30eb14",
                        "sourceText": "f. Height measured at Screening only. Body weight measured every 3 months during Part B."
                      },
                      {
                        "id": "14752fa9-d02a-450b-8171-5d91b50c3315",
                        "conditionType": "timing_after",
                        "text": "g. Vital signs measurements (supine BP, PR, RR, and oral temperature) are to be obtained at Screening and at each subsequent visit, with measurements performed predose and 1 hour (±5 minutes) after completion of administration of each dose of study drug.",
                        "footnoteId": "0511553c-62c4-4c96-9497-6b934cf7b3e8",
                        "timingConstraint": "PT1H",
                        "sourceText": "g. Vital signs measurements (supine BP, PR, RR, and oral temperature) are to be obtained at Screenin"
                      },
                      {
                        "id": "92e03c2a-7004-4aca-99ae-561059be2da0",
                        "conditionType": "general",
                        "text": "h. For a complete list of analytes, see protocol (Section 10.1, Appendix A).",
                        "footnoteId": "f394e24f-48ec-429c-b76d-7e454311b08d",
                        "sourceText": "h. For a complete list of analytes, see protocol (Section 10.1, Appendix A)."
                      },
                      {
                        "id": "e85db05f-cddd-4237-9712-6505a56c34f3",
                        "conditionType": "timing_before",
                        "text": "i. BIVV009 doses of 6.5 grams (if <75 kg) or 7.5 grams (if ≥75 kg) based on patient's baseline body weight will be administered via IV infusion over ~60 ±5 minutes on Days 0, 7, and every 14 days thereafter during Part A, and every 2 weeks starting at Week 27 during Part B. Patients with underlying cardiopulmonary disease may receive a 2-hour infusion with Sponsor approval. If a patient misses a scheduled dose (outside of the 2-day window or >17 days since last dose), they must return to site (unscheduled visit) to receive another loading dose 1 week prior to the next scheduled dose. Qualifying patients at participating sites may have study drug dosed at home during certain visits in Part B, according to the rules specified in Section 10.10 Appendix J (US, the Netherlands, Norway, France, Italy, Austria, Germany, Spain, and specific amendments.",
                        "footnoteId": "c524106a-4253-40c2-889a-384e793c6633",
                        "timingConstraint": "PT5H",
                        "sourceText": "i. BIVV009 doses of 6.5 grams (if <75 kg) or 7.5 grams (if ≥75 kg) based on patient's baseline body "
                      },
                      {
                        "id": "f4207ca3-bb02-4bc4-af60-031513944c4a",
                        "conditionType": "timing_after",
                        "text": "j. During Part A, PK and PD samples will be collected at predose and 1 hour (±15 minutes) postdose (ie, 1 hour after completion of study drug infusion) from all patients on Days 0, 7, 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175. An additional blood sample for PK and PD analysis will be collected during the EOT visit on Day 182 or at ET if a patient withdraws early. During Part B, PK and PD samples will be collected routinely at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals. PK and PD samples will also be collected if a patient experiences a hematologic breakthrough event at any point during the study.",
                        "footnoteId": "e5b8a893-aafe-47c7-bc3d-1b7e9a23f4b9",
                        "structuredCondition": "timing.after(completion of study drug infusion) from all patients on days 0, 7, 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175. an additional blood sample for pk and pd analysis will be collected during the eot visit on day 182 or at et if a patient withdraws early. during part b, pk and pd samples will be collected routinely at 3-month intervals during the 1st year of treatment in part b, and then at 6-month intervals. pk and pd samples will also be collected if a patient experiences a hematologic breakthrough event at any point during the study., PT1M)",
                        "timingConstraint": "PT1H",
                        "sourceText": "j. During Part A, PK and PD samples will be collected at predose and 1 hour (±15 minutes) postdose ("
                      },
                      {
                        "id": "efb45b27-ec78-4ef0-bba8-9d27325a3b3e",
                        "conditionType": "timing_after",
                        "text": "k. AEs will be recorded from the time the patient signs the informed consent form until 9 weeks after administration of the last dose of study drug.",
                        "footnoteId": "d8430ac1-340b-4681-99c5-6cffb17617c5",
                        "sourceText": "k. AEs will be recorded from the time the patient signs the informed consent form until 9 weeks afte"
                      },
                      {
                        "id": "c9d44a59-a08e-4451-b9e3-4efdfb84d809",
                        "conditionType": "general",
                        "text": "l. To be performed every 3 months.",
                        "footnoteId": "006114e9-af47-4254-8937-bda5e4ef3034",
                        "sourceText": "l. To be performed every 3 months."
                      },
                      {
                        "id": "a95c851a-113c-43b2-a312-a44ccbeb6ea4",
                        "conditionType": "general",
                        "text": "m. Refer to the Laboratory Manual for details of sample collection during Screening.",
                        "footnoteId": "48d1b48f-b31b-4c5a-8761-02e8604d8da2",
                        "sourceText": "m. Refer to the Laboratory Manual for details of sample collection during Screening."
                      },
                      {
                        "id": "924bc913-f9fd-4ab7-9b0f-9bd19380c453",
                        "conditionType": "timing_at",
                        "text": "n. Samples will be collected for a subset of the disease-related biomarkers at Day 91 only. Refer to the Laboratory Manual for details.",
                        "footnoteId": "9765d62f-b418-43ff-b202-410f2447c930",
                        "sourceText": "n. Samples will be collected for a subset of the disease-related biomarkers at Day 91 only. Refer to"
                      },
                      {
                        "id": "9f2e5b36-0f52-4af1-96c9-a1dcba4dd1f0",
                        "conditionType": "general",
                        "text": "o. During Part B, a 12-lead ECG will be conducting pre- and postdose at 3 months (Day 273).",
                        "footnoteId": "0a790877-b89d-4e13-902c-556e4606c7a3",
                        "sourceText": "o. During Part B, a 12-lead ECG will be conducting pre- and postdose at 3 months (Day 273)."
                      },
                      {
                        "id": "24989384-c9b6-4b08-988c-6b9c817619cb",
                        "conditionType": "general",
                        "text": "p. During Part B, the healthcare resource utilization data will be recorded every 4 weeks.",
                        "footnoteId": "a26f6e20-0b15-4a82-a27f-b9da72d15c2e",
                        "sourceText": "p. During Part B, the healthcare resource utilization data will be recorded every 4 weeks."
                      },
                      {
                        "id": "7ecfb860-ffab-4887-a11d-fe219ab0b250",
                        "conditionType": "timing_after",
                        "text": "q. To be performed in the following order: FACIT-Fatigue first, PGIS second, PGIC third, SF-12 fourth, and EQ-5D-5L fifth.",
                        "footnoteId": "8df2be77-ab8e-4a47-8d72-295c9a710ce9",
                        "sourceText": "q. To be performed in the following order: FACIT-Fatigue first, PGIS second, PGIC third, SF-12 fourt"
                      },
                      {
                        "id": "a8f004d5-350c-48b3-bf88-3d0e91c93d7b",
                        "conditionType": "timing_after",
                        "text": "r. During Part B, ADA samples will be collected at predose at 3-month intervals during the 1st year of treatment in Part B and then at 6-month intervals and at safety follow up visit 9 weeks after last dose. Samples will also be collected if a patient experiences a hematologic breakthrough event or withdraws from the study early.",
                        "footnoteId": "c5307557-c071-402e-8d17-ef84e4cc30bf",
                        "sourceText": "r. During Part B, ADA samples will be collected at predose at 3-month intervals during the 1st year "
                      },
                      {
                        "id": "a5ffc35a-7bb7-497c-afca-5e9b4e434f93",
                        "conditionType": "general",
                        "text": "s. SLE panel will be performed every 6 months in Part-B of the study.",
                        "footnoteId": "96770af7-5c52-4bcc-b04a-c69225e90c66",
                        "sourceText": "s. SLE panel will be performed every 6 months in Part-B of the study."
                      },
                      {
                        "id": "97ab4192-7d80-46b0-a995-15e8c4538df2",
                        "conditionType": "timing_after",
                        "text": "t. In Part B, hematology and clinical chemistry panels to be performed every 2 weeks after Week 25 and up to Week 79. For the remainder of Part B after Week 79, hematology and clinical chemistry panels to be performed every 4 weeks.",
                        "footnoteId": "a8500771-46d0-4e89-b4cb-ef38a6b22da8",
                        "sourceText": "t. In Part B, hematology and clinical chemistry panels to be performed every 2 weeks after Week 25 a"
                      },
                      {
                        "id": "73e7837d-26c8-41c0-b6d0-c67a55dedc5b",
                        "conditionType": "sequence",
                        "text": "u. To be performed at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals.",
                        "footnoteId": "fa2891c7-af7c-4f5f-82af-8e3a6a4b5ead",
                        "sourceText": "u. To be performed at 3-month intervals during the 1st year of treatment in Part B, and then at 6-mo"
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "30956364-e066-4797-968c-abed64ecafc5",
                        "name": "Primary: Efficacy Response (Part A)",
                        "endpointType": "Primary",
                        "inputs": [
                          "Hb",
                          "transfusion_history",
                          "baseline_Hb"
                        ],
                        "timeWindow": {
                          "reference": "Baseline to Week 26",
                          "duration": "P26W"
                        },
                        "algorithm": "(Hb_increase >= 2 g/dL OR Hb >= 12 g/dL) AND (no_transfusions_from_week_5_to_26) AND (no_prohibited_CAD_treatments)",
                        "successCriteria": "Hb increase ≥ 2 g/dL from baseline or Hb ≥ 12 g/dL at treatment assessment with no transfusions from Week 5 through Week 26",
                        "sourceText": "The primary efficacy endpoint is the proportion of patients who respond to BIVV009. A responder is defined as a patient who meets the following criteria: Hb increase ≥ 2 g/dL from baseline or Hb ≥ 12 "
                      },
                      {
                        "id": "0f44a8c8-1c6e-45f8-871c-b1cab17a0756",
                        "name": "Secondary: Immunogenicity of BIVV009",
                        "endpointType": "Secondary",
                        "inputs": [
                          "ADA_status",
                          "ADA_titer"
                        ],
                        "timeWindow": {
                          "reference": "Part A and Part B",
                          "duration": "P2Y"
                        },
                        "algorithm": "Count of subjects with positive Anti-Drug Antibodies (ADA) / Total subjects",
                        "successCriteria": "Characterization of immunogenicity profile",
                        "sourceText": "Secondary Exploratory Objective for Part A was added: To evaluate the immunogenicity of BIVV009."
                      },
                      {
                        "id": "0b56626c-57ce-49d1-a340-40857fb28126",
                        "name": "Exploratory: Home Infusion Satisfaction (Part B)",
                        "endpointType": "Exploratory",
                        "inputs": [
                          "satisfaction_score"
                        ],
                        "timeWindow": {
                          "reference": "First and fourth home infusion",
                          "duration": "Variable"
                        },
                        "algorithm": "Score at 4th infusion - Score at 1st infusion",
                        "successCriteria": "Assessment of patient satisfaction with convenience of home infusion",
                        "sourceText": "Part B Satisfaction with home infusion after first home infusion and after four home infusion will be assessed in patients with home infusion was added."
                      },
                      {
                        "id": "a00beb19-7018-4dc8-8b1a-359da684f7a1",
                        "name": "Safety: Home Infusion Adverse Events",
                        "endpointType": "Secondary",
                        "inputs": [
                          "AE_onset_time",
                          "infusion_time"
                        ],
                        "timeWindow": {
                          "reference": "home infusion",
                          "duration": "PT24H"
                        },
                        "algorithm": "AE_onset_time - infusion_time <= 24 hours",
                        "successCriteria": "Identification of treatment-emergent adverse events within 24 hours of home administration",
                        "sourceText": "For patients with home infusions, safety assessments include AEs with onset within 24 hours of infusion was added."
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "d42fe916-9e97-4cff-a5ab-9f8739f8688b",
                        "name": "Baseline Body Weight",
                        "variableType": "Baseline",
                        "sourceVariables": [
                          "Body Weight"
                        ],
                        "derivationRule": "Last non-missing weight measurement prior to the first dose of BIVV009",
                        "baselineDefinition": "Prior to treatment start",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Pre-dose",
                        "imputationRule": "None specified",
                        "unit": "kg"
                      },
                      {
                        "id": "91262a99-6625-4fcc-9528-07bb1c4d52ea",
                        "name": "Dose Group Assignment",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "Body Weight"
                        ],
                        "derivationRule": "If weight < 75 kg then 6.5 g; If weight >= 75 kg then 7.5 g (implied by weight-based fixed dosing logic)",
                        "baselineDefinition": "Weight at treatment start",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Baseline",
                        "imputationRule": "None specified",
                        "unit": "g"
                      }
                    ],
                    "stateMachine": {
                      "id": "61840a09-d211-4c7b-9b9e-8d678ce4b331",
                      "initialState": "Screening/observation period",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening/observation period",
                        "Baseline",
                        "Part A",
                        "Part B Extension phase",
                        "ET/EOS/Safety follow-up",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening/observation period",
                          "toState": "Baseline",
                          "trigger": "Progress to Baseline"
                        },
                        {
                          "fromState": "Baseline",
                          "toState": "Part A",
                          "trigger": "Progress to Part A"
                        },
                        {
                          "fromState": "Part A",
                          "toState": "Part B Extension phase",
                          "trigger": "Progress to Part B Extension phase"
                        },
                        {
                          "fromState": "Part B Extension phase",
                          "toState": "ET/EOS/Safety follow-up",
                          "trigger": "Progress to ET/EOS/Safety follow-up"
                        },
                        {
                          "fromState": "Screening/observation period",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Screening/observation period": "epoch_1",
                        "Baseline": "epoch_2",
                        "Part A": "epoch_3",
                        "Part B Extension phase": "epoch_4",
                        "ET/EOS/Safety follow-up": "epoch_5",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "5581c681-8ff6-4ae3-98d4-f8cf8179995f",
                        "treatmentName": "Trial Protocol",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 6.0,
                            "unit": "g"
                          },
                          {
                            "amount": 4.0,
                            "unit": "g"
                          },
                          {
                            "amount": 5.0,
                            "unit": "g"
                          }
                        ],
                        "sourceText": "Protocol 06 Page 2 of 99 Bioverativ USA Inc. Confidential PROTOCOL AMENDMENT SUMMARY OF CHANGES DOCUMENT HISTORY Document Country/Countries impacted by amendment Date Amended Clinical Trial Protocol 0"
                      },
                      {
                        "id": "66aca1cf-04d7-4cca-835e-aa43b35f70e6",
                        "treatmentName": "Protocol Version",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 5.0,
                            "unit": "g"
                          },
                          {
                            "amount": 3.0,
                            "unit": "g"
                          },
                          {
                            "amount": 4.0,
                            "unit": "g"
                          },
                          {
                            "amount": 6.0,
                            "unit": "g"
                          }
                        ],
                        "sourceText": "ial PROTOCOL AMENDMENT SUMMARY OF CHANGES DOCUMENT HISTORY Document Country/Countries impacted by amendment Date Amended Clinical Trial Protocol 06 Global 19 December 2019 Clinical Study Protocol Vers"
                      },
                      {
                        "id": "b7e9289a-c259-4c6d-87a8-6c46fb00059e",
                        "treatmentName": "BIVV009 is",
                        "frequency": "QW",
                        "route": "IV",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 180.0,
                            "unit": "mg"
                          }
                        ],
                        "durationDescription": "26 weeks",
                        "sourceText": "ffects from exaggerated pharmacology (ie, autoimmune diseases, bacterial infections) were observed in those studies. As a result, the no observed adverse effect (dose) level (NOAEL) established for BI"
                      },
                      {
                        "id": "ab444727-9d62-4545-88af-f5d33a8b6e78",
                        "treatmentName": "BIVV009",
                        "frequency": "Q2W",
                        "route": "IV",
                        "startDay": 1,
                        "durationDescription": "Part A (duration not specified in snippet) followed by Part B (2 years)",
                        "doseModifications": [
                          "Home infusion facilities provided for specific countries in Part B"
                        ]
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "be6cd852-566b-4ca7-baba-8c024a39948c",
                        "visitName": "Screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening",
                        "sourceText": "Section 6.1.1.1: Screening Assessments (initiating at Day -42)"
                      },
                      {
                        "id": "98fbdc6e-7822-455f-be4a-9deaca188f45",
                        "visitName": "Visit 009",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 2,
                        "sourceText": "BIVV009-03 Cardinal Amended Clinical Trial Protocol 06 Page 5 of 99"
                      },
                      {
                        "id": "ed09ace4-11be-44f1-9722-d3786bcf81d0",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 3,
                        "epoch": "Follow-up",
                        "sourceText": "following completion of LPO in Part A. The change was made to gather more evidence on long-term safety, tolerability"
                      },
                      {
                        "id": "007fae54-4575-4bfb-9b6d-b2b83e07a9fa",
                        "visitName": "end of study",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 4,
                        "sourceText": "early termination/end of study/safety follow-up was renumbered as 6.1.7. This change was made to evaluate the"
                      },
                      {
                        "id": "172a4b29-3a66-4ffd-abcc-2e2b6653a4c5",
                        "visitName": "EOT",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 5,
                        "sourceText": "EOT end of treatment EQ-5D-5L"
                      },
                      {
                        "id": "a4fd1ffe-cea0-4c0d-aaae-6ed9951bf3f5",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 6,
                        "sourceText": "baseline visit (and first infusion of study drug) must occur at least 7 days following the transfusion. Part A"
                      },
                      {
                        "id": "70e96915-110c-4080-9c96-33d720d64447",
                        "visitName": "Visit 9",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 7,
                        "sourceText": "Follow up visit 9 weeks after last dose. Samples will also be collected if a patient experiences a hematologic breakthrough or withdraws from the study. SAMPLE SIZE:"
                      },
                      {
                        "id": "e16c9413-cd8c-4510-b0d8-752dd756c881",
                        "visitName": "Part B Extension Phase (Bi-weekly)",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 8,
                        "epoch": "Part B Extension Phase"
                      },
                      {
                        "id": "eff1cadd-7554-4b1d-8584-0b37c26e3740",
                        "visitName": "Randomization",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 9,
                        "sourceText": "Randomization ............................................................................................................................... 54 6.2.4 Dose preparation and administration ............."
                      },
                      {
                        "id": "0eda0677-76c1-4efa-929f-a6fe1103c3c8",
                        "visitName": "Day 7",
                        "targetDay": 7,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 10,
                        "epoch": "Part A",
                        "sourceText": "points Day 7, 35, 77, 133 and 175, may be used to assay ADA was added. This change was made to help characterize"
                      },
                      {
                        "id": "c57e2ba3-313d-400f-8e06-7473514a8a2f",
                        "visitName": "Week 5",
                        "targetDay": 29,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 11,
                        "targetWeek": 5,
                        "sourceText": "transfusion from Week 5 through Week 26 (EOT) and did not receive treatment for CAgD beyond what is permitted per protocol. Additionally, the patient’s Hgb level must meet either of the following crit"
                      },
                      {
                        "id": "970e050a-3b8c-446a-b655-6b89e81d08fa",
                        "visitName": "Day 35",
                        "targetDay": 35,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 3,
                        "targetWeek": 5,
                        "epoch": "Part A"
                      },
                      {
                        "id": "c9a54c73-98ab-468a-acb9-dfba77caf1c8",
                        "visitName": "Day 77",
                        "targetDay": 77,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 4,
                        "targetWeek": 11,
                        "epoch": "Part A"
                      },
                      {
                        "id": "2c00c713-7dcf-498d-a1d5-6e8983346248",
                        "visitName": "Day 91",
                        "targetDay": 91,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 14,
                        "sourceText": "(Day 91 only) Xo"
                      },
                      {
                        "id": "ff288257-843d-400a-9f05-c536b81eed77",
                        "visitName": "Day 133",
                        "targetDay": 133,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 5,
                        "targetWeek": 19,
                        "epoch": "Part A"
                      },
                      {
                        "id": "a43255eb-1a2b-4116-90d5-368a89efdf49",
                        "visitName": "Week 23",
                        "targetDay": 155,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 16,
                        "targetWeek": 23,
                        "sourceText": "Week 23, 25, and 26)  Mean change from baseline in QOL, as assessed by the change in Functional"
                      },
                      {
                        "id": "4b72692f-ff54-422f-a979-e9015b38f08e",
                        "visitName": "Week 25",
                        "targetDay": 169,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": false,
                        "visitNumber": 17,
                        "targetWeek": 25,
                        "sourceText": "60 minutes on Day 0, Day 7, and every 14 days thereafter through Week 25 (ie, Days 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175). Patients who miss a dose (ie, outside the dosing window or"
                      },
                      {
                        "id": "0ac1aa44-4916-4fc7-bfd7-07f75bb1640e",
                        "visitName": "Day 175",
                        "targetDay": 175,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 6,
                        "targetWeek": 25,
                        "epoch": "Part A"
                      },
                      {
                        "id": "f0bb4cd0-44a0-4725-802d-b1536a320e4f",
                        "visitName": "Week 26",
                        "targetDay": 176,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 19,
                        "targetWeek": 26,
                        "sourceText": "(Week 26) ADA: In patients who consented to the use of their blood samples for future research, PD"
                      },
                      {
                        "id": "fa4703c3-5a93-4891-b47a-f888ea4cecaf",
                        "visitName": "Visit 1",
                        "targetDay": 182,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 20,
                        "targetWeek": 26,
                        "epoch": "Part A",
                        "sourceText": "visit 1 week prior to the next scheduled dose in order to receive an additional loading dose. Patients will have an End-of-Treatment (EOT) visit in Part A on Day 182 (Week 26). Patients who meet the t"
                      },
                      {
                        "id": "765415c2-942a-4109-b7de-8b92f8a31a42",
                        "visitName": "Week 27",
                        "targetDay": 183,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 21,
                        "targetWeek": 27,
                        "sourceText": "Bi-weekly dosing starting at Week 27 and continuing for 2 years after LPO in Part A"
                      },
                      {
                        "id": "af30d680-debd-4f26-86d6-edb9e14b8307",
                        "visitName": "Week 41",
                        "targetDay": 281,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 22,
                        "targetWeek": 41,
                        "sourceText": "qualified by the Investigator and no sooner than after Week 41 (Day 287) and without evidence of intolerance of the study drug as determined by the Investigator. No new risks related to home infusions"
                      },
                      {
                        "id": "30fbf002-1c7b-4c6a-a5a6-dda0d2b46541",
                        "visitName": "Day 287",
                        "targetDay": 287,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 23,
                        "sourceText": "qualified by the Investigator and no sooner than after Week 41 (Day 287) and without evidence of intolerance of the study drug as determined by the Investigator. No new risks related to home infusions"
                      },
                      {
                        "id": "d63456f4-6baf-4cfa-a32a-8b6c9b152181",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 24,
                        "sourceText": "early termination/end of study/safety follow-up was renumbered as 6.1.7. This change was made to evaluate the"
                      },
                      {
                        "id": "a087a0cc-099e-4d66-ba52-c5c6ecf7085c",
                        "visitName": "Week 79",
                        "targetDay": 547,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 25,
                        "targetWeek": 79,
                        "epoch": "Part B Extension Phase",
                        "sourceText": "week 79. This change was made to reflect the study assessments frequency in the 2nd year of"
                      }
                    ]
                  }
                }
              },
              {
                "id": "80ed0d01-cddd-4c0d-89ae-6712eded3192",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a. The 6-week Screening/Observation Period may be extended by 1 week for patients requiring a blood transfusion prior to study drug administration.\", \"b. Patients should return to the site 9 weeks after last dose for ET procedures, EOS assessment, or Safety Follow-up procedures upon completion of dosing in the study. If patient experiences a hematological breakthrough event, a PK, PD, and ADA sample should be collected at the time of the event.\", \"c. Applicable to patients who do not have documented vaccination against encapsulated bacterial pathogens within 5 years of enrollment. Refer to immunization recommendations per Section 6.1.1.1 for patients requiring vaccination. A blood sample for vaccine titers will be collected on Day 0 prior to study drug infusion to be used to determine serum relevant antibody titers should the patient be diagnosed with an infection associated with an encapsulated organism during the course of the study. A second sample will be collected during the study period if a patient presents with symptoms concerning for an infection with Streptococcus pneumoniae, Neisseria meningitidis or Haemophilus influenzae and analyzed if the infection is confirmed with one of the aforementioned organisms.\", \"d. Prior bone marrow biopsy report review, prior tissue assessment, or new bone marrow biopsy (as applicable). Sites will submit de-identified biopsy reports to independent central reader for eligibility adjudication. If biopsy is deemed unsuitable or insufficient to determine eligibility, either prior tissue may be submitted for additional hematopathology assessment or a new bone marrow biopsy will be performed during the screening period.\", \"e. Females of child-bearing potential only. Serum pregnancy test to be performed at Screening. Serum or urine pregnancy test to be performed on Days 0, 21, 49, 77, 105, 133, and 161, and at Week 26/EOT or at the ET Visit. Repeat serum or urine pregnancy test every 4 weeks (\\u00b12 days) during Part B.\", \"f. Height measured at Screening only. Body weight measured every 3 months during Part B.\", \"g. Vital signs measurements (supine BP, PR, RR, and oral temperature) are to be obtained at Screening and at each subsequent visit, with measurements performed predose and 1 hour (\\u00b15 minutes) after completion of administration of each dose of study drug.\", \"h. For a complete list of analytes, see protocol (Section 10.1, Appendix A).\", \"i. BIVV009 doses of 6.5 grams (if <75 kg) or 7.5 grams (if \\u226575 kg) based on patient's baseline body weight will be administered via IV infusion over ~60 \\u00b15 minutes on Days 0, 7, and every 14 days thereafter during Part A, and every 2 weeks starting at Week 27 during Part B. Patients with underlying cardiopulmonary disease may receive a 2-hour infusion with Sponsor approval. If a patient misses a scheduled dose (outside of the 2-day window or >17 days since last dose), they must return to site (unscheduled visit) to receive another loading dose 1 week prior to the next scheduled dose. Qualifying patients at participating sites may have study drug dosed at home during certain visits in Part B, according to the rules specified in Section 10.10 Appendix J (US, the Netherlands, Norway, France, Italy, Austria, Germany, Spain, and specific amendments.\", \"j. During Part A, PK and PD samples will be collected at predose and 1 hour (\\u00b115 minutes) postdose (ie, 1 hour after completion of study drug infusion) from all patients on Days 0, 7, 21, 35, 49, 63, 77, 91, 105, 119, 133, 147, 161, and 175. An additional blood sample for PK and PD analysis will be collected during the EOT visit on Day 182 or at ET if a patient withdraws early. During Part B, PK and PD samples will be collected routinely at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals. PK and PD samples will also be collected if a patient experiences a hematologic breakthrough event at any point during the study.\", \"k. AEs will be recorded from the time the patient signs the informed consent form until 9 weeks after administration of the last dose of study drug.\", \"l. To be performed every 3 months.\", \"m. Refer to the Laboratory Manual for details of sample collection during Screening.\", \"n. Samples will be collected for a subset of the disease-related biomarkers at Day 91 only. Refer to the Laboratory Manual for details.\", \"o. During Part B, a 12-lead ECG will be conducting pre- and postdose at 3 months (Day 273).\", \"p. During Part B, the healthcare resource utilization data will be recorded every 4 weeks.\", \"q. To be performed in the following order: FACIT-Fatigue first, PGIS second, PGIC third, SF-12 fourth, and EQ-5D-5L fifth.\", \"r. During Part B, ADA samples will be collected at predose at 3-month intervals during the 1st year of treatment in Part B and then at 6-month intervals and at safety follow up visit 9 weeks after last dose. Samples will also be collected if a patient experiences a hematologic breakthrough event or withdraws from the study early.\", \"s. SLE panel will be performed every 6 months in Part-B of the study.\", \"t. In Part B, hematology and clinical chemistry panels to be performed every 2 weeks after Week 25 and up to Week 79. For the remainder of Part B after Week 79, hematology and clinical chemistry panels to be performed every 4 weeks.\", \"u. To be performed at 3-month intervals during the 1st year of treatment in Part B, and then at 6-month intervals.\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "803ef156-3aa1-4ff8-ac9d-02d1bf1fc0c3",
                "name": "Trial Protocol Administration",
                "instanceType": "Administration",
                "dose": "6.0 g / 4.0 g / 5.0 g",
                "doseFrequency": "QD",
                "route": {
                  "id": "a6cdda21-b3f1-4a64-82d2-6f17c0df00c0",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "description": "Protocol 06 Page 2 of 99 Bioverativ USA Inc. Confidential PROTOCOL AMENDMENT SUMMARY OF CHANGES DOCUMENT HISTORY Document Country/Countries impacted by amendment Date Amended Clinical Trial Protocol 0"
              },
              {
                "id": "1acc6bbd-4557-45b6-bbb1-201c7a5addc3",
                "name": "Protocol Version Administration",
                "instanceType": "Administration",
                "dose": "5.0 g / 3.0 g / 4.0 g / 6.0 g",
                "doseFrequency": "QD",
                "route": {
                  "id": "aad3d565-98cb-4c2b-8128-5b279d2fd156",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "description": "ial PROTOCOL AMENDMENT SUMMARY OF CHANGES DOCUMENT HISTORY Document Country/Countries impacted by amendment Date Amended Clinical Trial Protocol 06 Global 19 December 2019 Clinical Study Protocol Vers"
              },
              {
                "id": "02f0c4fb-c018-4ca8-8b7f-eaa053f9e532",
                "name": "BIVV009 is Administration",
                "instanceType": "Administration",
                "dose": "180.0 mg",
                "doseFrequency": "QW",
                "route": {
                  "id": "93de1991-90fc-48dc-89f0-c621893fe314",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "26 weeks",
                "description": "ffects from exaggerated pharmacology (ie, autoimmune diseases, bacterial infections) were observed in those studies. As a result, the no observed adverse effect (dose) level (NOAEL) established for BI"
              },
              {
                "id": "49efbb7e-6d9e-48b9-b74a-a3dae00e335d",
                "name": "BIVV009 Administration",
                "instanceType": "Administration",
                "doseFrequency": "Q2W",
                "route": {
                  "id": "f0a68fad-e722-4981-8a44-6de75a4a58eb",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "Part A (duration not specified in snippet) followed by Part B (2 years)"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "c9aceea8-2877-4a78-96d6-8c1a1f4c5086",
            "text": "A PHASE 3, PIVOTAL, OPEN-LABEL, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WHO HAVE A RECENT HISTORY OF BLOOD TRANSFUSION",
            "type": {
              "id": "c312d0fc-e596-40cc-9f3a-a4212c2d6ed0",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "da5c5a73-10ee-4a2e-bb09-eeae6acc7f4c",
            "text": "Cardinal",
            "type": {
              "id": "51036ef1-3096-4625-a203-02798b254abe",
              "code": "Study Acronym",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Acronym",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "dd2fb336-81f8-43f3-814e-6b35b0fad646",
            "text": "NCT03347396",
            "instanceType": "StudyIdentifier",
            "scopeId": "e9db9746-0c70-426e-aa52-36753cf56a45",
            "type": {
              "code": "C172240",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinicaltrials.gov Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "99ef7461-54ab-4f6b-bc21-17bdfee09688",
            "text": "BIVV009-03",
            "instanceType": "StudyIdentifier",
            "scopeId": "f7a3f88f-dbd0-47cd-ad66-b10a64dd1828",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "785e502e-a738-4ccd-acda-7f547674b5e5",
            "text": "2017-003538-10",
            "instanceType": "StudyIdentifier",
            "scopeId": "861664e6-e37a-43c6-85b9-67c6c342546c",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "13ea1204-d9d6-481e-88a4-299f367a4226",
            "text": "128,190",
            "instanceType": "StudyIdentifier",
            "scopeId": "ecd5fdff-d43c-4e00-88bd-d80a92225451",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "537592a2-260a-442e-afe5-ff82e967e166",
            "text": "VV-CLIN-0562006 1.0",
            "instanceType": "StudyIdentifier",
            "scopeId": "bdb90f0d-4c74-421b-aa00-5c8b82ef939a",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "f7a3f88f-dbd0-47cd-ad66-b10a64dd1828",
            "name": "Bioverativ USA Inc.",
            "type": {
              "id": "3693af94-dbda-45a8-86fe-4dbcad55e94b",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Bioverativ USA Inc.",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "bdb90f0d-4c74-421b-aa00-5c8b82ef939a",
            "name": "Sanofi",
            "type": {
              "id": "31ec3555-a242-4870-ba9a-64ee8f39dc33",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Sanofi",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "e9db9746-0c70-426e-aa52-36753cf56a45",
            "name": "ClinicalTrials.gov",
            "type": {
              "id": "8c6519ff-2f06-455f-97ea-6b050650f369",
              "code": "C19326",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Healthcare Facility",
              "instanceType": "Code"
            },
            "identifier": "ClinicalTrials.gov",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "ecd5fdff-d43c-4e00-88bd-d80a92225451",
            "name": "FDA",
            "type": {
              "id": "20d7a052-2d4a-418f-ac8e-3f6ebabe5926",
              "code": "C25461",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Regulatory Agency",
              "instanceType": "Code"
            },
            "identifier": "FDA",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "f7a3f88f-dbd0-47cd-ad66-b10a64dd1828",
            "name": "Arizona Oncology Associates PC",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "49fc7c4f-dd2b-4f89-a140-f0af44bbb460",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "bdb90f0d-4c74-421b-aa00-5c8b82ef939a",
            "name": "USC/Keck School of Medicine",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "f800c21e-0d33-457d-84a2-012d9e7ac634",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e9db9746-0c70-426e-aa52-36753cf56a45",
            "name": "The Oncology Institute of Hope and Innovation",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "7e691dfd-01aa-42c9-b237-0ebbebe19292",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ecd5fdff-d43c-4e00-88bd-d80a92225451",
            "name": "Georgetown University Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "061828f9-66a9-4d51-8100-b148bca1be03",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c8625824-1e87-4b39-a7da-757051bb571e",
            "name": "Massachusetts General Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "66c6d269-7293-46d4-ad74-5754c1ab44a6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "df9faa52-a435-467e-9ddd-8cf1bb2c6e59",
            "name": "Brigham and Women's Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "45814d52-d724-462f-b2aa-d17aec3fa38c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2eb08142-e461-4369-b6bc-c1d4581cd28e",
            "name": "Montefiore Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "53353971-127d-49a3-8b74-70e408bedc30",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "052a844a-a4d7-4b04-a586-81e7cffd7e93",
            "name": "New York Medical College at Westchester Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "83af35db-226b-42f6-a6ac-22220446602a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5f6a0755-4bd7-48fe-a3f6-108555638e23",
            "name": "East Carolina University",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "587e4ecf-2cbd-489a-a017-aaaebd2f0084",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "edda4b82-6943-45f9-95ae-f1e606c470a2",
            "name": "Cleveland Clinic",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "7b0b6760-3be1-4f07-86b1-3a3e080ae24f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "01950252-c573-42e6-879f-bb9c946c8752",
            "name": "Hospital of the University of Pennsylvania",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "52a425f9-2250-435d-b096-0eaf13665b5c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fffbca48-be67-4000-aff6-89cff363f0c9",
            "name": "University of Pittsburgh Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "9b271b64-990c-41bd-a5aa-af9454d3925f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "21502832-9443-4bde-9777-30b87695ab03",
            "name": "UW Hospitals and Clinics",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "0d34c79f-20e5-42a6-b27f-d33a56c2dbe5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0c1404c9-ee8e-418d-a232-84fa6b9c3e9d",
            "name": "USC Health Clinics",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "e7b29807-ac86-47ca-bdb2-1de6b2b7e9dd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1dbeea21-b04c-4ec1-b1a9-4096fec3b9d3",
            "name": "Ballarat Oncology & Haematology",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "127e415b-d4b5-4265-a8b1-5458055f3844",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "563a7dca-cd66-43db-a9ee-b682759a3d2c",
            "name": "Monash Medical Centre",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "b87ed4b7-61cd-4a99-aa80-72028ce9b32d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8824af2d-0454-4354-bdd8-417559ae3f18",
            "name": "Medical University of Vienna",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "197ab7ec-2ee7-4f60-92ed-b075be222aa4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2ed44dc5-e082-4961-95c3-f7aa89627bce",
            "name": "ZNA Stuivenberg",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "50d296c7-90be-4625-9636-9a64ec6d1dec",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b52a2b0b-1251-4bbd-bbc1-c06f52d0086f",
            "name": "Centre Hospitalier Jolimont",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "3011b83c-8986-4d3f-becc-c5f99b882828",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "675e3f5c-07fe-4249-b53f-a2b259801f54",
            "name": "University Hospitals Leuven",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "24d241bb-73de-4d35-b4ea-74401b987168",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "39155eba-db00-420a-bf28-79e13703f4fe",
            "name": "St. Michael's Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "419d4a4a-959e-446a-9af0-d23be19dbd72",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "85457044-379d-43e9-8d50-6e047d15e545",
            "name": "McGill University Health Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "59908f49-a26f-4ce0-a8fe-68603096c9d9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "af3ad37b-0d6d-4ce9-9f0e-5c5ad3f15c5e",
            "name": "University of Alberta",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "17a0a1ff-0a96-4ecc-bd93-f58fa8dca0e6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "484133dd-8f3b-42c1-b129-0740261e9129",
            "name": "CHU de Caen",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "f3557e3b-d6ff-4ebb-86fd-ea34c3d96b37",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "bbbf6e44-d3b7-4f94-83c2-cad931c03675",
            "name": "Centre Hospitalier Henri Mondor",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "82e9640f-f914-4e25-aefd-f5e6ab023b19",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f714c9ef-6ccb-452f-ab44-ca1538446180",
            "name": "Centre Hospitalier Lyon Sud",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "058597d5-037e-4c82-9026-e53367f1b284",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d5d30376-708f-4b83-a03d-f4b4c78fb034",
            "name": "Gemeinschaftspraxis Hämatologie-Onkologie",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "cf10987f-4be6-4dfc-b6dd-36b033a8b098",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a2c6beae-b4be-49a8-bc6b-d8af0466a267",
            "name": "Universitätsklinikum Essen",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "71762f65-575f-4164-a375-cb8ac369035f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9d01ec73-61c8-4b0b-bff9-d6e85ec4324a",
            "name": "Univ Ulm, Inst Klin. Transfusions. Immungen",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "94259d52-8521-403e-a7fe-1392a23fe673",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f7fab9da-90a4-4181-ba0f-baf033a53daa",
            "name": "Hadassah Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "77af8f97-4ae7-42a5-8ee9-04b9352a6fc1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "54847a3c-6bab-43e1-9990-3a5593ae29a9",
            "name": "Laniado Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "83ffe48a-b41b-40c7-81fa-3734648a6f2e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "93cfc4c7-8888-4190-8420-cd679ceeda91",
            "name": "Tel Aviv Sourasky Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "d7f0c0b4-8749-4c62-bd1a-501bf0aa78c2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e08865b7-6a88-4132-819b-f6f0fc831771",
            "name": "A. O. Spedali Civili di Brescia",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "95d43ecc-483c-46c6-b61f-98904031d0c9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "46878268-71fe-4103-a581-1a35333f06b6",
            "name": "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "5b5ad875-e565-4e28-b260-cd410c57d825",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "600ae1ef-d193-4102-8f4f-74ebbe31c413",
            "name": "U.O.C. Ematologia- Policlinico \"A. Gemelli\"",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "bab93c82-5dbc-4566-b0b2-54df59dda38d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e52ca3a1-0a89-4248-ae5b-c536794b6fda",
            "name": "U.O.C. Ematologia Ospedale San Bortolo",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "5edd1a1d-b568-44ee-b6bd-d6b9c3893aa9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b9d7563d-e1a1-4e97-befe-87098a6a4aec",
            "name": "Tokai University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "1dced1a7-cd20-41fa-863a-fe1abc0678b6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6abcc9b0-46f0-4a96-b143-ebcf8945f7f7",
            "name": "Saitama Medical University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "fb6e977d-99b7-4ce3-9765-d812a3fd0aa5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b9416a7c-c13c-4011-a870-0d215827a3b3",
            "name": "Juntendo University Nerima Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "9c9c93e1-3ba6-4098-be70-a2ed98ff9191",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "18ccda38-ecf5-40a2-874a-6521bb832d7d",
            "name": "Academisch Medisch Centrum",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "e553290c-ff14-4a5f-bfde-1bb94cb00621",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6712c639-fd41-448f-a7c4-ac2767761fff",
            "name": "Haukeland University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "41",
            "type": {
              "id": "5a9b93e0-c053-4063-ac81-fb40dadf00c0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "538a187c-4c4c-40d4-8591-b65286a1b2ce",
            "name": "Oslo University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "42",
            "type": {
              "id": "aecad5ab-aa2e-4b12-a78c-6b3eaa56b7db",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ff5d7330-b757-4525-b6e5-7485aa5ec11a",
            "name": "St Olavs Hospital, Avdeling for blodsykdommer",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "43",
            "type": {
              "id": "96ab8297-85b5-48ad-a548-2c4cc335a0ce",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "973f7fdc-8a2b-4837-8853-2f0efd5935fd",
            "name": "Hospital Universitario Puerta de Hierro",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "44",
            "type": {
              "id": "8cf7affe-03e2-4e10-8dbc-ebfb4d821973",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d9276cc6-1c59-4296-9303-5b5fbfe29f63",
            "name": "Hospital Clinci i Provincial de Barcelona",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "45",
            "type": {
              "id": "fb9df341-d5a2-4f55-af94-463c194d56aa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "33e2a65c-70d1-4a37-8cf7-46d21ff434e0",
            "name": "Hospital Universitario Virgen del Rocio",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "46",
            "type": {
              "id": "1b5a6770-7ba7-43d6-b4d6-fa7c6f35c7a2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b10e894d-0ae2-4c63-a3d7-b70b5b054259",
            "name": "Hospital Universitario Dr. Peset",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "47",
            "type": {
              "id": "a787ab31-cede-4440-8296-f27e8efa6dfd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "26531941-2074-42ce-b975-607fc83e0bd7",
            "name": "St James Hospital, Leeds",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "48",
            "type": {
              "id": "caa850a8-fe20-41b0-b3b1-0e88a941218c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7712fa8f-b278-4024-803c-7acca6a328ea",
            "name": "University College London",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "49",
            "type": {
              "id": "135c2c8d-5f98-449e-96ca-f0ce08f0b9b6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "2e3352d3-bd5d-4782-8794-7874e1f154f3",
          "code": "Phase3",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase3",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "82cc2eb0-d395-4f84-b032-325f9ed971da",
            "name": "Age requirement",
            "text": "Adult males and females ≥18 years of age at Screening.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "94ba7a2e-447f-4755-bedb-11c01dbda633",
            "name": "Body weight",
            "text": "Body weight of ≥39 kg at Screening.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "90aba16c-926c-4e61-9e17-682b67d825fb",
            "name": "Confirmed diagnosis of primary CAgD",
            "text": "Confirmed diagnosis of primary CAgD based on the following criteria: a) Chronic hemolysis b) Polyspecific direct antiglobulin test (DAT) positive c) Monospecific DAT strongly positive for C3d d) Cold agglutinin titer ≥64 at 4℃ e) IgG DAT ≤1+, and f) No overt malignant disease",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "144cc2e9-5295-4764-bda4-4759bd4dc43b",
            "name": "Transfusion history",
            "text": "History of at least one documented blood transfusion within 6 months of enrollment.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b15339d2-fa4f-4fad-be2f-91a218a12741",
            "name": "Hemoglobin level",
            "text": "Hemoglobin level ≤10.0 g/dL.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "ac0da57c-de2f-41d6-a486-10ee3e7b5545",
            "name": "Bilirubin level",
            "text": "Bilirubin level above the normal reference range, including patients with Gilbert’s Syndrome.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "8c56df00-dada-4414-8dfb-ff3b68424060",
            "name": "Ferritin levels",
            "text": "Ferritin levels above the lower limit of normal. Concurrent treatment with iron supplementation is permitted if the patient has been on a stable dose during the previous 4 weeks.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "adcc847f-22b8-4740-b99f-e4ada8bc262a",
            "name": "CAgD-related signs or symptoms",
            "text": "Presence of one or more of the following CAgD-related signs or symptoms within 3 months of Screening: a) Symptomatic anemia defined as: i. Fatigue ii. Weakness iii. Shortness of breath iv. Palpitations, fast heart beat v. Light headedness and/or vi. Chest pain b) Acrocyanosis c) Raynaud’s syndrome d) Hemoglobinuria e) Disabling circulatory symptoms, and/or f) Major adverse vascular event (including thrombosis).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "f876bebe-8afb-4c9c-89b1-6692a0f7c2b5",
            "name": "Bone marrow biopsy",
            "text": "Bone marrow biopsy within 6 months of Screening with no overt evidence of lymphoproliferative disease or other hematological malignancy. An additional bone marrow biopsy will be required if the prior bone marrow is deemed unsuitable for analysis by the Sponsor.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "31db3567-7c90-4a19-bf8d-3d002a6a7760",
            "name": "Vaccinations",
            "text": "Documented vaccinations against encapsulated bacterial pathogens (Neisseria meningitis, including serogroup B meningococcus where available, Haemophilus influenzae, and Streptococcus pneumoniae) within 5 years of enrollment or as specified in Section 6.1.1.1.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "3b35cb5d-c505-468b-8f87-a9e3b1c60551",
            "name": "IV access",
            "text": "Adequate IV access.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c05fed08-c30d-4c79-a055-04c2951ce82c",
            "name": "Female contraception",
            "text": "If female, must be post-menopausal, surgically sterile, or be established on (≥3 months prior to Screening) and agree to continue to use the same highly effective methods of birth control throughout the study and for 9 weeks following administration of the last dose of study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "bc340ce9-f8f3-4db9-a7e1-6fbef9789b9c",
            "name": "Male contraception",
            "text": "Males must be surgically sterile for at least 90 days or when sexually active with female partners of child-bearing potential will agree to use highly effective contraception from Day 0 until 9 weeks following administration of the last dose of study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b18ec504-08cd-4613-a13e-61584ca8b39b",
            "name": "Informed consent",
            "text": "Able to comprehend and give informed consent.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "88e4619e-5346-44aa-b948-fbd4c1df2c4f",
            "name": "Compliance",
            "text": "Able to comply with the requirements of the study and to complete the full sequence of protocol-related procedures.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "e32d0d28-641c-4300-9be4-b8923ebbbc9f",
            "name": "Secondary CAS exclusion",
            "text": "Cold agglutinin syndrome secondary to infection, rheumatologic disease, or active hematologic malignancy.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b2c1507f-4d82-4b37-a450-4e27b9e4e37d",
            "name": "Clinically relevant infection",
            "text": "Clinically relevant infection of any kind within the month preceding enrollment (eg, active hepatitis C, pneumonia).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "6897b7da-b926-4ca3-91b5-7987159e2ded",
            "name": "SLE or autoimmune disorders",
            "text": "Clinical diagnosis of systemic lupus erythematosus (SLE) or other autoimmune disorders with anti-nuclear antibodies at Screening. Anti-nuclear antibodies of long-standing duration without associated clinical symptoms will be adjudicated on a case-by-case basis during the Confirmatory Review of Patient Eligibility (Section 6.1.1.3).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5730649f-6676-4e36-b706-fa610c5b4b10",
            "name": "Hepatitis panel",
            "text": "Positive hepatitis panel (including hepatitis B surface antigen and/or hepatitis C virus antibody) prior to or at Screening.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "9cb6647f-96ea-49b9-b964-4936f8aea1e5",
            "name": "HIV antibody",
            "text": "Positive human immunodeficiency virus (HIV) antibody at Screening.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5e8630ed-0c04-409c-9e80-c3aee820f522",
            "name": "Rituximab treatment",
            "text": "Treatment with rituximab monotherapy within 3 months or rituximab combination therapies (eg, with bendamustine, fludarabine, ibrutinib, or cytotoxic drugs) within 6 months prior to enrollment.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5d405a8f-c2ee-4577-a1a0-ef3a2b9b788e",
            "name": "Corticosteroids",
            "text": "Concurrent treatment with corticosteroids other than a stable daily dose equivalent to ≤10 mg/day prednisone for previous 3 months.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "30b8d02f-33f2-4e86-943b-d4af6aa06fd9",
            "name": "Erythropoietin deficiency",
            "text": "Erythropoietin deficiency. Concurrent treatment with erythropoietin is permitted if the patient has been on a stable dose for the previous 3 months.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "a16710ae-4cda-4f98-b2a7-5ab4204692f3",
            "name": "Iron supplementation",
            "text": "Concurrent usage of iron supplementation unless the patient has been on a stable dose for at least 4 weeks.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "fb03eac7-a3bc-4926-926e-b75855d0f15e",
            "name": "Significant medical history",
            "text": "Clinically significant medical history or ongoing chronic illness that would jeopardize the safety of the patient or compromise the quality of the data derived from his/her participation in this study (as determined by the Investigator [or designee]) at Screening.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "984fde3d-d820-44ee-b419-28c9ef72406b",
            "name": "Experimental drugs",
            "text": "Concurrent treatment with other experimental drugs or participation in another clinical trial with any investigational drug within 30 days or 5 half-lives, whichever is greater, prior to treatment start.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "4b74efb1-d971-42c7-83fc-2bf8150fb9c1",
            "name": "Pregnancy or lactation",
            "text": "Females who are pregnant, lactating, or, if having reproductive potential, are considered potentially unreliable with respect to contraceptive practice.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5f8c34e7-aefb-458d-a869-9a613bc2aeeb",
            "name": "Hypersensitivity",
            "text": "History of hypersensitivity to BIVV009 or any of its components.",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "7f16802e-c59f-4dfd-a453-ec99024a5795",
            "name": "BIVV009",
            "type": {
              "id": "c371f75b-72f6-4086-a253-ec557fabea21",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "345d0fc8-2dd4-40f7-8951-20518029027c",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Humanized monoclonal antibody (mAb) directed against human complement factor C1s.",
            "productIds": [
              "d4ff2f28-e07e-4d5c-9f84-4fa9f005cbac"
            ],
            "administrationIds": [
              "dff1c24b-170b-4758-bdda-22c349a2d08f",
              "a23b85d8-37f2-4ca9-a5e3-d4dfdccc862d",
              "3107742a-ca67-409f-be6c-2fdb9d4df9b0"
            ]
          },
          {
            "id": "b70eba87-6592-4172-b4a4-c5d6763d0982",
            "name": "Blood transfusion",
            "type": {
              "id": "1cc3bb86-c933-4b3f-b21a-8d9775e97ea4",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "c17aef5b-394f-45a2-b065-73f466182b77",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Administered if Hgb <9 g/dL and symptomatic, or Hgb <7 g/dL and asymptomatic.",
            "administrationIds": [
              "7558c292-25da-4b61-9978-2d0b474d80c3"
            ]
          },
          {
            "id": "8b96444e-2886-47dd-a09a-1511533d3d54",
            "name": "Iron supplementation",
            "type": {
              "id": "25bae57f-e325-48a7-b67e-6d669f20b8a9",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "0daf0e28-20e4-4a28-b74d-84bf35d6e2b2",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted if patient has been on a stable dose for at least 4 weeks.",
            "administrationIds": [
              "3b495ccc-2512-436a-9673-3a21e2ea58e4"
            ]
          },
          {
            "id": "e9f7a82b-0c47-4f6b-b991-ddf6e576f6cc",
            "name": "Erythropoietin",
            "type": {
              "id": "a108b0f5-af85-4af1-9424-d6629aa01e93",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "845c631d-c9f9-4327-b6fd-f3abe35cb308",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted if patient has been on a stable dose for the previous 3 months."
          },
          {
            "id": "44c584c2-f7ce-4926-9e69-93019e8fe84d",
            "name": "Corticosteroids",
            "type": {
              "id": "8c46f4db-4695-44a9-802f-0a8574a01fa6",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "89b013c4-953a-4cfc-9ddd-df97d45e2392",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted only as a stable daily dose equivalent to ≤10 mg/day prednisone for previous 3 months."
          },
          {
            "id": "b0c61bb1-6606-4a1a-ad36-f2e079295cea",
            "name": "Vaccinations against encapsulated bacterial pathogens",
            "type": {
              "id": "cca591b3-39de-44ab-b81e-1d52a353614d",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "20acaa6c-f67c-46cd-90b8-b4ffe6349e90",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Required vaccinations including Neisseria meningitis, Haemophilus influenzae, and Streptococcus pneumoniae."
          },
          {
            "id": "6fbf0332-e4ef-4040-8bf5-0de68ee75e44",
            "name": "Rituximab",
            "type": {
              "id": "f0f8fad0-1ec6-41be-a365-77c52a256680",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "6e08bdb0-3b79-4267-ac30-5860870ede86",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited within 3 months (monotherapy) or 6 months (combination therapy) prior to enrollment."
          }
        ],
        "administrableProducts": [
          {
            "id": "d4ff2f28-e07e-4d5c-9f84-4fa9f005cbac",
            "name": "BIVV009",
            "administrableDoseForm": {
              "id": "e43add72-7219-4a7d-8b49-aa1a2f9503d2",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "d68570ac-1d90-4ee2-811f-7357a9981f00",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "0b4e8757-2737-45b5-a699-0bb768f88efe",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "6.5 g or 7.5 g",
            "substanceIds": [
              "e93b9c1e-40e4-4134-b6e9-757152afcf32"
            ],
            "manufacturer": "Bioverativ USA Inc."
          }
        ],
        "narrativeContents": [
          {
            "id": "65ea6e41-3253-443f-a522-e20c4e3eaaf2",
            "name": "SYNOPSIS",
            "text": "SYNOPSIS",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "SYNOPSIS",
            "sectionType": {
              "id": "47e83b9c-6653-48ac-96ab-716cfa82fcfd",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            }
          },
          {
            "id": "7db888ae-4da7-44a8-a35f-0fcc67d6e40b",
            "name": "INTRODUCTION",
            "text": "INTRODUCTION",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "INTRODUCTION",
            "sectionType": {
              "id": "d864a603-4be0-4e17-92e1-3865de936364",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "92bacfdc-6493-41a1-a47d-344572f82397",
              "0cb6c0f3-45d8-4186-b554-c7ba7269e994",
              "b3a07fa0-b752-4a2f-88b7-5c455fcf0da1",
              "e03ffbea-dabf-49dd-8028-a31e0090b6a0",
              "8afb841d-dc54-4680-b493-a5723498c04b",
              "c4b2dda2-07c3-4902-88b2-274b336404d6"
            ]
          },
          {
            "id": "bb8305c1-848b-4ee2-9fc6-e885b4cd169d",
            "name": "STUDY OBJECTIVES",
            "text": "STUDY OBJECTIVES",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "STUDY OBJECTIVES",
            "sectionType": {
              "id": "5a5156a3-b19d-492b-8e4f-fb9f0470c19e",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            },
            "childIds": [
              "890a6564-78d4-4fad-8ae0-23c1aaf23219",
              "2bf8fbe0-eb7a-40a1-9131-fb0f1f4ef286",
              "0e2b1103-2d7c-4e9e-912e-69895e87e615",
              "31f56f51-3624-4627-a65b-2cc9ca45ec31",
              "8fcf7733-cfc1-4bb5-aa92-9c3f97f07318"
            ]
          },
          {
            "id": "8de6e6ef-c79c-45a3-ac21-356c50663b8c",
            "name": "INVESTIGATIONAL PLAN",
            "text": "INVESTIGATIONAL PLAN",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4",
            "sectionTitle": "INVESTIGATIONAL PLAN",
            "sectionType": {
              "id": "3f24aae5-6beb-4ac5-881b-796324afb9ea",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "913f6aa7-b9ee-4589-9ca1-41f9746a6ad0",
              "993ddbe1-896a-4f2b-83e3-f4a2e2ee4811",
              "61d4c3c6-8f8a-4252-958b-206744b3fe10",
              "9c5b8eec-327e-47ca-a591-797b8ba106e0",
              "46fc32d5-5d87-4305-8da3-000b42ef8e99",
              "ab9d6736-adbd-4a50-b805-c6bc94793e82",
              "8e9d437a-7bbc-453e-b5a0-cacecd3d9a99",
              "154d8cf5-fef6-4878-aa81-c8c6347db6cb",
              "dcff0b61-dfb0-4461-b33e-e6619106817a",
              "a39677bc-e7a3-4b69-b165-3e36dce70410"
            ]
          }
        ],
        "narrativeContentItems": [
          {
            "id": "92bacfdc-6493-41a1-a47d-344572f82397",
            "name": "PHARMACOLOGY OF BIVV009",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "PHARMACOLOGY OF BIVV009"
          },
          {
            "id": "0cb6c0f3-45d8-4186-b554-c7ba7269e994",
            "name": "BACKGROUND AND STUDY RATIONALE",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "BACKGROUND AND STUDY RATIONALE"
          },
          {
            "id": "b3a07fa0-b752-4a2f-88b7-5c455fcf0da1",
            "name": "Non-clinical experience",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2.1",
            "sectionTitle": "Non-clinical experience"
          },
          {
            "id": "e03ffbea-dabf-49dd-8028-a31e0090b6a0",
            "name": "Clinical experience",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2.2",
            "sectionTitle": "Clinical experience"
          },
          {
            "id": "8afb841d-dc54-4680-b493-a5723498c04b",
            "name": "Pharmacokinetic experience and dose justification",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2.3",
            "sectionTitle": "Pharmacokinetic experience and dose justification"
          },
          {
            "id": "c4b2dda2-07c3-4902-88b2-274b336404d6",
            "name": "Potential risks and benefits",
            "text": "",
            "order": 5,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2.4",
            "sectionTitle": "Potential risks and benefits"
          },
          {
            "id": "890a6564-78d4-4fad-8ae0-23c1aaf23219",
            "name": "PRIMARY OBJECTIVE (PART A)",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.1",
            "sectionTitle": "PRIMARY OBJECTIVE (PART A)"
          },
          {
            "id": "2bf8fbe0-eb7a-40a1-9131-fb0f1f4ef286",
            "name": "SECONDARY OBJECTIVES (PART A)",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.2",
            "sectionTitle": "SECONDARY OBJECTIVES (PART A)"
          },
          {
            "id": "0e2b1103-2d7c-4e9e-912e-69895e87e615",
            "name": "PRIMARY OBJECTIVE (PART B)",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.3",
            "sectionTitle": "PRIMARY OBJECTIVE (PART B)"
          },
          {
            "id": "31f56f51-3624-4627-a65b-2cc9ca45ec31",
            "name": "SECONDARY OBJECTIVE (PART B)",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.4",
            "sectionTitle": "SECONDARY OBJECTIVE (PART B)"
          },
          {
            "id": "8fcf7733-cfc1-4bb5-aa92-9c3f97f07318",
            "name": "EXPLORATORY OBJECTIVE (PART B)",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.5",
            "sectionTitle": "EXPLORATORY OBJECTIVE (PART B)"
          },
          {
            "id": "913f6aa7-b9ee-4589-9ca1-41f9746a6ad0",
            "name": "STUDY DESIGN",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.1",
            "sectionTitle": "STUDY DESIGN"
          },
          {
            "id": "993ddbe1-896a-4f2b-83e3-f4a2e2ee4811",
            "name": "DISCUSSION OF STUDY DESIGN",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.2",
            "sectionTitle": "DISCUSSION OF STUDY DESIGN"
          },
          {
            "id": "61d4c3c6-8f8a-4252-958b-206744b3fe10",
            "name": "STUDY ENDPOINTS",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3",
            "sectionTitle": "STUDY ENDPOINTS"
          },
          {
            "id": "9c5b8eec-327e-47ca-a591-797b8ba106e0",
            "name": "Primary endpoint (Part A)",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3.1",
            "sectionTitle": "Primary endpoint (Part A)"
          },
          {
            "id": "46fc32d5-5d87-4305-8da3-000b42ef8e99",
            "name": "Secondary efficacy endpoints (Part A)",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3.2",
            "sectionTitle": "Secondary efficacy endpoints (Part A)"
          },
          {
            "id": "ab9d6736-adbd-4a50-b805-c6bc94793e82",
            "name": "Exploratory efficacy endpoints (Part A)",
            "text": "",
            "order": 5,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3.3",
            "sectionTitle": "Exploratory efficacy endpoints (Part A)"
          },
          {
            "id": "8e9d437a-7bbc-453e-b5a0-cacecd3d9a99",
            "name": "Efficacy endpoints (Part B)",
            "text": "",
            "order": 6,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3.4",
            "sectionTitle": "Efficacy endpoints (Part B)"
          },
          {
            "id": "154d8cf5-fef6-4878-aa81-c8c6347db6cb",
            "name": "Safety Endpoints",
            "text": "",
            "order": 7,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3.5",
            "sectionTitle": "Safety Endpoints"
          },
          {
            "id": "dcff0b61-dfb0-4461-b33e-e6619106817a",
            "name": "Pharmacokinetic Endpoints",
            "text": "",
            "order": 8,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3.6",
            "sectionTitle": "Pharmacokinetic Endpoints"
          },
          {
            "id": "a39677bc-e7a3-4b69-b165-3e36dce70410",
            "name": "Pharmacodynamic Endpoints",
            "text": "",
            "order": 9,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3.7",
            "sectionTitle": "Pharmacodynamic Endpoints"
          }
        ],
        "abbreviations": [
          {
            "id": "d63aad6e-e560-4bd3-87a4-f4e5030f077d",
            "abbreviatedText": "ADA",
            "expandedText": "antidrug antibody",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4c4befdd-ec1d-4950-93f5-2d4546956730",
            "abbreviatedText": "ADL",
            "expandedText": "activities of daily living",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a8aaf4c4-44df-4fec-bf6d-e57895006758",
            "abbreviatedText": "AE",
            "expandedText": "adverse event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "158c0bf8-ed8b-40be-8113-e6a196376fcd",
            "abbreviatedText": "AMR",
            "expandedText": "antibody-mediated rejection",
            "instanceType": "Abbreviation"
          },
          {
            "id": "092d910a-3f95-49e9-9627-00e170e00f88",
            "abbreviatedText": "AUC",
            "expandedText": "area under the concentration-time curve",
            "instanceType": "Abbreviation"
          },
          {
            "id": "65864e3d-79cd-4f13-9fe0-f08919d642d4",
            "abbreviatedText": "BLA",
            "expandedText": "Biologics License Application",
            "instanceType": "Abbreviation"
          },
          {
            "id": "efd31c51-9831-4d1e-91f0-5d65a21cccee",
            "abbreviatedText": "BP",
            "expandedText": "bullous pemphigoid",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f47284e8-d001-424d-8a89-1dd5c028de08",
            "abbreviatedText": "CAgD",
            "expandedText": "cold agglutinin disease",
            "instanceType": "Abbreviation"
          },
          {
            "id": "665e2618-a9ee-4adb-aedd-4e2724b38f66",
            "abbreviatedText": "CFR",
            "expandedText": "Code of Federal Regulations",
            "instanceType": "Abbreviation"
          },
          {
            "id": "2ec7a4f5-f19e-42c0-a48a-ab45d0e318c0",
            "abbreviatedText": "CI",
            "expandedText": "confidence interval",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6747b906-54ea-4815-832e-3d57b462f56d",
            "abbreviatedText": "CIC",
            "expandedText": "circulating immune complex",
            "instanceType": "Abbreviation"
          },
          {
            "id": "09b3980f-9e3b-4893-a6cc-a996c288c1f5",
            "abbreviatedText": "Cmax",
            "expandedText": "maximum observed concentration",
            "instanceType": "Abbreviation"
          },
          {
            "id": "afdf564a-947f-4533-8e33-38c17fedb78b",
            "abbreviatedText": "CP",
            "expandedText": "complement classical pathway",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b4c98fd9-b3ab-4bb2-955a-a7f1ae99db3d",
            "abbreviatedText": "CRO",
            "expandedText": "Clinical Research Organization",
            "instanceType": "Abbreviation"
          },
          {
            "id": "c3501e27-e008-47dd-93f5-f2a03f54bab8",
            "abbreviatedText": "CTCAE",
            "expandedText": "common terminology criteria for adverse events",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b8ed9c73-ae58-42f9-9290-57cd99f41865",
            "abbreviatedText": "DAT",
            "expandedText": "direct antiglobulin test",
            "instanceType": "Abbreviation"
          },
          {
            "id": "22cdf531-a9d2-482e-bf75-9a3a45f05589",
            "abbreviatedText": "DNA",
            "expandedText": "deoxyribonucleic acid",
            "instanceType": "Abbreviation"
          },
          {
            "id": "65963ec7-83eb-4b37-9ff0-9bbe7d09b527",
            "abbreviatedText": "dsDNA",
            "expandedText": "double-stranded DNA",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b65b7537-32fb-4fd4-8557-852c25459b77",
            "abbreviatedText": "EC",
            "expandedText": "Ethics Committee",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b5b9f728-7759-4795-9aab-4f6e799496b8",
            "abbreviatedText": "ECG",
            "expandedText": "electrocardiogram",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0a993f45-2795-4ea7-b37d-ab799981200a",
            "abbreviatedText": "eCRF",
            "expandedText": "electronic Case Report Form",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0c2bd21b-2e0f-4483-b393-8f77a4b56b9e",
            "abbreviatedText": "EDC",
            "expandedText": "electronic data capture",
            "instanceType": "Abbreviation"
          },
          {
            "id": "985dc865-a635-4f17-bff0-e4372658793c",
            "abbreviatedText": "EOS",
            "expandedText": "end of study",
            "instanceType": "Abbreviation"
          },
          {
            "id": "eca05cba-c9a3-4f80-97cb-94c340a8965a",
            "abbreviatedText": "EOT",
            "expandedText": "end of treatment",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f4090db0-3060-4df9-8030-ccbb001e9e13",
            "abbreviatedText": "EQ-5D-5L",
            "expandedText": "five level EuroQol - five dimensions questionnaire",
            "instanceType": "Abbreviation"
          },
          {
            "id": "239e61d6-c844-43bc-9c90-a367a35fbb1f",
            "abbreviatedText": "ET",
            "expandedText": "early termination",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e2f0a8e9-b43a-4830-bee5-00f59d18afb9",
            "abbreviatedText": "FACIT",
            "expandedText": "functional assessment of chronic illness therapy",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4b32d8ee-42a4-41d4-a8a3-6e322b4201e8",
            "abbreviatedText": "FAX",
            "expandedText": "facsimile",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f29cf797-9bb5-41d0-9d52-8581799fa175",
            "abbreviatedText": "FDA",
            "expandedText": "Food and Drug Administration",
            "instanceType": "Abbreviation"
          },
          {
            "id": "609714a3-8c24-48cd-aebc-749bfb03b4bb",
            "abbreviatedText": "FIH",
            "expandedText": "first in human",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9c2cdbc0-8a81-4c6d-88e2-a791722044d4",
            "abbreviatedText": "GCP",
            "expandedText": "Good Clinical Practice",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4521c1a5-8507-4c67-b4fa-03124e689cc9",
            "abbreviatedText": "Hgb",
            "expandedText": "hemoglobin",
            "instanceType": "Abbreviation"
          },
          {
            "id": "8646c3b7-5eac-4bbc-8d86-2893101d49f6",
            "abbreviatedText": "HIV",
            "expandedText": "human immunodeficiency virus",
            "instanceType": "Abbreviation"
          },
          {
            "id": "c021dbe5-70a2-4b4c-82e4-0365004fa2a6",
            "abbreviatedText": "IB",
            "expandedText": "investigator’s brochure",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f10e7455-5753-46bc-8e27-c2501ed3a5e4",
            "abbreviatedText": "ICF",
            "expandedText": "informed consent form",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f5680165-d7fd-44e2-bdcd-72aa7dbab067",
            "abbreviatedText": "ICH",
            "expandedText": "International Council for Harmonisation",
            "instanceType": "Abbreviation"
          },
          {
            "id": "bdfd56a1-7801-4706-b619-4f72e9d0070b",
            "abbreviatedText": "IM",
            "expandedText": "intramuscularly",
            "instanceType": "Abbreviation"
          },
          {
            "id": "015d540b-db57-428d-ac41-70c5746c54fe",
            "abbreviatedText": "IRB",
            "expandedText": "Institutional Review Board",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a2e3f36a-0caf-4f80-a29e-53628978113e",
            "abbreviatedText": "ITT",
            "expandedText": "intent-to-treat",
            "instanceType": "Abbreviation"
          },
          {
            "id": "ad0488c0-1cde-40f4-afa4-454b124a8424",
            "abbreviatedText": "IUD",
            "expandedText": "intrauterine device",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a8dfd760-3ea2-4caa-9235-2041c820a36d",
            "abbreviatedText": "IV",
            "expandedText": "intravenous",
            "instanceType": "Abbreviation"
          },
          {
            "id": "85132f06-9161-4ddd-91c9-339e0ff72e82",
            "abbreviatedText": "LDH",
            "expandedText": "lactate dehydrogenase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "97c62f87-1220-47b2-b6d4-d29678415ba6",
            "abbreviatedText": "LPO",
            "expandedText": "last patient out",
            "instanceType": "Abbreviation"
          },
          {
            "id": "d6311bd7-257c-4893-9e1a-0ae44774d805",
            "abbreviatedText": "MAA",
            "expandedText": "Market Authorization Application",
            "instanceType": "Abbreviation"
          },
          {
            "id": "8ad30736-da4f-4e1e-8859-5f0096bbb2b5",
            "abbreviatedText": "FAS",
            "expandedText": "Full Analysis Set",
            "instanceType": "Abbreviation"
          },
          {
            "id": "ee06525b-14fc-436a-8717-de6ad3cbf49c",
            "abbreviatedText": "PK",
            "expandedText": "Pharmacokinetic",
            "instanceType": "Abbreviation"
          },
          {
            "id": "35e3b2ca-37fb-498b-ab7e-860f50708c3b",
            "abbreviatedText": "PD",
            "expandedText": "Pharmacodynamic",
            "instanceType": "Abbreviation"
          },
          {
            "id": "25870097-11ba-41a1-87fa-2256f26f8f93",
            "abbreviatedText": "QOL",
            "expandedText": "quality of life",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "32094d0d-01e8-4120-bf42-c72877531138",
            "number": "06",
            "name": "Amendment 06",
            "scope": {
              "id": "0b1b23b8-6771-426d-b048-5265402d9598",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "f2f6bea2-d0c0-4906-9d6f-a941a8401600",
              "code": {
                "id": "88f8695b-3233-42fb-b93b-fc0606b994d4",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "69f5d273-4c35-4289-9e4c-c326ea3e38ee",
                "type": {
                  "id": "60f09962-c9d9-4037-83b1-355190e5c95a",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary reasons for this amendment to Protocol BIVV009-03 (Cardinal) are to extend Part B duration from 1 to 2 years after Last Patient Out from Part A, to provide home infusion facilities to the patients (for US, the Netherlands, Norway, France, Italy, Austria, Germany, and Spain specific amendments), to add new exploratory objective of immunogenicity, to introduce additional time points when samples for ADAs against BIVV009 are collected, to specify that left over PD samples will be used to assess immunogenicity in patients who consented to future use of samples, to introduce additional time points for SLE panel in Part B, and to introduce a correction in Section 10.1 Appendix A.",
            "effectiveDate": "2019-12-19",
            "reasonIds": [
              "0f130002-a935-42c9-aed6-7ebd419c37cf",
              "40f87f17-546a-4dc3-a3df-fd62c2959959",
              "dde507c5-54c6-4877-83da-559b16ab4c88"
            ],
            "previousVersion": "5",
            "newVersion": "06"
          },
          {
            "id": "f374e7bb-38b3-47ae-8e89-0ce17872c6e3",
            "number": "5",
            "name": "Amendment 5",
            "scope": {
              "id": "af30290b-1d09-48fb-9fdd-dbc72766c2c1",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "65e27699-8f24-43d4-8df0-742aa67e66dd",
              "code": {
                "id": "8cf8311a-480f-42c0-a16a-2aa3bbd1b550",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "d779689a-fca1-492f-af69-e857761ebe45",
                "type": {
                  "id": "06c7c2d7-a6d7-4c5e-b349-99446dd26e14",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The following corrections or changes were made to the protocol for clarity, consistency, and accuracy: The page headers were updated with Version 5 of the protocol. The abbreviation list was updated. The tables of contents were updated. The Investigator’s and Sponsor’s agreement pages were updated with Version 5 and the date of approval. Minor grammatical and formatting changes were made throughout the protocol. Clarification as to how data corrections would be shown. Changed PK and PD postdose sample collection time from 2 hours to 1 hour postdose.",
            "effectiveDate": "2018-07-17",
            "reasonIds": [
              "bb1c2680-f93a-4d78-abe9-148990deca9e",
              "50315977-473c-42ad-b667-5f817141ab0a"
            ],
            "previousVersion": "4",
            "newVersion": "5"
          }
        ],
        "medicalDevices": [
          {
            "id": "da20afaf-2d26-419f-b746-93f9e0596248",
            "name": "Intravenous Access Device",
            "instanceType": "MedicalDevice",
            "label": "IV Access",
            "description": "Cannula or catheter for intravenous drug administration",
            "deviceType": {
              "id": "23361945-1025-48c9-9276-45473f12a2c5",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            },
            "manufacturer": "Not Specified",
            "modelNumber": "Not Specified"
          },
          {
            "id": "d7e310f1-6838-4e31-bd7b-4f0043417976",
            "name": "Electrocardiograph",
            "instanceType": "MedicalDevice",
            "label": "ECG Machine",
            "description": "Device used to record the electrical activity of the heart",
            "deviceType": {
              "id": "c27e203d-123b-42d3-9b9e-f2f3293410c9",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            },
            "manufacturer": "Not Specified",
            "modelNumber": "Not Specified"
          }
        ],
        "conditions": [
          {
            "id": "a7cf2f4f-197f-4579-a2a4-e5af7f462074",
            "name": "Part A Responder Criteria",
            "instanceType": "Condition",
            "description": "Criteria for determining treatment success in Part A",
            "text": "No blood transfusion from Week 5 through Week 26 AND (Hgb level >= 12 g/dL OR Hgb increase >= 2 g/dL from baseline) at treatment assessment endpoint."
          },
          {
            "id": "e9ef22e6-0efa-46cd-bdb0-502016625021",
            "name": "Dose Level Weight Threshold",
            "instanceType": "Condition",
            "description": "Weight-based dosing logic",
            "text": "Weight < 75 kg receive 6.5 g; Weight >= 75 kg receive 7.5 g."
          },
          {
            "id": "03a5d127-930e-44d7-a752-8fd141a5e29e",
            "name": "Home Infusion Eligibility",
            "instanceType": "Condition",
            "description": "Criteria to move to home-based dosing",
            "text": "Determined to have tolerated BIVV009 well and qualified by Investigator per Appendix J."
          }
        ],
        "studySites": [
          {
            "id": "b2378441-f225-463e-ac30-23ad2c425d27",
            "name": "Arizona Oncology Associates PC",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "f7a3f88f-dbd0-47cd-ad66-b10a64dd1828",
            "country": "United States"
          },
          {
            "id": "07f2a25c-390c-41b8-973d-9053d2ba2d2a",
            "name": "USC/Keck School of Medicine",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "bdb90f0d-4c74-421b-aa00-5c8b82ef939a",
            "country": "United States"
          },
          {
            "id": "e45ccae3-1ae4-453f-afd9-66847bc937ee",
            "name": "The Oncology Institute of Hope and Innovation",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "e9db9746-0c70-426e-aa52-36753cf56a45",
            "country": "United States"
          },
          {
            "id": "c14808e3-2666-435f-bbee-f6a82366c0da",
            "name": "Georgetown University Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "ecd5fdff-d43c-4e00-88bd-d80a92225451",
            "country": "United States"
          },
          {
            "id": "7d41a9d0-591c-42d0-a753-103fcfb7b765",
            "name": "Massachusetts General Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "c8625824-1e87-4b39-a7da-757051bb571e",
            "country": "United States"
          },
          {
            "id": "a862b040-80ca-4460-8044-67892472ee82",
            "name": "Brigham and Women's Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "df9faa52-a435-467e-9ddd-8cf1bb2c6e59",
            "country": "United States"
          },
          {
            "id": "b5825cae-5548-4550-aa6b-ee55e3f939ee",
            "name": "Montefiore Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "2eb08142-e461-4369-b6bc-c1d4581cd28e",
            "country": "United States"
          },
          {
            "id": "e3c25b70-b407-4eec-8546-c3f9c95a4bc3",
            "name": "New York Medical College at Westchester Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "052a844a-a4d7-4b04-a586-81e7cffd7e93",
            "country": "United States"
          },
          {
            "id": "04439e42-4a40-4188-854d-ec2dc04621f2",
            "name": "East Carolina University",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "5f6a0755-4bd7-48fe-a3f6-108555638e23",
            "country": "United States"
          },
          {
            "id": "03254763-24c2-4932-9313-faf9aa7669df",
            "name": "Cleveland Clinic",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "edda4b82-6943-45f9-95ae-f1e606c470a2",
            "country": "United States"
          },
          {
            "id": "10aa7689-eed2-4fe6-b178-df53456d80fc",
            "name": "Hospital of the University of Pennsylvania",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "01950252-c573-42e6-879f-bb9c946c8752",
            "country": "United States"
          },
          {
            "id": "c8769e19-47e5-4b1c-a7a6-14ff46b3cef9",
            "name": "University of Pittsburgh Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "fffbca48-be67-4000-aff6-89cff363f0c9",
            "country": "United States"
          },
          {
            "id": "a56ae1b9-4ec6-4d5e-9d09-4d8f0c74386d",
            "name": "UW Hospitals and Clinics",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "21502832-9443-4bde-9777-30b87695ab03",
            "country": "United States"
          },
          {
            "id": "486aacc4-171e-4681-b8cd-7ef4b02e94ad",
            "name": "USC Health Clinics",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "0c1404c9-ee8e-418d-a232-84fa6b9c3e9d",
            "country": "Australia"
          },
          {
            "id": "fd7669a1-1341-42c0-ab38-e1ca16e0c7b9",
            "name": "Ballarat Oncology & Haematology",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "1dbeea21-b04c-4ec1-b1a9-4096fec3b9d3",
            "country": "Australia"
          },
          {
            "id": "2594fa47-9017-4bf1-9476-0e7755cbf479",
            "name": "Monash Medical Centre",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "563a7dca-cd66-43db-a9ee-b682759a3d2c",
            "country": "Australia"
          },
          {
            "id": "b9322cab-ee01-4169-b8aa-170a69f050e6",
            "name": "Medical University of Vienna",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "8824af2d-0454-4354-bdd8-417559ae3f18",
            "country": "Austria"
          },
          {
            "id": "b687e1e2-f05f-40cd-bc7b-6958cde99487",
            "name": "ZNA Stuivenberg",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "2ed44dc5-e082-4961-95c3-f7aa89627bce",
            "country": "Belgium"
          },
          {
            "id": "0978c5b2-8e86-4288-a2f1-348cca816c39",
            "name": "Centre Hospitalier Jolimont",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "b52a2b0b-1251-4bbd-bbc1-c06f52d0086f",
            "country": "Belgium"
          },
          {
            "id": "d390acb9-55ac-4fa9-9fe3-e4d7137687df",
            "name": "University Hospitals Leuven",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "675e3f5c-07fe-4249-b53f-a2b259801f54",
            "country": "Belgium"
          },
          {
            "id": "084279ef-b39e-49a2-be21-f75cecabd3f4",
            "name": "St. Michael's Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "39155eba-db00-420a-bf28-79e13703f4fe",
            "country": "Canada"
          },
          {
            "id": "0dd91ae1-e452-43e6-837d-b8ff87b86311",
            "name": "McGill University Health Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "85457044-379d-43e9-8d50-6e047d15e545",
            "country": "Canada"
          },
          {
            "id": "483717cf-8ec6-4320-b637-dd0f2a08bb1b",
            "name": "University of Alberta",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "af3ad37b-0d6d-4ce9-9f0e-5c5ad3f15c5e",
            "country": "Canada"
          },
          {
            "id": "0dd5eba9-7186-414a-909c-0daadd5597ad",
            "name": "CHU de Caen",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "484133dd-8f3b-42c1-b129-0740261e9129",
            "country": "France"
          },
          {
            "id": "9d982e23-63a4-4c53-b7f7-f1d925dd9115",
            "name": "Centre Hospitalier Henri Mondor",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "bbbf6e44-d3b7-4f94-83c2-cad931c03675",
            "country": "France"
          },
          {
            "id": "8e37103f-0d62-4acb-9b33-e027b573ca31",
            "name": "Centre Hospitalier Lyon Sud",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "f714c9ef-6ccb-452f-ab44-ca1538446180",
            "country": "France"
          },
          {
            "id": "aea71b2f-32d9-4086-a395-d08c86160011",
            "name": "Gemeinschaftspraxis Hämatologie-Onkologie",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "d5d30376-708f-4b83-a03d-f4b4c78fb034",
            "country": "Germany"
          },
          {
            "id": "538862c7-3c1b-4944-9cbf-3c1730928700",
            "name": "Universitätsklinikum Essen",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "a2c6beae-b4be-49a8-bc6b-d8af0466a267",
            "country": "Germany"
          },
          {
            "id": "324e2e8f-07a6-4d0c-b84b-25084558b587",
            "name": "Univ Ulm, Inst Klin. Transfusions. Immungen",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "9d01ec73-61c8-4b0b-bff9-d6e85ec4324a",
            "country": "Germany"
          },
          {
            "id": "9bd0a08b-54ee-46f3-b271-cea0ade8d047",
            "name": "Hadassah Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "f7fab9da-90a4-4181-ba0f-baf033a53daa",
            "country": "Israel"
          },
          {
            "id": "e01d166c-4262-44e5-a8a6-3dcfd834310b",
            "name": "Laniado Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "54847a3c-6bab-43e1-9990-3a5593ae29a9",
            "country": "Israel"
          },
          {
            "id": "eb55cedf-f007-4efe-9cf6-ff48e34ff217",
            "name": "Tel Aviv Sourasky Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "93cfc4c7-8888-4190-8420-cd679ceeda91",
            "country": "Israel"
          },
          {
            "id": "20bf2d19-771b-423e-830e-09e733bbe9e2",
            "name": "A. O. Spedali Civili di Brescia",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "e08865b7-6a88-4132-819b-f6f0fc831771",
            "country": "Italy"
          },
          {
            "id": "1f9c1694-6ffd-4fa0-9298-ae806505656f",
            "name": "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "46878268-71fe-4103-a581-1a35333f06b6",
            "country": "Italy"
          },
          {
            "id": "1f747655-d859-4ea8-8c0a-6b9601e72f4d",
            "name": "U.O.C. Ematologia- Policlinico \"A. Gemelli\"",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "600ae1ef-d193-4102-8f4f-74ebbe31c413",
            "country": "Italy"
          },
          {
            "id": "4a37ea5e-9a4f-44d8-be0f-2696b8e5e9d1",
            "name": "U.O.C. Ematologia Ospedale San Bortolo",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "e52ca3a1-0a89-4248-ae5b-c536794b6fda",
            "country": "Italy"
          },
          {
            "id": "225c68b9-80f8-4517-a802-492c72a39602",
            "name": "Tokai University Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "b9d7563d-e1a1-4e97-befe-87098a6a4aec",
            "country": "Japan"
          },
          {
            "id": "93baa7d3-dab2-4bb7-b794-880187e55055",
            "name": "Saitama Medical University Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "6abcc9b0-46f0-4a96-b143-ebcf8945f7f7",
            "country": "Japan"
          },
          {
            "id": "6940c27e-2434-4028-abfb-fc0a6c60fb94",
            "name": "Juntendo University Nerima Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "b9416a7c-c13c-4011-a870-0d215827a3b3",
            "country": "Japan"
          },
          {
            "id": "962b3034-bf86-4c1e-9a07-e941a8fbbc94",
            "name": "Academisch Medisch Centrum",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "18ccda38-ecf5-40a2-874a-6521bb832d7d",
            "country": "Netherlands"
          },
          {
            "id": "e77e9c9f-cfbd-4ad5-b71d-313401b6eefe",
            "name": "Haukeland University Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "41",
            "organizationId": "6712c639-fd41-448f-a7c4-ac2767761fff",
            "country": "Norway"
          },
          {
            "id": "fc12eb26-4e51-4514-b6f9-2a3944e4bd0f",
            "name": "Oslo University Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "42",
            "organizationId": "538a187c-4c4c-40d4-8591-b65286a1b2ce",
            "country": "Norway"
          },
          {
            "id": "239b2b00-5070-4493-9c5e-4cf301c8a475",
            "name": "St Olavs Hospital, Avdeling for blodsykdommer",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "43",
            "organizationId": "ff5d7330-b757-4525-b6e5-7485aa5ec11a",
            "country": "Norway"
          },
          {
            "id": "1367fb71-ebfe-4f32-9212-625748128412",
            "name": "Hospital Universitario Puerta de Hierro",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "44",
            "organizationId": "973f7fdc-8a2b-4837-8853-2f0efd5935fd",
            "country": "Spain"
          },
          {
            "id": "74b91546-5736-497d-a05f-3efc1e8faf21",
            "name": "Hospital Clinci i Provincial de Barcelona",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "45",
            "organizationId": "d9276cc6-1c59-4296-9303-5b5fbfe29f63",
            "country": "Spain"
          },
          {
            "id": "c700f20a-8777-4da8-96de-58d88f18272d",
            "name": "Hospital Universitario Virgen del Rocio",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "46",
            "organizationId": "33e2a65c-70d1-4a37-8cf7-46d21ff434e0",
            "country": "Spain"
          },
          {
            "id": "671118af-799f-4e93-9ba4-45326c44599c",
            "name": "Hospital Universitario Dr. Peset",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "47",
            "organizationId": "b10e894d-0ae2-4c63-a3d7-b70b5b054259",
            "country": "Spain"
          },
          {
            "id": "2a85becf-bf24-4c9d-bdd4-b642b1badec8",
            "name": "St James Hospital, Leeds",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "48",
            "organizationId": "26531941-2074-42ce-b975-607fc83e0bd7",
            "country": "United Kingdom"
          },
          {
            "id": "204dda93-4fb0-4b1a-b412-8b705d440254",
            "name": "University College London",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "49",
            "organizationId": "7712fa8f-b278-4024-803c-7acca6a328ea",
            "country": "United Kingdom"
          }
        ],
        "administrations": [
          {
            "id": "1f8fd734-3f8a-4a51-8d80-361ffba10466",
            "name": "Administration of Trial Protocol",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "623c99c4-e7d4-4dca-b340-7b4c2248f1e5",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "4646869d-bdb3-4ea7-b72a-348bc8662a95",
            "name": "Administration of Protocol Version",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "47b1e205-cacd-455d-ae97-c62a29ee606b",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "a23b85d8-37f2-4ca9-a5e3-d4dfdccc862d",
            "name": "Administration of BIVV009 is",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.WEEKLY",
            "instanceType": "Administration",
            "route": {
              "id": "f6ff61eb-ede1-47f9-9823-53b7df4db5b1",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          },
          {
            "id": "3107742a-ca67-409f-be6c-2fdb9d4df9b0",
            "name": "Administration of BIVV009",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.EVERY_TWO_WEEKS",
            "instanceType": "Administration",
            "route": {
              "id": "60960356-1041-4b42-961d-8d70c4861d32",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A PHASE 3, PIVOTAL, OPEN-LABEL, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WHO HAVE A RECENT HISTORY OF BLOOD TRANSFUSION"
  },
  "administrations": [
    {
      "id": "dff1c24b-170b-4758-bdda-22c349a2d08f",
      "name": "BIVV009 Part A Regimen",
      "instanceType": "Administration",
      "dose": "6.5 g (if <75 kg) or 7.5 g (if ≥75 kg)",
      "doseFrequency": "Day 0, Day 7, and every 14 days thereafter",
      "route": {
        "id": "9bfcd4ed-9776-4f2e-9454-866ddaac6236",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "25 weeks"
    },
    {
      "id": "7558c292-25da-4b61-9978-2d0b474d80c3",
      "name": "BIVV009 Part B Regimen",
      "instanceType": "Administration",
      "dose": "6.5 g (if <75 kg) or 7.5 g (if ≥75 kg)",
      "doseFrequency": "Every 2 weeks",
      "route": {
        "id": "79c217df-28cf-4abe-9d81-a2cb3fa2381c",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "2 to 3 years"
    },
    {
      "id": "3b495ccc-2512-436a-9673-3a21e2ea58e4",
      "name": "BIVV009 Loading Dose (Missed Dose)",
      "instanceType": "Administration",
      "dose": "6.5 g or 7.5 g",
      "doseFrequency": "Once (1 week prior to next scheduled dose)",
      "route": {
        "id": "81065d02-fdb4-49c7-9288-6ae375c97411",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "Single dose"
    }
  ],
  "substances": [
    {
      "id": "e93b9c1e-40e4-4134-b6e9-757152afcf32",
      "name": "BIVV009",
      "instanceType": "Substance",
      "description": "Humanized monoclonal antibody targeting human complement factor C1s"
    }
  ],
  "studyDefinitionDocument": {
    "id": "df964715-b952-4c2a-8271-1cf60449de1a",
    "name": "Cardinal Study: A Phase 3, pivotal, open-label, multicenter study to assess the efficacy and safety of BIVV009 in patients with primary cold agglutinin disease who have a recent history of blood transfusion",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "Amended Clinical Trial Protocol 06",
    "versionDate": "19-Dec-2019",
    "contentIds": [
      "65ea6e41-3253-443f-a522-e20c4e3eaaf2",
      "7db888ae-4da7-44a8-a35f-0fcc67d6e40b",
      "bb8305c1-848b-4ee2-9fc6-e885b4cd169d",
      "8de6e6ef-c79c-45a3-ac21-356c50663b8c"
    ]
  },
  "geographicScope": {
    "id": "79162ca9-5e4d-475a-8473-bab68d67e4e7",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "f46ea003-3879-4060-be1b-0eb842cde40b",
      "3157879b-5f8b-4270-aa84-324895179a25",
      "b0a1effa-cc26-4982-8a1f-658c878239ce",
      "7f146860-3bd4-48b8-9df4-698074ea268b",
      "587bb353-ed68-436f-9184-eaf0a46db916",
      "ded48891-4892-41a9-9bea-d1ccf18bff5c",
      "f91b4f2a-9940-4843-9a5a-750bbeb8e358",
      "a25a6040-3139-4769-bcf2-51af62ecf7ae",
      "ea9af621-db2f-418d-acc1-5ee52aac050d",
      "e2c3d539-1ed7-42c0-a983-74589ba880a5",
      "9a0f099c-8929-4b32-9624-5404a4e33812"
    ],
    "regions": [
      "North America",
      "Europe",
      "Asia"
    ]
  },
  "countries": [
    {
      "id": "f46ea003-3879-4060-be1b-0eb842cde40b",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    },
    {
      "id": "3157879b-5f8b-4270-aa84-324895179a25",
      "name": "Netherlands",
      "instanceType": "Country",
      "code": "NL"
    },
    {
      "id": "b0a1effa-cc26-4982-8a1f-658c878239ce",
      "name": "Norway",
      "instanceType": "Country",
      "code": "NO"
    },
    {
      "id": "7f146860-3bd4-48b8-9df4-698074ea268b",
      "name": "France",
      "instanceType": "Country",
      "code": "FR"
    },
    {
      "id": "587bb353-ed68-436f-9184-eaf0a46db916",
      "name": "Italy",
      "instanceType": "Country",
      "code": "IT"
    },
    {
      "id": "ded48891-4892-41a9-9bea-d1ccf18bff5c",
      "name": "Austria",
      "instanceType": "Country",
      "code": "AT"
    },
    {
      "id": "f91b4f2a-9940-4843-9a5a-750bbeb8e358",
      "name": "Germany",
      "instanceType": "Country",
      "code": "DE"
    },
    {
      "id": "a25a6040-3139-4769-bcf2-51af62ecf7ae",
      "name": "Spain",
      "instanceType": "Country",
      "code": "ES"
    },
    {
      "id": "ea9af621-db2f-418d-acc1-5ee52aac050d",
      "name": "Japan",
      "instanceType": "Country",
      "code": "JP"
    },
    {
      "id": "e2c3d539-1ed7-42c0-a983-74589ba880a5",
      "name": "Belgium",
      "instanceType": "Country",
      "code": "BE"
    },
    {
      "id": "9a0f099c-8929-4b32-9624-5404a4e33812",
      "name": "United Kingdom",
      "instanceType": "Country",
      "code": "GB"
    }
  ],
  "ingredients": [
    {
      "id": "b3d05e00-a3d8-4056-b7cd-bc1ceddf5566",
      "name": "BIVV009",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "Sutimlimab"
    },
    {
      "id": "167648c0-f7a1-44b4-b207-093d66624623",
      "name": "Rituximab",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "Rituximab"
    },
    {
      "id": "50dab695-1cb7-4147-898c-ea98f6244112",
      "name": "Prednisone",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "Prednisone"
    }
  ],
  "strengths": [
    {
      "id": "95ff0e29-f70e-4721-9d19-698a1e2e33a0",
      "instanceType": "Strength",
      "value": 6.5,
      "unit": "g",
      "numerator": {
        "value": 6.5,
        "unit": "g"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "a38b211c-bb1b-42c0-ba50-3c5198060edb",
      "instanceType": "Strength",
      "value": 7.5,
      "unit": "g",
      "numerator": {
        "value": 7.5,
        "unit": "g"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "8436eb70-880b-424a-b7a8-10bc396d479a",
      "instanceType": "Strength",
      "value": 10,
      "unit": "mg/day",
      "numerator": {
        "value": 10,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "day"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "bfb268f6-b8e6-4a62-ba63-46ded6bb422e",
      "name": "Part A to Part B Transition",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "3e6c7426-030b-4a7c-8e32-92a1914a429c",
      "toElementId": "3757589e-60e9-4637-bd49-05643f93da5f",
      "text": "Patients who complete Part A per protocol through the EOT visit will participate in Part B."
    },
    {
      "id": "22fcd338-2d19-40c3-9d8f-44e68fc27515",
      "name": "Dose Modification - Loading Dose",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Should patients deviate from their scheduled dosing, a repeat loading dose may be required."
    },
    {
      "id": "388e5189-1989-4b26-bb5a-2683a9416e8a",
      "name": "Safety Discontinuation - SLE",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Clinical signs of SLE or any other immune complex disease."
    },
    {
      "id": "3fa7d918-aec8-4428-9b27-4a4f7a731edb",
      "name": "Home Infusion Interruption",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Return to bi-weekly site dosing if AE occurs that jeopardizes safety during home infusion."
    }
  ],
  "documentContentReferences": [
    {
      "id": "095ff769-82bb-48fe-bf90-10e18621ebc1",
      "name": "Home Infusion Appendix Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.10",
      "sectionTitle": "Appendix J",
      "description": "Reference for country-specific home infusion requirements and inclusion/exclusion criteria"
    },
    {
      "id": "33fbcfeb-906f-441e-9c19-839190c117fa",
      "name": "Clinical Laboratory Evaluations Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.1",
      "sectionTitle": "Appendix A",
      "description": "Reference for the complete list of laboratory analytes"
    },
    {
      "id": "1ace668b-9fde-469e-abae-57bdcea98c91",
      "name": "Concomitant Medication Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.2.6",
      "sectionTitle": "Concomitant Medications",
      "description": "Reference for excluded and allowed concomitant medications"
    },
    {
      "id": "f05806ca-97ac-4d38-88c7-e8c7ae57c37d",
      "name": "Vaccination Schedule Japan",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.9",
      "sectionTitle": "Appendix I",
      "description": "Reference for the specific vaccination schedule for patients in Japan"
    },
    {
      "id": "5ad3873b-88ed-4d82-9fdc-8784e109db4d",
      "name": "Study Schedule of Events",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.1",
      "sectionTitle": "Table 3",
      "description": "Reference to the primary schedule of events table"
    },
    {
      "id": "4883a4a2-7c85-42c6-b2a2-29c91d6f96d2",
      "name": "Quality of Life Appendices",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.3-10.8",
      "sectionTitle": "Appendices C through H",
      "description": "References to various QOL assessment scales (FACIT-Fatigue, EQ-5D-5L, SF-12, PGIC, PGIS, Healthcare Resource Utilization)"
    }
  ],
  "commentAnnotations": [
    {
      "id": "846c2360-7c98-4af0-928a-551f76a1ea51",
      "text": "The name and numbering of the protocol is based on a new numbering system followed by the Sponsor.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Document History",
      "pageNumber": 2
    },
    {
      "id": "ad85d666-c661-424e-9e85-7b98816e4292",
      "text": "Any patient withdrawing from the study after Week 5 and prior to the Week 23 visit will be considered a non-responder.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Responder definition",
      "pageNumber": 31
    },
    {
      "id": "9f02e7b7-a6ac-4e83-8196-4d3fd3f03302",
      "text": "BIVV009 doses of 6.5 grams (if <75 kg) or 7.5 grams (if ≥75 kg) based on patient’s baseline body weight will be administered via IV infusion",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Table 3 - Study schedule of events (Footnote i)",
      "pageNumber": 45
    },
    {
      "id": "2ebe4cca-ff0b-4621-9243-2416770d787c",
      "text": "In patients who consented to the use of their blood samples for future research, PD back-up samples collected at the following time points Day 7, 35, 77, 133 and 175, may be used to assay ADA.",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Weeks 1-25",
      "pageNumber": 50
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "141b9341-50f9-4b3c-a867-f87d9a4dab28",
      "versionNumber": "06",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2019-12-19",
      "description": "Amended Clinical Trial Protocol 06 - Global",
      "amendmentNumber": "Amendment 6"
    },
    {
      "id": "a07d69fe-7369-4cdd-834b-95d4b60f5b59",
      "versionNumber": "5.0",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2018-07-17",
      "description": "Clinical Study Protocol Version 5 - Global",
      "amendmentNumber": "Amendment 5"
    },
    {
      "id": "0d416485-952f-494d-a50c-aa112b9d5aa7",
      "versionNumber": "4.0",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2018-06-29",
      "description": "Clinical Study Protocol Version 4 - Global",
      "amendmentNumber": "Amendment 4"
    },
    {
      "id": "e395d43f-8bc0-4329-b1bb-1ec5a06722ce",
      "versionNumber": "1.0",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2017-08-24",
      "description": "Clinical Study Protocol - Global",
      "amendmentNumber": "Original"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "89b527c4-f94d-4109-a653-196557acfc1d",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "affectedSection": "Section 1: Synopsis; Section 4.4: Duration of the Study",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Extension of Part B open-label duration from 1 year to 2 years following Last Patient Out from Part A."
    },
    {
      "id": "66b68df4-a26c-449b-ad5d-65b7eadc9996",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "affectedSection": "Section 1: Synopsis; Section 6.1.6; Section 10.10: Appendix J",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Introduction of home infusion facilities for patients in preselected countries."
    },
    {
      "id": "b8ffdba5-6f11-49d5-b7fc-4d8aebbced1f",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "affectedSection": "Section 3.2; Section 3.5; Section 4.3.8; Section 7.7",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Addition of immunogenicity (ADA) as a new exploratory objective and endpoint."
    },
    {
      "id": "4183b140-0f05-401c-9296-b66872e512c6",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "affectedSection": "Section 10.1: Appendix A",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Correction of clinical laboratory evaluations by removing specific parameters."
    },
    {
      "id": "c6846478-2b08-40c9-a573-82fe81f8459d",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "affectedSection": "Throughout Document",
      "impactLevel": "Administrative",
      "instanceType": "StudyAmendmentImpact",
      "description": "Replacement of statistical terminology (ITT to FAS) and alignment with Sanofi documentation standards."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "d563c012-dafc-48df-a566-d26d72fed1e0",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "reasonText": "Gather more evidence on long-term safety, tolerability and durability of response of BIVV009.",
      "category": "Scientific",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "d2e15e06-aa99-44c2-83cd-8581223db49c",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "reasonText": "Evaluate the safety and patient satisfaction with the convenience of home infusion.",
      "category": "Operational",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "e6f14461-1159-454c-8749-51aefb6448a6",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "reasonText": "Help characterize immunogenicity of BIVV009.",
      "category": "Scientific",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "616c2208-5ad3-4c80-8fbf-b5a7812401ac",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "reasonText": "Comply with Sanofi standards and provide clarification of clinical laboratory evaluations.",
      "category": "Administrative",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "7537701f-6f04-4b60-996c-5fa7269b1a10",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "1.0",
      "beforeText": "1 year following last patient out (LPO) under Part A",
      "afterText": "2 years following last patient out (LPO) under Part A",
      "summary": "Extended Part B duration."
    },
    {
      "id": "51dcbcd9-cc2f-4113-b09a-4fda8b47bf43",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "1.0",
      "beforeText": "Intent to treat (ITT)",
      "afterText": "Full Analysis Set (FAS)",
      "summary": "Updated statistical analysis set terminology."
    },
    {
      "id": "d1506193-02e8-4f16-a478-7c2c5265c30d",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "3.5",
      "afterText": "Exploratory Objectives were added for Part B to describe the safety and patient satisfaction with the convenience of home infusion and to evaluate the immunogenicity of BIVV009.",
      "summary": "Added new exploratory objectives for the extension phase."
    },
    {
      "id": "7bf40255-26fe-4ae5-b76a-74075e57a52f",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "changeType": "Deletion",
      "instanceType": "StudyChange",
      "sectionNumber": "10.1",
      "beforeText": "Iron",
      "summary": "Removed Iron from the clinical chemistry panel in Appendix A."
    },
    {
      "id": "23c4b46f-65d5-4f0d-83e6-10683a8dd103",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "6.1.1.1",
      "afterText": "Revaccination with booster doses should be given according to regional guidelines for patients with persistent complement deficiency.",
      "summary": "Clarified vaccination requirements for encapsulated bacterial pathogens."
    },
    {
      "id": "56b87092-0f65-46ae-a3e2-6139bc9b9c55",
      "amendmentId": "789ede0c-2f93-4ce3-8bba-421037f48b74",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "6.1.5.2",
      "afterText": "Hematology panel (beginning at Week 79) and Clinical chemistry panel (beginning at Week 79)",
      "summary": "Added assessment frequency for the second year of Part B."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "complete"
  }
}